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ABSTRACT

THE ROLE OF CALCINEURIN IN DENDRITIC REMODELING AND
EPILEPTOGENESIS IN A RAT MODEL OF TRAUMATIC BRAIN INJURY
By John N. Campbell
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2012
Director: Severn B. Churn, Ph.D.
Associate Professor, Departments of Neurology,
Anatomy & Neurobiology, Pharmacology & Toxicology,
and Physiology & Biophysics

Traumatic brain injury (TBI), a leading cause of death and disability in the United
States, causes potentially preventable damage in part through the dysregulation of
neural calcium levels. This dysregulation likely affects the activity of the calciumsensitive phosphatase, calcineurin, with serious implications for neural function. To test
this possibility, the present study characterized the role of calcineurin in a rat model of
brain trauma, the lateral fluid percussion injury model. Golgi-Cox histochemistry
revealed an acute post-TBI loss and delayed overgrowth of dendritic spines on principal
cortical cells. The spine loss appeared to require calcineurin activity, since
administering a calcineurin inhibitor, FK506, 1 hour after TBI prevented the spine loss.

ix

Additional experiments showed how calcineurin activity might be related to the spine
loss. Specifically, Western blots and enzyme activity assays revealed an acute
increase in the cortical activity of calcineurin and its downstream effector, the actindepolymerizing protein, cofilin. The cofilin activation was blocked by the same FK506
treatment that prevented spine loss, suggesting a relationship between cofilin
activation and spine loss. To investigate long-term consequences of calcineurin
activation after TBI, rats were administered FK506 (Tacrolimus) 1 hour after TBI and
then monitored for spontaneous seizure activity months later. Acute post-TBI treatment
with FK506 reduced the frequency of late non-convulsive seizures but did not prevent
late convulsive seizures, cortical atrophy, or thalamic damage. The results of the
present study implicate calcineurin in the acute dendritic remodeling and late nonconvulsive seizures that occur after TBI. Importantly, these findings reveal calcineurin
as a potential therapeutic target in the treatment of TBI and its sequalae.

x

INTRODUCTION

The Exciting but Risky Lives of Dendritic Spines
Experience leaves a trace in the adult brain through the formation and
elimination, strengthening and weakening of individual synapses [1,2]. In vertebrates
this plasticity depends largely on tiny protuberances of neuronal membrane, known as
dendritic spines [3]. Dendritic spines abound in forebrain regions where memories are
formed and stored [4], regions in which nearly all excitatory synapses are formed on
dendritic spines [5] and in which nearly all spines bear at least one excitatory synapse
[6]. The importance of these spines to synaptic plasticity is further evidenced by their
composition: each spine is equipped with a diverse complement of signaling proteins
which work together to not only transduce synaptic communication, but to regulate
synaptic efficacy in an activity-dependent and synapse-specific manner [7,8,9]. Such
plasticity may, however, be risky business for the dendritic spine. Excitatory signaling
can occur to toxic excess in many forms of brain injury and disease [10]. This
excitotoxicity can trigger the rapid retraction of spines into the parent dendrite [11],
potentially coinciding with a breakdown of the post-synaptic machinery [12,13] and
separating the pre- and post-synaptic membranes. The collapse of a spine could
therefore mean the loss of its synapse. However, this may be neuroprotective under
certain circumstances. For example, by weakening or disconnecting an overactive

1

synapse, the collapse of a dendritic spine may help to prevent further excitotoxic
damage to the parent neuron. Spine collapse could therefore act like a circuit-breaker.
On the other hand, the collapse of a dendritic spine may entail risks for neuronal
networks, especially if spine collapse disconnects synaptic partners or impairs synaptic
communication. The resulting decrease in network activity may be temporary if the
synaptic partners are able to re-connect. Still, a decrease in network activity lasting a
day or longer can trigger homeostatic increases in the sensitivity of remaining excitatory
synapses [14], or provoke the formation of new excitatory synapses [15]. Dendritic
spines are a therefore a likely substrate for injury-induced and potentially pathological
changes in brain circuitry. A better understanding of the mechanisms of dendritic spine
collapse may reveal therapeutic targets for the treatment of brain injury and its
sequelae.
This introduction considers potential mechanisms of dendritic spine collapse.
The terms “spine loss” and “spine collapse” are used interchangeably herein to describe
the retraction of a spine into the parent dendrite. Many mechanisms of spine loss have
been demonstrated experimentally, including some which are pre-synaptic (e.g., [16]),
and others which are extra-synaptic, such as the removal of synapses by microglia
[17,18,19,20]. Other studies have identified mechanisms which appear to be contained
within the post-synaptic neuron. These post-synaptic mechanisms of spine loss are the
focus of this introduction.
Since much of spine plasticity depends on intracellular Ca2+ ions, the first part of
this introduction considers Ca2+ signaling within the dendritic spine and how this
signaling affects spine structure and function.
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Calcium in Dendritic Spine Plasticity
Intracellular Ca2+ signaling is integral to many cellular functions, including
synaptic plasticity. Normally, excitatory signaling at the spine synapse causes an
accumulation of Ca2+ ions within the dendritic spine. These ions relay the excitatory
signal from the synaptic surface to Ca2+-sensitive proteins within the dendritic spine.
The Ca2+-sensitive proteins then act on divergent biochemical pathways which
ultimately determine post-synaptic structure and function. Some pathways alter the
number or sensitivity of receptors at the spine synapse, thereby adjusting its response
to subsequent signals [21,22]. Other pathways expand, lengthen, or shrink the spine by
remodeling its cytoskeleton [23,24], morphological changes which can influence the
spread of electrical and molecular signals [25,26,27]. Because antagonistic pathways
compete for Ca2+ binding, the outcome of this competition depends on their relative
Ca2+ sensitivity as well as on the magnitude and duration of the Ca2+ signal [28]. Likely
for this reason, Ca2+ dynamics are tightly controlled in the dendritic spine. Indeed, Ca2+
dynamics are subject to a host of locally-regulated processes, including Ca2+ influx
through gated channels and efflux through ion pumps, Ca2+ sequestration in organelles
and binding of proteins, even the geometry of the dendritic spine [29,30,31]. However,
many of these regulatory processes can be disrupted or over-activated by brain injury
[32,33,34,35]. The resulting dysregulation of Ca2+-sensitive pathways may have
substantial consequences for the structure and function of the dendritic spine.
A major trigger for Ca2+ accumulation in the dendritic spine is glutamate.
Glutamate, the predominant excitatory neurotransmitter in the mammalian brain, binds
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metabotropic and ionotropic glutamate receptors expressed on the surface of the
dendritic spine [30]. The interaction of glutamate with any type of glutamate receptor
can affect the Ca2+ content of a dendritic spine. For example, metabotropic glutamate
receptors (mGluRs) are coupled to G proteins that mediate, among other things, the
release of intracellular stores of Ca2+ [36]. But while mGluRs do mediate some forms of
spine plasticity [37,38,39], the role of these receptors under pathological conditions is
not well understood. Some in vitro studies suggest that mGluR activation during
excitotoxicity limits the post-synaptic influx of Ca2+ and the related neuronal
degeneration [40,41]; other studies report evidence to the contrary [42]. A more recent
in vivo study found that the truncation of mGluRs by calpain is a critical step in neuronal
excitotoxicity [43]. Still, it is unclear to what extent mGluRs participate in Ca2+dependent mechanisms of dendritic spine collapse.
Ionotropic glutamate receptors open channels which make the cell membrane
permeable to cations. All three known subtypes of ionotropic glutamate receptors can
be expressed by dendritic spines: the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)
proprionate (AMPA) receptor, the kainate receptor, and the N-methyl-D-aspartate
(NMDA) receptor. These receptor subtypes differentially affect the Ca2+ content of a
dendritic spine and so are described separately below.

AMPA Receptors
The AMPA receptor (AMPAR) is the primary route of fast synaptic input at the
dendritic spine. The expression of AMPARs at the spine synapse is activity-dependent,
which is integral to long-term plasticity of the post-synapse [44]. Upon binding
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glutamate, the AMPAR opens a pore in the spine membrane through which ions travel
along their concentration gradient. Due to the charge profile of this pore [45], AMPARs
mostly conduct Na+ and K+, resulting in the rapid depolarization of the dendritic spine
membrane. However, the ion permeability of the AMPAR is a function of its subunit
composition. One subunit in particular, GluR2, confers impermeability to divalent
cations, due to the presence of a polar arginine residue at a key site along the GluR2
pore-forming domain [46]. Therefore, AMPARs can be permeable to divalent cations
such as Ca2+ and Zn2+ when formed without a GluR2 subunit, or when formed with a
GluR2 in which a non-polar glutamine was substituted for the key arginine [47].
Normally in the adult brain, GluR2-lacking, Ca2+-permeable AMPARs are expressed
stably by interneurons but only transiently by principal cells of the neocortex and
hippocampus [47,48]. The transient expression of Ca2+-permeable AMPARs by
principal cells is thought to be a mechanism of synaptic scaling – in this case, a
sensitization of the post-synapse in response to a loss of synaptic activity [47].
Synaptic scaling by Ca2+-permeable AMPARs can also occur pathologically. For
example, hippocampal pyramidal neurons that are vulnerable to either ischemic or
epileptogenic injury show an increased proportion of GluR2-lacking AMPARs in
response to that particular injury [49]. This change in AMPAR composition may help to
explain the pattern of neuronal death following ischemia [48]. However, it is unclear to
what extent the cell death involves Ca2+ permeability, Zn2+ permeability, or other GluR2related issues [50,51]. In fact, studies of transgenic mice have suggested that the Ca2+
conducted by Ca2+-permeable AMPARs may not be directly toxic [52,53]. Instead,
Ca2+-permeable AMPARs may cause problems by facilitating the long-term potentiation
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(LTP) of excitatory synapses [52]. Such synaptic scaling could promote
hyperexcitability in neuronal networks and so indirectly contribute to pathology [54].

Kainate Receptors
Similar to the AMPAR, the post-synaptic kainate receptor contributes to
membrane depolarization and exhibits subunit-dependent Ca2+ permeability [55].
However, at least in the hippocampus, the composition and function of post-synaptic
kainate receptors appear to be region-specific [55,56]. Furthermore, kainate receptors
appear to be expressed at specific types of synapses within these regions. For
example, pyramidal neurons in hippocampal CA3 express post-synaptic kainate
receptors almost exclusively on thorny excrescences [56], multi-lobed spines found at
the synapses between mossy fibers and CA3 pyramidals [57].
Both kainate receptors and AMPARs can indirectly generate an influx of Ca 2+ into
the dendritic spine in a number of ways. First, membrane depolarization by AMPARs
and/or kainate receptors is essential to the activation of NMDA receptors, a principal
source of spine Ca2+ (see below). This depolarization may also open local voltagesensitive Ca2+ channels (VSCCs) [58]. These VSCCs appear to enhance or support
plasticity at hippocampal synapses [58], though the role of VSCCs in the pathological
plasticity of dendritic spines is not yet known. Finally, kainate receptors and AMPARs
may conduct enough Na+ to reverse the flow of local Na+/Ca2+ transporters, resulting in
an inward Ca2+ current across those transporters [59]. However, there is conflicting
evidence over the role of Na+/Ca2+ transporters in neuronal excitotoxicity [59,60].
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NMDA Receptors
The NMDA receptor (NMDAR) is a major conduit of Ca2+ into dendritic spines
throughout the neocortex and hippocampus [30]. Like the AMPAR and the kainate
receptor, the NMDAR exhibits activity-dependent permeability to Na+ and K+ and
subunit-dependent permeability to Ca2+ [61]. However, the Ca2+ permeability of the
NMDAR can be 20 times greater than that of the other ionotropic glutamate receptors
[62] and is far less dependent on subunit composition [63]. The subunit composition of
the NMDAR does, however, determine its inactivation time and other functional
properties that affect the size of its Ca2+ current [63,64]. Also unique among the
ionotropic glutamate receptors, activation of the NMDAR requires the co-incidence of
multiple events: binding of glutamate; binding of a co-agonist, such as glycine or Dserine; and a depolarization of the local membrane sufficient to dislodge the Mg2+ ion
which normally occludes the NMDAR ion channel.
NMDARs play a central, well-characterized role in neuronal excitotoxicity [65].
Selective agonists of NMDARs can cause excitotoxicity in vitro, and glutamate-induced
excitotoxicity is mostly blocked by NMDAR-selective antagonists (e.g., [66]). Similarly,
NMDAR antagonists have proven to be neuroprotective in models of stroke and
traumatic brain injury in vivo [67,68], suggesting that NMDAR activity can be neurotoxic.
This NMDAR toxicity appears to be largely Ca2+-dependent, as cell-permeable Ca2+
chelators are neuroprotective during excitotoxicity in vitro and in vivo [69].
Many studies have demonstrated that high intracellular Ca2+ concentrations are
neurotoxic [32,70]. Yet, the amount of Ca2+ does not solely determine its toxicity. For
instance, excitotoxic NMDAR activity can generate high intracellular concentrations of
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Ca2+, but an equivalent concentration of Ca2+ achieved with ionophores is not toxic to
neurons in vitro [71]. The particular toxicity of NMDAR-mediated Ca2+ may be explained
in a number of ways. One possibility is that NMDARs conduct Ca2+ into a diffusionlimited space, the head of the dendritic spine, thereby creating toxic foci of highly
concentrated Ca2+. However, this seems unlikely to explain the toxicity of NMDARmediated Ca2+: excitotoxicity can still occur by NMDA receptors expressed on the
dendritic shaft, a space which is less diffusion-limited [72]. Another, more likely
possibility is that the toxicity relates to the special environment of the NMDAR, e.g., its
neighboring clusters of Ca2+-sensitive proteins and their effector pathways.

Calcium Nanodomains
The NMDAR-mediated Ca2+ current is a principal determinant of dendritic spine
plasticity. This Ca2+ activates pathways which antagonistically control the size and
shape of the dendritic spine as well as the expression and sensitivity of post-synaptic
glutamate receptors [28]. The underlying pathways are mediated by Ca2+-sensitive
proteins anchored near NMDARs at the post-synaptic density [73], which suggests a
competition among these pathways for the Ca2+ signal [7]. Yet, the size of the Ca2+
influx does not alone determine which Ca2+ sensitive proteins are activated [39]. Other
important variables may be involved, including the Ca2+ sensitivity of the protein, its
proximity to the Ca2+ signal, and any post-translational modifications of the protein due
to cross-talk with other pathways. These variables are part of the “nanodomain,” the
nano-scale environment in which a Ca2+ influx becomes an intracellular signaling event.
In the dendritic spine, Ca2+ nanodomains may decide the outcome in the competition
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between Ca2+-sensitive pathways [74], ultimately determining whether LTP or LTD
occurs, whether the spine grows or shrinks, and so on.
Ca2+ nanodomains may also influence the neuronal response to excitotoxicity
[75]. For example, in vitro studies have demonstrated that toxicity of Ca2+ depends
more on the source than on the amount of Ca2+ [71,76]. This “source specificity” of Ca2+
toxicity [75] may be related to proximity of Ca2+-sensitive elements, such as
mitochondria and apoptotic signaling pathways [77].
Other Ca2+-sensitive elements of the nanodomain may determine different
neuronal responses to excitotoxicity. One response in particular, the collapse of
dendritic spines, is associated with a variety of excitotoxic brain injuries in humans and
the relevant animal models [78,79]. But the collapse of dendritic spines may be more
than a symptom of neuronal excitotoxicity; spine collapse potentially could contribute to
injury-related pathology, such as cognitive impairment or epilepsy [78]. For this reason,
a better understanding of dendritic spine collapse can be instructive in the treatment of
brain injury. Research over the past decade has revealed a variety of biochemical
mechanisms to explain dendritic spine collapse following brain injury. The following
section is a review of four such mechanisms.

Post-Synaptic Mechanisms of Dendritic Spine Collapse
Dendritic Beading
In the late 1970’s, James Olney and colleagues reported kainic acid caused
spherical swellings in neuronal dendrites [80]. Similar swellings had been described by
Santiago Ramon y Cajal in 1909, but their etiology remained unknown for nearly a

9

century. The formation of these varicosities, known as dendritic beading [78], is now
generally regarded as an early and reversible sign of neuronal excitotoxicity [81].
Dendritic beading is commonly observed following brain injuries, especially those in
which excitotoxicity is involved, such as epilepsy [78,82], stroke [83,84], and traumatic
brain injury [85,86,87]. Dendritic beading can be induced by a variety of experimental
conditions, including treatment with ionotropic glutamate receptor agonists
[84,88,89,90], ischemia [91,92,93,94], activation of microglia [95], or by cooling [96,97].
Interestingly, neuronal degeneration is worsened when experimental conditions prevent
dendritic beading, suggesting that the beading may be a neuroprotective response [90]
(but see also [98]).
Two mechanisms are independently sufficient to induce dendritic beading: an
osmotic shift involving ligand-gated and voltage-sensitive ion channels, and a Ca2+dependent disruption of dendritic cytoskeleton. The osmotic shift begins with an influx
of ions into the dendrite, first through ionotropic glutamate receptors [80,84,89,90,94]
and then through voltage-sensitive sodium [99,100,101] and chloride channels [98].
Eventually, the influx of ions outstrips their efflux through the Na +/K+ pump [102] and
other means of extrusion, resulting in hyperosmotic foci within the dendrite. These foci
draw fluid from neighboring segments of dendrite and/or from the extracellular
environment [93], producing the characteristic appearance of spherical swellings
separated by narrowed segments of dendrite [96,102].
Interestingly, the NMDAR-mediated Ca2+ current does not contribute substantially
to the osmotic shift [89,99,102]. This may be due to Ca2+ uptake and buffering within
the dendrite, which would minimize the effect of Ca2+ on osmolarity. However, the Ca2+
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influx does induce a different mechanism of dendritic beading, one in which Ca 2+sensitive enzymes lead to the disruption the dendrite cytoskeleton. Evidence for this
mechanism comes from reports of fragmented microtubules in electron micrographs of
dendritic beads [96] and in neurons during excitotoxicity [103]. These microtubules are
normally stabilized by the binding of microtubule associated protein 2 (MAP2) [104,105].
However, a dramatic loss of MAP2 occurs with excitotoxicity in vivo [106] and is
attributed to Ca2+ signaling [103,107]. The loss of MAP2 and dendritic beading can both
be prevented by the microtubule-stabilizing drug, taxol, in an acute hippocampal slice
model of excitotoxicity [103]. Conversely, beading is induced when microtubules are
destabilized by various agents, including nocodazole, platelet activating factor, or
methyl-carbamyl platelet activating factor [108].
Microtubule disruption may explain the Ca2+-dependent form of dendritic beading
observed in the literature [96,103,107,109]. Unlike the beading induced by the osmotic
shift, these Ca2+-dependent beads are smaller in diameter [96] and more irregular in
form [107]. Since Ca2+-dependent and -independent (i.e., osmotic shift) forms have
both been reported, the literature contains some disagreement over the etiology of
dendritic beading. However, at least some conflicting reports may be explained by
differences in experimental design. For example, dendritic beading tends to be Ca2+dependent when induced by NMDAR agonists [96,103,107] and Ca2+-independent
when induced by agonists of other, less Ca2+-permeable glutamate receptors
[80,89,99,101,106]. The Ca2+-dependent form of dendritic beading has also been
observed in kainic acid-treated Purkinje neurons [109]. Because mature Purkinje cells
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lack NMDARs [110], this beading likely involves voltage-sensitive Ca2+ channels
opened upon membrane depolarization by kainate receptors/AMPARs.
Though both Ca2+-dependent and -independent mechanisms can be induced
experimentally, both likely contribute to the dendritic beading observed in injured brains.
In fact, their effects appear to be complementary: Ca2+-dependent dendritic beads have
an irregular, oblong shape [96,107], similar to Ca2+-independent beads induced in the
presence of a voltage-gated calcium channel blocker [101]. Therefore, the spherical
shape of dendritic beads observed in vivo seems to require both Ca2+-dependent and independent mechanisms.
Dendritic beading is associated with a significant loss of dendritic spines, up to
50% on affected segments of dendrite [88]. Yet, most of this spine loss is only an
apparent loss. Just as the fingers of a rubber glove are absorbed upon its inflation,
dendritic spines may be engulfed by the swelling dendrite. However, within a few hours
of a brief excitotoxic challenge, the dendritic beads gradually resolve and most of their
spines re-emerge [84,88,97]. Importantly, this temporary spine loss does not appear to
disrupt spine synapses. In vitro and slice culture studies have found that, while some
synapses are lost in the process, most retracted spines re-emerge at their original sites
[88,97]. Time-lapse imaging of mouse cortical neurons in vitro shows that pre- and
post-synaptic components remain apposed during NMDA-induced spine collapse [88].
Therefore, synapses on collapsed spines may remain intact during brief excitotoxic
challenges.
While the loss of dendritic spines during beading may be superficial and
temporary, other mechanisms underlie more chronic spine loss as well as the
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elimination of spine synapses. These mechanisms are all Ca2+-dependent and their
actions may be complementary. Interestingly, at least two of these mechanisms are
mediated by the Ca2+-sensitive phosphatase, calcineurin.

Calcineurin-Mediated Cofilin Activation
Calcineurin is a neurally-enriched, serine/threonine phosphatase which is
stimulated upon its binding Ca2+/calmodulin [111,112,113]. Calcineurin is expressed by
every cell type in the brain, though its role in neurons has been particularly wellcharacterized. In fact, neuronal calcineurin appears to play a variety of roles in synaptic
plasticity [114]. Notably, calcineurin is essential for the induction of long-term
depression (LTD) at synapses in some hippocampal regions [115,116], where it
regulates functional aspects of LTD, including the desensitization and endocytosis of
post-synaptic AMPA receptors [21,117]. Furthermore, calcineurin is involved in the
structural plasticity of dendritic spines: it is responsible for the shrinkage of dendritic
spines associated with the induction of LTD [23], and for the collapse of dendritic spines
following excitotoxic injury [11,118]. Though many details are still under investigation, a
number of candidate pathways linking calcineurin activity to dendritic spine collapse
have been identified. One such pathway involves proteins of the actin depolymerizing
factor (ADF)/cofilin family (cofilin).
Cofilin binds and severs actin filaments (F-actin) and accelerates their
depolymerization [119]. Since actin filaments are the major cytoskeletal element in the
dendritic spine [120,121], actin breakdown by cofilin can destabilize the spine
cytoskeleton, resulting in spine shrinkage [23] or even collapse. Indeed, the distribution
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of cofilin fits with its role in the remodeling of dendritic spines. Cofilin is distributed
heterogeneously in the dendritic spine, found abundantly in the PSD and the spine
periphery but is mostly absent from the spine core [122]. This distribution overlaps the
outer edges of the spine’s more dynamic actin network, a pool of F-actin that rapidly
responds to glutamate stimulation [123]. Therefore, the co-localization of cofilin with
this dynamic pool of actin is consistent with the role of cofilin in spine remodeling.
Like many proteins in the dendritic spine, the activity of cofilin is regulated by
phosphorylation. In the case of cofilin, its activity depends on the phosphorylation state
of a key amino acid residue, serine 3 (ser3). Phosphorylation of ser3 decreases the
ability of cofilin to bind (and therefore sever) actin filaments [119]. Ser3 phosphorylation
is catalyzed by LIM kinases [124,125,126,127,128]. In turn, LIM kinase activity depends
on the signaling cascades of the Rho, Rac and Cdc42 family of small GTPases
[129,130], some of which are influenced by Ca2+-sensitive pathways that begin at the
NMDA receptors. Therefore, NMDA receptors may be linked to cofilin inactivation by
Ca2+-dependent pathways involving the small GTPases (e.g., Rac1 and Ras) and LIM
kinase.
NMDA receptors are also linked to cofilin activation by a different Ca 2+-sensitive
pathway, one mediated by calcineurin. This is because calcineurin dephosphorylates
and thereby activates Slingshot [131], a family of cofilin phosphatases [132,133] which
are enriched in neurons [134] and which localize to dendritic spines [135]. Slingshot
then dephosphorylates the cofilin ser3 residue [132], which increases the binding and
breakdown of F-actin by cofilin [119]. Thus, NMDA receptor activity can stimulate cofilin
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via a calcineurin-Slingshot pathway, or inactivate cofilin via a small GTPase-LIMK
pathway.
The calcineurin-Slingshot pathway is one mechanism which couples NMDAR
activity with cofilin activity. Indeed, cofilin activation is associated with spine shrinkage
following low frequency stimulation of NMDARs (i.e., LTD) [23] and with spine collapse
following excessive stimulation of NMDARs (i.e., excitotoxicity) [118]. Yet, frequencies
of NMDAR activation that induce long-term potentiation (LTP) also cause cofilin
inactivation and spine growth [24,136]. So, how could LTP-inducing frequencies
inactivate cofilin, while lower and higher frequencies have just the opposite effect? One
possibility is that there are multiple, cofilin-activating pathways which differ in Ca2+
sensitivity. For example, cofilin activating pathways may be either very sensitive or very
insensitive to Ca2+, such that only excitotoxic levels of Ca2+ could induce both types of
pathways, which together overwhelm the opposing pathways, resulting in cofilin
activation.
An alternative but not exclusive possibility is that cofilin does not work alone in
the collapse of dendritic spines. In fact, the effect of cofilin on F-actin can be simulated
with latrunculin A, a drug which inhibits actin polymerization [137]. Yet, treating cultured
neurons with latrunculin A does not entirely reproduce the spine collapse associated
with NMDA excitotoxicity [72,138]. Wispy, filopodia-like structures remain. These
structures, termed “spine remnants” [138,139,140], have been offered as evidence that
the dendritic spine is bolstered by the proteins contained within, not just by the spine’s
cytoskeleton [140]. Indeed, each dendritic spine contains a dense network of proteins
[9] which may suffice to stabilize the spine in vitro. However, it remains to be seen

15

whether this protein netowrk is enough to prevent collapse in the more densely packed
in vivo environment, where the spine is likely subject to greater external pressures.
Nonetheless, recently published in vitro studies have demonstrated the critical role of
two proteins in dendritic spine stability, and in doing so, identified novel mechanisms of
dendritic spine collapse. These mechanisms involve intracellular pathways that extend
far beyond the dendritic spine, even one that reaches to the cell nucleus and back.

Snk-Mediated SPAR Proteolysis
Another intracellular event associated with spine collapse is the proteolysis of
SPAR, the spine-associated Rap guanosine triphosphatase activating protein
[12,141,142]. SPAR is a 190kDa protein with separate binding sites for actin and postsynaptic density (PSD) proteins, and a guanosine triphosphatase activating protein
(GAP)-like domain [12]. SPAR is localized to the dendritic spine, where the binding and
catalytic domains of SPAR suggest its involvement in cytoskeletal regulation. For
example, its binding domains may allow SPAR to physically bridge the post-synaptic
density to the spine cytoskeleton [141], which could stabilize the spine. Additionally, its
catalytic domain allows SPAR to inactivate two functionally distinct [143] cytoskeletal
regulating members of the Ras family of small GTPases [144]: Rap2 and, to a lesser
extent, Rap1 [141].
Clues to the role of SPAR in the dendritic spine have emerged from experiments
which altered SPAR protein expression. One study found that SPAR re-organizes
cytoskeletal actin when expressed in COS-7 cells, and that SPAR over-expression
induces spine growth in cultured hippocampal neurons [141]. Another study reported
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that RNAi knockdown of SPAR weakened post-synaptic responsiveness to glutamate in
cultured hippocampal neurons [145]. These studies suggest that SPAR stabilizes both
structural and functional aspects of the dendritic spine.
Excitotoxic insult causes a loss of SPAR in vitro, which correlates with a loss of
dendritic spines and of the major PSD scaffold protein, PSD-95 [12,142]. This
excitotoxic depletion of SPAR requires the following: a Ca2+ influx mediated by NMDA
receptors and/or voltage gated Ca2+ channels; the activation of calcineurin; and a
downstream increase in the transcription of serum inducible kinase, Snk (also known as
polo-like kinase 2) which upregulates Snk protein expression [12]. Snk then
phosphorylates SPAR, targeting it for ubiquitination and subsequent proteolysis
[12,145,146]; the proteolysis likely occurs by proteosomes transported into the spine in
response to NMDA receptor activity [147]. Despite its dependence on nuclear events,
SPAR depletion can be detected within a few hours of excitotoxic insult. For example,
in cultured hippocampal neurons, a significant loss of SPAR protein is observed from 3
hours to over 72 hours after exposure to glutamate [142]. This degradation of SPAR is
matched in timing and magnitude by an increase in Snk protein levels [142].
Loss of SPAR also corresponds to a decrease in miniature excitatory postsynaptic currents (mEPSCs) [145]. This post-synaptic desensitization has led to the
hypothesis that SPAR proteolysis is a mechanism of synaptic scaling (for review, see
[148]) – in this case, a homeostatic reduction of synaptic activity in response to
excessive synaptic activity [145]. This synaptic scaling may be a neuroprotective
mechanism deployed in response to excitotoxicity. However, it is not yet understood
how SPAR proteolysis is able to downscale post-synaptic activity. One possibility is that
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the related loss of PSD-95, an important scaffold protein of the post-synaptic density,
disrupts the clustering of NMDA receptors at the post-synaptic density. The dispersal of
synaptic NMDARs does correspond to increased resistance to excitotoxicity in another
in vitro model [72].
Another possibility is that the collapse of the dendritic spine physically separates
the pre- and post-synaptic components. This spine collapse may be due to the loss of
SPAR as either a structural protein or as a negative regulator of the GTPase Rap2.
Constitutively active Rap2 causes a loss of dendritic spines and spine synapses in
cultured neurons [143]; a similar outcome may occur when proteolysis of SPAR
releases Rap2 from negative regulation. Future studies could test this hypothesis by
transfecting neurons with a mutant SPAR lacking an inactive RapGAP domain. More
investigation is needed to appreciate the relationship between the Snk-SPAR pathway
and excitotoxic spine collapse.

MARCKS Proteolysis
SPAR degradation is not the only proteolytic event associated with the
excitotoxic collapse of dendritic spines. The targeted degradation of another spine
protein, myristoylated alanine-rich C-kinase substrate (MARCKS), is also activitydependent and linked to dendritic spine collapse [138]. MARCKS is expressed
heterogeneously across the neocortex and subcortical structures, and enriched in
neuronal processes [149]. MARCKS is also found in some dendritic spines [149],
though its function there is not completely understood. Yet, recent evidence implicates
MARCKS in the activity-dependent plasticity of dendritic spines [150,151,152,153],
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where it is thought to integrate converging signals from protein kinase C (PKC) and
Ca2+/calmodulin [154]. When neither phosphorylated by PKC nor bound by calmodulin,
MARCKS adheres to the cell membrane and promotes the growth of the actin network,
potentially by sequestering phospholipids which affect actin dynamics [155].
Furthermore, by physically anchoring the cytoskeleton to the cell membrane, MARCKS
may stabilize dendritic structure [156]. Therefore, the loss of MARCKS can limit the
growth and anchorage of the actin cytoskeleton, which may destabilize dendritic spines.
Experimental depletion of MARCKS in vitro has revealed its importance to the
stability of dendritic spines. For example, spine density and size are significantly
decreased following RNA interference of MARCKS protein expression in cultured
hippocampal cells [150]. MARCKS protein levels and spine density are also reduced
following exogenous activation of PKC [150], suggesting that PKC phosphorylation may
target MARCKS for proteolysis. PKC is active during NMDA-induced excitotoxicity
[157,158], which may explain the extensive proteolysis of MARCKS under those
conditions. Indeed, within 10 minutes of a 30 second treatment with 50μ M NMDA,
MARCKS protein is reduced by nearly 50% and spine density by roughly 75% in
cultured hippocampal neurons [138]. Strikingly, all of the MARCKS proteolysis and
nearly half of the spine loss were blocked by inhibitors of cathepsin B/L [138], cysteine
proteases for which MARCKS is a known substrate [159]. Considered together, these
observations support a mechanism of dendritic spine collapse as follows: excessive
NMDA receptor activity leads to MARCKS phosphorylation by PKC and subsequent
proteolysis by cathepsin B/L; the loss of MARCKS protein inhibits actin growth and/or
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disconnects the cytoskeleton from the plasma membrane, which progressively
destabilizes and ultimately collapses the dendritic spine.
The Snk-SPAR pathway is one putative mechanism of synaptic scaling, could
MARCKS proteolysis be another? One recent publication found that MARCKS
proteolysis is associated with the post-ischemic development of NMDA tolerance. In
this study, cultured neocortical neurons were deprived of glucose and oxygen for 30
minutes. One hour later, these neurons showed a 23% loss of MARCKS protein, a
transient, 75% reduction in dendritic spine density, and a similarly transient tolerance to
NMDA-induced excitotoxicity [151]. Treatment with the actin-stabilizing compound,
jasplakinolide, blocked both the dendritic spine loss and NMDA tolerance, as did
treatment with proteosome inhibitors that preserved MARCKS protein levels* [151].
Therefore, the spine loss and NMDA tolerance required both proteolysis and the
breakdown of the actin cytoskeleton. Yet, it is unclear just how NMDA tolerance is
related to these other phenomena. One possibility is that proteolytic events (e.g.,
MARCKS) drive the breakdown of the spine cytoskeleton, which destabilizes the spine
and disperses glutamate receptors and/or related signaling proteins from the postsynaptic region. If the dispersal of signaling proteins affected signal reception or
processing, this could explain the decreased response of these post-ischemic neurons
to NMDA treatment. Consistent with this scenario, the authors reported that brief
ischemia decreased the actin binding of two important post-synaptic proteins, the
NMDA receptor subunit NR2B, and PSD-95, but did not affect their protein expression

*

Curiously, one of the proteosome inhibitors, MG132, was ineffective in blocking MARCKS proteolysis in
the study by Graber et al. (2004). However, the Graber study induced excitotoxicity with NMDA, not
ischemia. Therefore, the discrepancy between the two studies may be explained by differences in
experimental design.
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[151]. These observations suggest that post-synaptic proteins detach from the spine
cytoskeleton following brief ischemia, which could disperse the signaling proteins and
reduce their responsiveness to subsequent signals.
Dendritic spine collapse may protect the parent neuron at the expense of the
neuronal network. The resulting disruptions in network activity or connectivity could
contribute to the cognitive impairment which follows injury, and may even facilitate the
development of epilepsy . The next section considers traumatic brain injury, a common
form of brain injury which is associated with both dendritic spine loss and epilepsy.

Traumatic Brain Injury and Post-Traumatic Epilepsy
Traumatic brain injury (TBI) occurs when the brain is damaged by external
forces, such as impact, penetration, blast, or a sudden change in velocity. TBI occurs
approximately every 19 seconds in the United States and is a leading cause of
morbidity and mortality, resulting in more than 1.3 million hospitalizations and more than
50,000 deaths in the U.S. each year [160]. Those that survive TBI often face lifelong
impairments and other complications [161] which incur lifelong costs in quality of life,
productivity, and medical care. Indeed, the personal, financial, and societal costs of a
single TBI can last for decades, since TBI predominantly affects children and young
adults [160]. The high incidence and chronic costs make TBI one of the most expensive
diseases in the U.S., estimated at $60 billion dollars in the year 2000 alone [162].
One significant complication of TBI is post-traumatic epilepsy. This form of
acquired epilepsy is characterized by spontaneous, recurrent seizures which begin
weeks to years after TBI. Epilepsy is a common consequence of TBI, diagnosed in 2-
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25% of TBI survivors [163,164]. Conversely, TBI is a common cause of epilepsy,
accounting for about 5% of all cases of epilepsy in the general population [165]. Most
post-traumatic epileptics exhibit partial seizures as the dominant seizure type (91%
cases), originating in either the temporal lobe (54% cases) or in the frontal neocortex
(33% cases) [166,167]. Though conventional anti-seizure drugs are indicated for its
treatment, post-traumatic epilepsy is often refractory to drugs and surgery [168,169].
Though difficult to treat, post-traumatic epilepsy may be preventable, as the latency
between TBI and seizure onset suggests a wide window for therapeutic intervention.
While efforts to prevent human post-traumatic epilepsy have so far been disappointing
[170], hope has emerged from research in rodent models of the disease [171].
Several models of closed-head injury, the predominant form of human TBI, have
been adapted for studying post-traumatic epilepsy. In two of these models, the cortical
contusion model and the fluid percussion model, rats and mice subjected to a laterallyplaced TBI develop spontaneous, recurrent seizures within weeks to months
[172,173,174,175]. However, the mechanisms which lead from TBI to seizures in these
models have not been identified. Nor is it known when these mechanisms are initiated,
though some studies of humans and rodent models suggest that epileptogenesis begins
within minutes of TBI [176,177]. A better understanding of the mechanisms and timing
of epileptogenesis are essential to developing prophylactic treatments for post-traumatic
epilepsy.
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CHAPTER I
TRAUMATIC BRAIN INJURY CAUSES AN FK506-SENSITIVE LOSS AND AN
OVERGROWTH OF DENDRITIC SPINES

INTRODUCTION
Survivors of traumatic brain injury (TBI), most of whom are young adults, often
suffer lifelong disabilities. The devastating consequences of TBI derive in part from its
progressive nature: the immediate, mechanical destruction of tissue can be followed by
days to weeks of excitotoxic and inflammatory damage [178,179]. This cumulative injury
can alter neural function well beyond the focally-damaged tissue and so may contribute
to TBI-induced neuropathologies, such as cognitive impairment and post-traumatic
epilepsy. Animal modeling of TBI has revealed that cognitive impairment can occur in
the absence of cell death (e.g., [180]) and that the onset of PTE can be many months
after TBI [181]. It is therefore likely that cognitive impairment and PTE develop from
disruptions in neural circuitry beyond the acute loss of cells. A better understanding of
how TBI disrupts neural circuitry should uncover novel therapeutic targets for treating
TBI-induced neuropathologies.
One potential mechanism of disrupted neural circuitry may be the loss of
dendritic spines. Dendritic spines are specialized protuberances of dendritic membrane
which form the post-synaptic component of most excitatory synapses in the brain [5].
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The stability of the dendritic spine depends on synaptic activity [182]. Indeed, the loss of
its pre-synaptic partner can cause the spine to retract into the dendritic shaft [16], and
spine collapse due to deafferentation is a well-characterized phenomenon. However, an
excess of synaptic activity can also cause spine collapse, through the toxic excitation of
glutamate receptors [84]. Multiple post-synaptic mechanisms linking excitotoxicity to
dendritic spine loss have been proposed and demonstrated in vitro (reviewed in [183]).
Interestingly, at least two of these mechanisms are mediated by the calcium-sensitive
phosphatase, calcineurin (CaN) [11,12]. Since CaN is activated by glutamate signaling
[184] and glutamate signaling occurs to excess after TBI [185], it is plausible that an
increase in CaN activity leads to dendritic spine loss after TBI.
Here we report an extensive analysis of dendritic spine density in the laterally
injured brain. In addition, this study and its companion [186] present evidence of CaNdependent mechanisms by which TBI results in dendritic spine loss. In particular, this
study describes a region-specific loss of dendritic spines which can be blocked by a
single, post-injury injection of FK506, a pharmacological inhibitor of CaN. This spine
loss coincides, temporally and regionally, with changes in cofilin activity observed by our
companion study [186]. In addition, the spine loss is followed by an apparent
overgrowth of dendritic spines in both hemispheres of hippocampus. Overall, these
findings suggest that the rat forebrain undergoes an extensive turnover of dendritic
spines during recovery from lateral brain injury, which may participate in the
development of cognitive impairment and post-traumatic epilepsy. Furthermore, these
findings identify CaN as a potential therapeutic target in the treatment of TBI.
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MATERIALS AND METHODS
Animal Use and Care
Use of animal subjects was performed in strict accordance with the Guide for the
Care and Use of Laboratory Animals, provided by the National Institutes of Health, and
approved in advance by the Virginia Commonwealth University Institutional Animal Care
and Use Committee. Animal subjects received ad libitum access to food and water and
were maintained on 12hr light/dark cycles throughout the experiment.

Surgical preparation and fluid percussion injury
Adult male Sprague-Dawley rats (90 day old; 350-400g; n=21) were anesthetized
with sodium pentobarbital (54 mg/kg intraperitoneally; i.p.) and placed into a stereotactic
frame. A 4.8-mm hole was made over the left hemisphere using a trephine centered
4mm caudal to bregma and -3mm lateral to the sagittal suture. A screw was inserted
over the opposite hemisphere to anchor the skull attachments. A modified female LuerLoc syringe hub (2.6mm inside diameter) was placed over the exposed dura, affixed
with a cyanoacrylate adhesive, and then secured with dental acrylic. On the following
day, subjects were anesthetized (4% isoflurane in a carrier gas mixture of 26% N2O and
70% O2) in a chamber, then removed from the chamber and immediately subjected to
fluid percussion of the intact dura over their left parietal cortex. The fluid percussion
device used in these experiments is identical to that described by Dixon and colleagues
[187]. The Luer-Loc fitting, screw, and dental cement were removed from the skull
immediately following injury. Subjects were then placed in a supine position and the
time at which they righted themselves was recorded. Upon recovery of righting reflexes,
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subjects were placed on a heating pad for at least 30 minutes (and up to 1 hour) until
ambulatory, then returned to home cages and monitored daily. At 1hr post-injury, some
subjects received a single intraperitoneal injection of FK506 (5mg/kg; Fujisawa
Chemical Company, Osaka, Japan).

Golgi-Cox histology and light microscopy
At 1hr, 24hr, and 1wk after lateral fluid percussion injury, subjects were injected
with a lethal dose of pentobarbital, perfused intracardially with saline (0.9%, 120mL,
room temperature), and decapitated. Brains were quickly extracted and immersed into a
Golgi-Cox staining solution prepared from a commercially-available kit (FD Rapid
Golgistain Kit, FD Neurotechnologies, Inc., Baltimore, MD, U.S.A.). After 24hr of
staining, brains were blocked to remove tissue rostral and caudal to the hippocampus,
immersed in fresh staining solution, and stored at room temperature in the dark for a
total of 2 weeks. The remainder of the staining procedure was performed according to
the kit instructions.
Following the staining procedure, brains were cut into 200μm thick coronal
sections using a vibratome (Leica, Wetzler, Germany). Sections were mounted onto
2%-gelatin coated slides and air-dried at room temperature in the dark overnight. Slidemounted sections were developed and dehydrated according to the kit instructions, and
coverslipped with Permount.
Three brain sections nearest the injury site were selected for further analysis.
Golgi-impregnated principal cells from the following regions were assessed for dendritic
spine density: layers II and III of parietal neocortex penumbral to the site of injury
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(“ipsilateral neocortexII,III”) and an analogous area of the contralateral hemisphere
(“contralateral neocortexII,III”); the pyramidal cell layer of the hippocampal subfields CA1
and CA3 in each hemisphere; and the granule cell layer of the dorsal leaf of the dentate
gyrus (dDG; Figure 1) in each hemisphere. Brain region identification was aided by a
standard atlas of the rat brain [188]. Golgi-stained principal cells were then visualized by
light microscope (Nikon Optiphot-2, Nikon Optiphot, Melville, NY, U.S.A.). Under a 40x
objective lens, pyramidal and granule neurons were identified by their location within
cell layers and by the shape of their soma and dendritic arbor. Dendrites were
visualized using a 100x/oil-immersion lens for manual tracing and dendritic spine
quantification.

Dendrite tracing and dendritic spine quantification
To ensure consistency of sampling, the following inclusion criteria were applied.
The dendrite sampled had to be (1) a second- or third-order branch, (2) within 30μm150μm of the parent cell soma (as measured along the dendrite; “proximal”) (3) not
obscured by other Golgi-stained tissue, (4) showing no signs of degeneration which
would interfere with spine quantification (i.e., blebbing or beading of the proximal
dendrite), and (5) connected to a soma which did not appear swollen or necrotic.
For each group of animals, at least 10 neurons per brain region per hemisphere
were included in the analysis (for n values, see Table 1). Fully-stained principal neurons
within each region of interest were first selected under minimal magnification (4x
objective). Under high magnification (100x oil-immersion objective), selected neurons
were then screened according to the inclusion criteria described above. For each
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neuron, one proximal branch of dendrite was traced to a minimum length of 20μm. With
regard to granule cells of the dDG, only dendrites oriented dorsolaterally were analyzed.
Dendrites were traced through the x-, y-, and z-planes using a digitizing microscope
stage under control of Neurolucida (MicroBrightField, Inc., Williston, VT, U.S.A.). The
lengths of tracings were computed by Neurolucida Explorer software (MicroBrightField,
Inc.). Along each traced segment of dendrite, dendritic spines were counted according
to their morphology [189,190]: thin spines and mushroom-shaped spines were counted
together as “pedunculated spines,” whereas spines lacking a neck constriction (e.g.,
stubby spines and filopodia-like spines) were counted as “non-pedunculated spines”
(Figure 2). Spine density was calculated as the number of spines visible along a traced
segment of dendrite, divided by the length of the traced segment. No correction was
made for spines not seen due to the angle or plane of section.

Statistical analyses
Mean spine densities in injured brains were statistically compared to those from
the corresponding dendritic arbor and brain region of age- and drug treatment-matched
control brains. Each mean was derived from a pool of spine densities obtained from 3
identically-treated rats. Student’s t-tests were used to compare the FK506-treated
injured group to the FK506-treated uninjured group, while one-way analysis of variance
(ANOVA) with Tukey post hoc test was used for all other comparisons. Statistical
analyses were performed with GraphPad Prism, version 5.0 (GraphPad Software, Inc.,
La Jolla, CA, U.S.A.). Comparisons generating p values less than 0.05 were considered
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statistically significant. Data are presented as group mean ± standard error of the mean
(SEM).

RESULTS
Lateral fluid percussion injury
Adult male rats received a traumatic brain injury by fluid percussion of the dura
overlying their left parietal cortex (mean pressure, 2.22 ± 0.02atm; between groups, p >
0.05). A common correlate of injury severity is the length of time between injury and the
recovery of righting reflexes (“righting time”) [191]. In the present study, the mean
righting time was 8min 52sec ± 1min 31sec (n = 12) and was not significantly different
between groups (p > 0.05). Some subjects exhibited apnea immediately following injury
(5 out of 12 subjects) and were mechanically ventilated as needed (mean duration of
ventilation, 1min 32sec ± 52sec). All subjects survived the injury.

Dendritic spine quantification in injured and uninjured forebrain
To determine the effect of TBI on dendritic structure, brains were recovered 1hr,
24hr, and 1wk after lateral fluid percussion injury (LFPI) and subjected to a modified
Golgi-Cox procedure (see Materials and Methods). Proximal dendrites (within 30-150μm
of soma) of Golgi-stained principal cells were manually traced (mean length of tracing ±
standard deviation, 33.90 ± 9.43μm) and spine density was quantified, in the following
forebrain regions: neocortexII,III penumbral to the LFPI site (“ipsilateral neocortexII,III”)
and in an analogous region of the contralateral hemisphere (“contralateral
neocortexII,III”); the hippocampal subfields, CA1 and CA3; and the dorsal leaf of the
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dentate gyrus (dDG; Figure 1). Mean densities of pedunculated spines (thin spines and
mushroom-shaped spines; Figure 2) and non-pedunculated spines (stubby spines and
filopodia-like spines; Figure 2) are provided in a supplementary table (Table 1). Overall,
1,264 dendrites were traced and 57,372 dendritic spines were counted.

On apical dendrites in neocortexII,III, lateral fluid percussion injury caused a transient
decrease in spine density
Pyramidal cells in neocortexII,III receive excitatory synapses on spines throughout
their apical and basilar dendritic arbors. To investigate the effect of traumatic brain
injury on these dendritic spines, we began by assessing spine density on the apical
dendrites of neocortexII,III pyramidal cells in control and laterally injured brains (Figure
3). In control brains, neocortexII,III pyramidal cells (n=14) displayed an average of 1.20 ±
0.08 spines/μm on proximal apical dendrites, consistent with previously published data
[192]. This spine density included an average of 0.74 ± 0.05 pedunculated spines/μm
and an average of 0.46 ± 0.04 non-pedunculated spines/μm. At 1hr post-LFPI, the total
spine density of these dendrites did not differ significantly from that of controls, in
ipsilateral or contralateral neocortexII,III (each vs. control, p > 0.05; Figure 4a). Nor was
the pedunculated or non-pedunculated spine density of these dendrites appreciably
different from control values, in ipsilateral or contralateral neocortexII,III (each vs. control,
p > 0.05; Figure 4b,c).
By 24hr post-LFPI however, apical dendrites in neocortexII,III showed a significant
loss of spine density. Specifically, in ipsilateral neocortexII,III, the total spine density of
these dendrites decreased by 21% relative to controls (vs. control, p < 0.05; Figure 4a).
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Further analysis revealed an underlying change in the density of pedunculated spines:
pedunculated spine density decreased 30% from control values (vs. control, p < 0.01;
Figure 4b). Since the non-pedunculated spine density of these dendrites was relatively
unchanged at this time (vs. control, p > 0.05; Figure 4c), it is likely that the loss of
pedunculated spine density involved more than just a change in spine phenotype (i.e.,
from pedunculated to non-pedunculated). Furthermore, the effect on spine density
appeared to be greater in the ipsilateral hemisphere. In contralateral neocortex II,III, the
pedunculated spine density of apical dendrites decreased 14% relative to controls, a
change which was not statistically significant (vs. control, p > 0.05; Figure 4b). Thus, the
data indicate that by 24hr post-LFPI there is a selective loss of pedunculated spine
density from apical dendrites in ipsilateral neocortexII,III. Because pedunculated spines
are associated with stable synapses [193], a decrease in their density could indicate
synaptic re-modeling in the injured brain.
The decrease in pedunculated spine density was not permanent. By 1wk postLFPI in ipsilateral neocortexII,III, the pedunculated spine density of apical dendrites
recovered to control levels (vs. control, p > 0.05; Figure 4b). Likewise in contralateral
neocortexII,III, the pedunculated spine density of these dendrites did not differ
significantly from control values (vs. control, p > 0.05; Figure 4b). Nor was the nonpedunculated spine density altered relative to controls, in either hemisphere of
neocortexII,III (vs. control, p > 0.05; Figure 4c). The data therefore describe a recovery in
the pedunculated spine density of apical dendrites in neocortexII,III by 1wk post-LFPI.
Overall, these results suggest that lateral TBI transiently decreased the
pedunculated spine density of apical dendrites in ipsilateral neocortexII,III. This decrease
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is not likely due to acute mechanical trauma, as it occurred by 24hr but not by 1hr postLFPI. The timing is more consistent with a secondary injury process, such as
excitotoxicity. Importantly, these changes in post-synaptic structure could indicate
extensive alterations of neocortexII,III circuitry in the injured brain.

On basilar dendrites in neocortexII,III, spine density fluctuated during recovery from
lateral fluid percussion injury
Basilar dendrites in neocortexII,III were also studied in control and laterally injured
brains. In control brains, the proximal basilar dendrites of neocortexII,III pyramidals
(n=13) displayed 1.07 ± 0.04 spines/μm; a similar value has been reported previously
[192]. This spine density included 0.65 ± 0.03 pedunculated spines/μm and 0.43 ± 0.02
non-pedunculated spines/μm. Following LFPI, the spine density of these dendrites did
not differ significantly from controls (p > 0.05). However, basilar spine density did
change significantly across time points after LFPI, as summarized below. Micrographs
of representative dendrites from ipsilateral neocortexII,III are also provided
(Supplementary Figure 1).
From 1hr to 24hr post-LFPI in ipsilateral neocortexII,III the total spine density of
basilar dendrites decreased by 27% (1hr post-LFPI vs. 24hr post-LFPI, p < 0.001;
Figure 5a). Further analysis revealed an underlying, 35% decrease in pedunculated
spine density (1hr post-LFPI vs. 24hr post-LFPI, p < 0.01; Figure 5b) but no change in
non-pedunculated spine density (1hr post-LFPI vs. 24hr post-LFPI, p > 0.05; Figure 5c),
across these time points. In the contralateral hemisphere, a similar pattern was
observed. From 1hr to 24hr post-LFPI in contralateral neocortexII,III, basilar dendrites
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showed a 26% decrease in pedunculated spine density (1hr post-LFPI vs. 24hr postLFPI, p < 0.001; Figure 5b) while non-pedunculated spine density was relatively
unchanged (vs. control, p > 0.05; Figure 5c). Thus, the data demonstrate that from 1hr
to 24hr post-LFPI basilar dendrites undergo a selective loss of pedunculated spine
density in the bilateral neocortexII,III.
The decrease in basilar spine density was followed by an increase. From 24hr to
1wk post-LFPI, basilar spine density increased by 35% in the ipsilateral neocortexII,III
and by 26% in the contralateral neocortexII,III (24hr post-LFPI vs. 1wk post-LFPI, p <
0.01; Figure 5a). Again, the underlying change was in pedunculated spine density,
which increased by 46% in the ipsilateral neocortexII,III and by 32% in the contralateral
neocortexII,III across these time points (24hr post-LFPI vs. 1wk post-LFPI, p < 0.001 and
p < 0.01, respectively; Figure 5b). The non-pedunculated spine density of basilar
dendrites did not change from 24hr to 1wk post-LFPI, however, but did increase
significantly from 1hr to 1wk post-LFPI in the contralateral neocortexII,III (1hr post-LFPI
vs. 1wk post-LFPI, p < 0.05; Figure 5c). The data suggest extensive remodeling of
basilar dendritic structure in the bilateral neocortexII,III during recovery from LFPI.

On apical dendrites in hippocampal CA1, lateral fluid percussion injury caused a
delayed increase in spine density
CA1 pyramidal cells have proximal dendrites which form spine synapses
primarily with Shaffer collateral and commissural axons [194]. In the rat brain, these
synapses occur throughout the proximal apical and basilar dendritic arbors of CA1
pyramidal cells [194]. We investigated the effect of TBI on the spine density of these
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dendrites, beginning with the apical dendrites. In control brains, the proximal apical
dendrites of CA1 pyramidals (n=15) exhibited 1.56 ± 0.08 dendritic spines/μm,
consistent with previously published studies [195,196]. This spine density consisted of
0.83 ± 0.04 pedunculated spines/μm and 0.52 ± 0.05 non-pedunculated spines/μm.
Similar to dendrites in neocortexII,III, apical dendritic spine density was not affected at
1hr post-LFPI, in either hemisphere of CA1 (vs. control, p > 0.05; Figure 6a-c). Nor was
there any appreciable change in spine density by 24hr post-LFPI (vs. control, p > 0.05;
Figure 6a-c), in contrast to what was observed in neocortexII,III. However, there was a
delayed increase in the spine density of CA1 apical dendrites, as described below.
Micrographs of representative dendrites from ipsilateral CA1 are provided as a
supplementary figure (Supplementary Figure 2).
By 1wk post-LFPI, the spine density of proximal apical dendrites increased
dramatically in both hemispheres of CA1. In ipsilateral CA1, for instance, the spine
density of these dendrites rose by 32% relative to controls (vs. control, p < 0.001; Figure
4a). Further analysis revealed underlying changes in pedunculated and nonpedunculated spine density, which increased by 31% and 33% respectively, compared
to controls (vs. control, p < 0.001 and 0.01, respectively; Figure 6b,c). Meanwhile, in the
contralateral CA1, spine density increased by 22% relative to controls (vs. control, p <
0.05; Figure 6a), though pedunculated and non-pedunculated spine density did not
differ significantly from that of controls (each vs. control, p > 0.05; Figure 6b,c). Overall,
the data indicate that LFPI causes a delayed, but substantial increase in the spine
density of proximal apical dendrites in bilateral CA1. These changes are consistent with
an increased density of excitatory synapses on CA1 dendrites, e.g., reactive
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synaptogenesis [197,198], and so could have considerable implications for hippocampal
circuitry in the injured brain.

On basilar dendrites in hippocampal CA1, lateral fluid percussion injury caused a
delayed increase in spine density
Proximal basilar dendrites of CA1 pyramidals were also examined. In control
brains, the proximal basilar dendrites of CA1 pyramidals (n=12) exhibited 1.48 ± 0.11
spines/μm, similar to previously published data [196]. This total spine density included
0.92 ± 0.08 pedunculated spines/μm and 0.56 ± 0.04 non-pedunculated spines/μm. As
with CA1 apical dendrites, the spine density of CA1 basilar dendrites at 1hr or 24hr
post-LFPI did not differ significantly from that of controls (ipsilateral or contralateral vs.
control, p > 0.05; Figure 7a-c).
By 1wk post-LFPI however, basilar dendrites in both hemispheres of CA1
showed significant increases in spine density. In ipsilateral CA1 for example, spine
density increased 23% relative to controls (1.82 ± 0.08 total spines/μm vs. control, p <
0.01; Figure 7a), though neither pedunculated nor non-pedunculated spine density at
1wk post-LFPI differed significantly from controls (each vs. control, p > 0.05; Figure
7b,c). However, the pedunculated spine density at this time point was increased when
compared to earlier time points, by 33% relative to 1hr post-LFPI and by 49% relative to
24hr post-LFPI (1hr post-LFPI vs. 1wk post-LFPI, p < 0.01; 24hr post-LFPI vs. 1wk postLFPI, p < 0.001; Figure 7b).
Meanwhile, in the contralateral CA1, a similar increase in spine density observed.
Basilar dendrites in contralateral CA1 showed a 27% increase in total spine density (vs.
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control, p < 0.05; Figure 7a), apparently driven by a 25% rise in pedunculated spine
density (vs. control, p < 0.05; Figure 7b). Therefore, the data indicate that LFPI causes
a delayed, but significant increase in basilar dendritic spine density bilaterally in CA1.
As with the apical dendrites in CA1, this increase in spine density could signify the
formation of novel excitatory circuits in the injured brain.

On apical dendrites in hippocampal CA3, lateral fluid percussion injury caused a
delayed increase in spine density
Pyramidal cells of hippocampal CA3 form synapses with associational and
commissural fibers on dendritic spines throughout their proximal apical and basilar
arbors [194]. To understand the effect of LFPI on these spines, we compared apical
dendritic spine density between control and laterally injured brains. In control brains, the
proximal apical dendrites of CA3 pyramidals (n=10) averaged 1.24 ± 0.11 dendritic
spines/μm, comprising 0.72 ± 0.08 pedunculated spines/μm and 0.52 ± 0.04 nonpedunculated spines/μm. Similar to what was observed in CA1, apical dendritic spine
density at 1hr or 24hr post-LFPI did not differ significantly from that of controls, in either
hemisphere of CA3 (vs. control, p > 0.05; Figure 8a-c).
As was also observed in CA1, however, LFPI caused a delayed increase in the
spine density of apical CA3 dendrites. By 1wk post-LFPI in ipsilateral CA3, for instance,
spine density increased 31% relative to controls (vs. control, p < 0.01; Figure 8a).
Further analysis revealed an underlying, 33% increase in pedunculated spine density
(vs. control, p < 0.05; Figure 8b) but no significant change in non-pedunculated spine
density (vs. control, p > 0.05; Figure 8c), relative to controls. However, unlike what was
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observed in CA1, the effect appeared to be limited to the ipsilateral hemisphere: in the
contralateral CA3, spine density at 1wk post-LFPI did not differ significantly from that of
controls (vs. control, p > 0.05; Figure 8a-c) though pedunculated spine density had
increased 44% relative to the 24hr post-LFPI time point (24hr post-LFPI vs. 1wk postLFPI, p < 0.05; Figure 8b). Therefore, LFPI caused a delayed increase in the spine
density of CA3 apical dendrites, and to a greater extent in the ipsilateral hemisphere. As
with the neocortex and CA1, this increase in spine density could have substantial
implications for the excitatory circuitry of the injured forebrain.

On basilar dendrites in hippocampal CA3, lateral fluid percussion injury caused a
delayed increase in spine density
Basilar dendrites of CA3 pyramidal cells were also examined in control and
laterally injured brains. In control brains, the proximal basilar dendrites of CA3
pyramidals (n=12) exhibited 1.28 ± 0.09 dendritic spines/μm, which consisted of 0.73 ±
0.05 pedunculated spines/μm and 0.55 ± 0.04 non-pedunculated spines/μm. Consistent
with the apical dendrites in this region, the spine density of basilar dendrites at 1hr or
24hr post-LFPI did not differ significantly from that of controls, in either hemisphere of
CA3 (vs. control, p > 0.05; Figure 9a-c). However, these dendrites also showed a
delayed increase in spine density, as described below. Micrographs of representative
dendrites from ipsilateral CA3 are provided as a supplementary figure (Supplementary
Figure 3).
By 1wk post-LFPI, the spine density of CA3 basilar dendrites increased
significantly above control levels in both hemispheres. In the ipsilateral CA3, for
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example, these dendrites showed a 34% increase in total spine density, driven by a
41% increase in pedunculated spine density (each vs. control, p < 0.01; Figure 9b).
While non-pedunculated spine density at 1wk post-LFPI did not change significantly
relative to controls, it did increase by 66% from 1hr post-LFPI and by 27% from 24hr
post-LFPI (1hr post-LFPI vs. 1wk post-LFPI, p < 0.001; 24hr post-LFPI vs. 1wk postLFPI, p < 0.05; Figure 9c). Meanwhile, in the contralateral CA3, similar changes in spine
density were observed: total spine density increased by 25%, driven by a 36% increase
in pedunculated spine density, compared to controls (vs. control, p < 0.05 and p < 0.01,
respectively; Figure 9b).
In general, the data indicate that LFPI caused a delayed increase in basilar spine
density in both hemispheres of CA3. As with neocortexII,III and CA1, this increase in
spine density could indicate an increased density of excitatory synapses and therefore
have considerable implications for hippocampal circuitry in the injured brain.

On dentate granule cell dendrites, lateral fluid percussion injury caused an acute
decrease and a delayed increase in spine density
Granule cells, the principal cells of the dentate gyrus, receive mostly
associational and commissural synapses on spines of their proximal dendrites [194].
The spine density of these dendrites in the dorsal dentate gyrus (dDG) was compared
between control and laterally injured brains. In control brains, the proximal dendrites of
dDG granule cells (n=27) displayed 1.43 ± 0.06 total spines/μm, as previously reported
[199]. This spine density included 0.83 ± 0.04 pedunculated spines/μm and 0.60 ± 0.03
non-pedunculated spines/μm. At 1hr after LFPI, the spine density of these dendrites
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was relatively unchanged in either hemisphere, relative to controls (vs. control, p > 0.05;
Figure 10a-c). However, LFPI did cause a loss and subsequent gain of spine density in
dDG at later time points, as described below. Micrographs of representative dendrites
from ipsilateral dDG are provided as a supplementary figure (Supplementary Figure 4).
By 24hr post-LFPI, dDG showed a hemisphere-specific loss of spine density.
Specifically, in the ipsilateral dDG, pedunculated spine density decreased 20% (vs.
control, p < 0.05; Figure 10b) without any appreciable change in non-pedunculated
spine density (vs. control, p > 0.05; Figure 10c), relative to controls. However, in the
contralateral dDG, spine density at 24hr post-LFPI did not differ significantly from that of
controls (vs. control, p > 0.05; Figure 10a-c).
As observed in neocortexII/II, the loss of spine density in dDG was not permanent.
In fact, by 1wk post-LFPI, spine density in the ipsilateral dDG had increased above
control levels. In particular, total spine density increased 17% over control values (vs.
control, p < 0.05; Figure 10a), apparently driven by an 18% rise in pedunculated spine
density relative to controls (vs. control, p < 0.05; Figure 10b). While the nonpedunculated spine density of these dendrites did not change relative to controls (vs.
control, p > 0.05; Figure 10c), it did increase 20% relative to the 1hr and 24hr post-LFPI
time points (1hr post-LFPI vs. 1wk post-LFPI, p < 0.05; 24hr post-LFPI vs., 1wk postLFPI; Figure 10c).
In the contralateral dDG, spine density also increased at 1wk post-LFPI, but only
when compared to earlier post-LFPI time points. For example, total spine density in
contralateral dDG increased 22% from 1hr post-LFPI and 23% from 24hr post-LFPI (1hr
post-LFPI vs. 1wk post-LFPI, p < 0.05; 24hr post-LFPI vs. 1wk post-LFPI, p < 0.05;
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Figure 10a). Likewise, pedunculated spine density in contralateral dDG increased 26%
from 1hr post-LFPI and 43% from 24hr post-LFPI (1hr post-LFPI vs. 1wk post-LFPI, p <
0.05; 24hr post-LFPI vs. 1wk post-LFPI, p < 0.001; Figure 10b). However, nonpedunculated spine density at this time point did not differ significantly from controls nor
from earlier post-LFPI time points (vs. control, 24hr post-LFPI, or 1hr post-LFPI; p >
0.05; Figure 10c). Overall, the data show that LFPI causes a delayed increase in the
proximal dendritic spine density of granule cells in the ipsilateral dDG. This increase in
spine density, like that observed in the other hippocampal subfields, may indicate
substantial re-wiring of the hippocampus in response to lateral brain injury.

FK506 administration increased dendritic spine density in uninjured neocortex II,III
In vivo imaging has revealed a daily turnover in dendritic spine populations of the
adult rodent brain [200,201]. If this turnover of dendritic spines is mediated by CaN, then
inhibiting CaN could increase the density of dendritic spines. To test this hypothesis and
reduce a potential confound to the present study, uninjured subjects were administered
the calcineurin inhibitor, FK506 (5mg/kg; i.p.) and their brains were recovered 2hr or
23hr later for Golgi-Cox analysis of spine density. The mean spine densities and ratio P:N
are provided in Table 1.
FK506 administration caused significant increases in the pedunculated spine
density of basilar dendrites in neocortexII,III, relative to drug-naïve controls. Specifically,
at 2hr post-injection, the pedunculated spine density of these dendrites increased 29%
relative to drug-naïve controls (vs. drug-naïve control, p < 0.05; Figure 11b). This
increase appeared to persist for many hours. By 23hr post-injection, pedunculated spine
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density was increased 31% relative to drug-naïve controls, driving a significant 29%
increase in the total spine density, relative to drug-naïve controls (vs. drug-naïve
control, p < 0.001 and p < 0.01, respectively; Figure 11a,b). A similar effect was recently
reported in adult mice given daily doses of FK506 [202], and another study found that
CaN inhibition increases synaptogenesis [203]. However, these findings are beyond the
scope of the present study. Still, to avoid a potential confound to our study, FK506treated, injured subjects were compared only to FK506-treated, uninjured subjects.

FK506 administration prevented the loss of dendritic spine density at 24hr post-injury
CaN activity has been implicated in the injury-induced loss of dendritic spine
density in vitro [11] and in vivo [118,204]. To determine whether CaN activity could
explain the loss of spine density at 24hr post-LFPI, some experimental subjects (n=3)
were administered the CaN inhibitor, FK506 (5mg/kg; i.p) 1hr after LFPI. The timing of
this injection was based on evidence that CaN activity increases within hours of LFPI
[186]. Furthermore, this dosage of FK506 has been shown to block dendritic spine loss
in a different in vivo model of brain injury [118]. Brains of FK506-treated subjects were
harvested 24hr after LFPI and subjected to Golgi-Cox histochemistry. Some uninjured
subjects (n=3) were used as drug controls and received a single injection of FK506
(5mg/kg; i.p.) 23hr prior to sacrifice.
A single, post-injury injection of FK506 completely blocked the decreases in
spine density otherwise observed at 24hr post-LFPI. Indeed, spine density was not
statistically different between uninjured and injured subjects treated with FK506, in any
region examined, on either apical or basilar dendrites (each vs. control, p > 0.05; Figure
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12). This means that FK506 preserved spine density in those regions which otherwise
lost roughly 20% of their spine density at this time point (i.e., ipsilateral neocortexII,III and
dDG). The data thus strongly suggest that CaN activity is necessary for the loss of spine
density at 24hr post-LFPI.

DISCUSSION
This study demonstrates that LFPI can cause significant changes in dendritic
spine density and that these changes are time- and brain region-specific. One major
finding is that LFPI caused a loss of spine density on proximal dendrites in ipsilateral
neocortexII,III and dDG. This loss of spine density was prevented by administration of
FK506, a pharmacological inhibitor of CaN, which represents a second major finding in
this study. Indeed, a single, post-injury dose of FK506 preserved spine density at 24hr
post-LFPI. A third major finding is that LFPI causes a delayed, regional increases in
spine density in both hemispheres of rat hippocampus, which is consistent with reactive
synaptogenesis (e.g., [197,198]). Specifically, within 1wk of LFPI, spine density
increased in CA1 and CA3 bilaterally, and in dDG ipsilaterally. The implications of each
of these major findings are considered below.

Lateral fluid percussion injury decreased spine density in neocortex and dentate gyrus
In theory, a reduction in dendritic spine density could be due to a loss of spines
or to a lengthening of the dendrite. Though the latter possibility cannot be excluded by
this study, it seems unlikely for three reasons: first, a shortening, rather than a
lengthening, of pyramidal dendrites has been reported in a lateral TBI model [205];

42

second, in vitro imaging of developing neurons suggests that dendrites grow from the
terminal tip or branch point [206], which would not affect the medial portion that we
sampled for spine density; third, our data indicate that LFPI differentially affects
pedunculated and non-pedunculated spine densities. For these reasons, a loss of
spines most likely explains the reduction in spine density we observed. Interestingly,
this spine loss corresponds in time, region, and magnitude with a loss of synaptic
proteins reported in a different TBI model [207]. Taken together, these findings suggest
that lateral TBI causes synapse degeneration near the site of focal injury.
Interestingly, the apparent loss of pedunculated spines we observed at 24hr
post-LFPI occurred independent of any change in non-pedunculated spine density.
There are a number of possible explanations for this phenotype-specific effect. One
possibility relates to the mechanism of spine loss: if an excess (or lack) of synaptic
activity caused the spine loss, only spines with synapses would be directly affected.
Since the pedunculated phenotype is typical of synapse-bearing spines [193], this can
explain why only pedunculated spines were lost after LFPI.
An alternative explanation is that both spine populations decrease after LFPI, but
only non-pedunculated spines are replenished by 24hr post-LFPI. Non-pedunculated
spines could replenish in response to a decrease in synaptic activity after LFPI. Indeed,
immature spines are formed in response to a pharmacological blockade of synaptic
transmission in the hippocampus in vitro [208]; a similar effect could occur with a
reduction in synaptic transmission, or with a loss of synapses, e.g., the 60% loss that
occurs within days of lateral cortical contusion [209].
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A third possibility is that LFPI causes some pedunculated spines to shrink and
assume a non-pedunculated morphology. Shrinkage of pedunculated spines could
mask a loss of non-pedunculated spines. Indeed, spine shrinkage is associated with
activation of the actin binding protein, cofilin [23]. Our companion study [186] reports
that cofilin activation in the neocortex and hippocampus coincides with the spine loss
we observed. For these reasons, spine shrinkage could explain why only pedunculated
spines appeared to be affected by LFPI. Future studies using in vivo imaging and
transgenic techniques are needed to better characterize the fate of pedunculated and
non-pedunculated spines in this brain injury model.
Further study is also needed to determine whether the spine loss we observed
corresponds to a loss of synapses. Studies in which cultured neurons were exposed to
glutamate receptor agonists [11,88] or cold [97] suggest that collapsed dendritic spines
can maintain synaptic contacts. However, other in vitro studies show that spine collapse
can disrupt synapses: in hippocampal slices, excessive synaptic activity leads to an
FK506-sensitive upregulation of Snk (serum-inducible kinase), resulting in proteolysis of
the spine stabilizing protein, SPAR (spine-associated Rap guanosine triphosphatase
activating protein) [12]. This Snk-SPAR pathway leads to spine loss as well as
reductions in miniature post-synaptic potentials and in the immunoreactivity of the
critical post-synaptic protein, PSD-95 [12,145]. Interestingly, the Snk-SPAR pathway
primarily affects pedunculated spines on proximal dendrites [12] and requires hours to
develop [142,210]. These in vitro findings are therefore consistent with our observation
that spine loss occurred on proximal dendrites and can explain the delay in the onset of
spine loss after brain injury. Furthermore, our companion study found a slight loss of
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SPAR immunoreactivity in the ipsilateral hippocampus at 18hr post-LFPI [186]. This
finding raises the possibility that SPAR proteolysis can explain the spine loss observed
by the present study in the ipsilateral dentate gyrus. Therefore, the potential role of this
FK506-sensitive signaling pathway in TBI-induced spine loss is an intriguing topic for
further study.

Pharmacological inhibition of calcineurin prevented the decrease in spine density at
24hr post-injury
CaN is a calcium-stimulated phosphatase which mediates functional and
structural plasticity on both sides of the synapse [23,114]. One mechanism by which
CaN regulates post-synaptic structure involves the breakdown of the spine
cytoskeleton. As demonstrated in vitro, CaN dephosphorylates and so activates
Slingshot [131], a family of phosphatases which in turn activate proteins of the actin
depolymerizing factor (ADF)/cofilin family (cofilin) [132]. Activated cofilin binds and
breaks apart filaments of actin, enabling many forms of functional and structural
plasticity in the neuron (for review, see [119]). For example, cofilin is responsible for the
shrinkage of dendritic spines that accompanies the long-term depression of spine
synapses [23].
Our companion study reports evidence that LFPI caused significant increases in
cofilin activity [186]. In some cases, the cofilin activation observed in our companion
study corresponds to spine loss observed in the present study. Specifically, our
companion study reports that the ipsilateral neocortex and hippocampus each show
increases in cofilin activity at 24hr post-LFPI (signified by decreases in the
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phosphorylation of the cofilin serine 3 residue; [186]). At the same time point and in the
same forebrain regions, the present study reports a significant loss of dendritic spines.
These parallel findings raise the possibility that cofilin activation is responsible for spine
loss after LFPI (but see also Discussion in [186]). Other brain injury models have also
linked cofilin activation to spine loss [118,204,211].
Another parallel between the present study and its companion involves the CaN
inhibitor, FK506. Our companion study found that a single, post-injury injection of FK506
blocked cofilin de-phosphorylation in the neocortex at 24hr post-LFPI [186]. At the same
time point and in the same brain region, an identical treatment with FK506 prevented
spine loss in the present study. Therefore, in the neocortex at least, the FK506-sensitive
de-phosphorylation of cofilin corresponds to spine loss after LFPI. These findings agree
with our previous research in a rat model of status epilepticus, in which FK506
treatment (5mg/kg) prevented cofilin de-phosphorylation and a coinciding loss of
dendritic spines. Preventing spine loss in these different models of brain injury could
maintain synaptic integrity and so reduce the risk of cognitive impairment and other
sequelae. Therefore, these results emphasize the potential of CaN as a therapeutic
target in treating brain injury.

Lateral fluid percussion injury caused a delayed overgrowth of dendritic spines in CA1,
CA3, and dDG
Previously published studies do not predict an increase in dendritic spine density
following lateral brain injury. For example, in a study by Schwarzbach and colleagues
(2006), moderate (1.4-2.1atm) lateral fluid percussion injury had no effect on the apical
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and basilar dendritic spine densities of mouse CA1 pyramidals at 1wk post-injury [195].
In addition, Scheff and colleagues (2005) found that lateral cortical contusion caused a
loss of synapses in CA1 stratum radiatum which lasted at least 60 days post-injury
[209]. Consequently, though using a different model of TBI, we were surprised to find an
increase in the dendritic spine density of CA1 apical dendrites (as well as in other brain
regions) at 1wk post-LFPI.
It is possible that the spine overgrowth we observed in CA1 occurred only on
proximal dendrites. Unlike previously published studies, our study focused on secondor third-order dendrites within 30-150μm of the cell soma. Compared to distal dendrites,
these proximal regions of CA1 pyramidal dendrites are less dense with synapses [212].
Proximal dendrites may therefore be a more accessible target for re-innervating axons
following injury. Indeed, the apical dendritic field of CA1, the stratum radiatum, is reinnervated within a week or so of lateral cortical contusion in rat [209,213]. If reinnervating fibers connect with de novo dendritic spines, this could explain the
increased spine density in CA1 at 1wk post-LFPI.
Delayed increases in spine density have also been associated with experimental
denervation [214] and ischemia. Within days of ischemic injury, for example, CA1 apical
dendrites show an increase in spine density [196,215]. Since moderate LFPI can
depress cerebral blood flow [216], further investigation is needed to know whether there
is a mechanistic relationship between spine overgrowth in the ischemia and LFPI
models.
An overgrowth of dendritic spines may be a clue to understanding the altered
electrophysiology of the hippocampus following lateral brain injury. An
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electrophysiological study by Akasu and colleagues found an increase in the excitability
of rat CA1 at 1wk after moderate LFPI (1.5-2.0atm) [217]. Other research suggests that
this increased excitability is due to recurrent circuits formed by CA1 axon collaterals.
Indeed, CA1 axons invade the stratum radiatum within weeks of epileptogenic brain
injury in rat, and this corresponds to an increase in CA1 excitability [198]. It is likely that
these CA1 axons form synapses on CA1 dendrites, since CA1 pyramidals become
increasingly interconnected when brain injury leads to epilepsy [218]. Alternatively, the
increased spine density in CA1 and CA3 may represent innervation by commissural or
extra-hippocampal regions. In any case, further investigation is needed to determine
whether reactive synaptogenesis can explain the spine overgrowth we observed. A
better understanding of how the brain is re-wired after injury holds promise for the
treatment of TBI-related pathologies such as cognitive impairment and post-traumatic
epilepsy.

48

FIGURE 1 – Forebrain regions sampled for dendritic spine density. Shown is a
micrograph of a Golgi-stained section of adult rat brain recovered 24hr after lateral fluid
percussion injury of the left hemisphere. The approximate site of fluid percussion is
indicated with an asterisk (*). Dendritic spine density was sampled in the shaded brain
regions located ipsilateral and contralateral to the impact site, including layer II,III of the
parietal neocortex (“Ctx”), the hippocampal subfields CA1 and CA3, and the dorsal leaf
of the dentate gyrus (“dDG”). Analogous regions of uninjured brains were similarly
assessed for spine density. Also visible in this image is where a wedge-shaped portion
of ventral neocortex was excised prior to sectioning, to mark the ipsilateral hemisphere.
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FIGURE 2 – Dendritic spines on a Golgi-stained pyramidal neuron from layer II,III
of rat neocortex. A thin spine and a mushroom-shaped spine are marked, respectively,
with a thin arrow and a thick arrow. A stubby spine and a filopodia-like spine are
marked, respectively, with an arrowhead and a hollow arrow. Thin spines and
mushroom-shaped spines were counted together as “pedunculated” spines, whereas
stubby spines and filopodia-like spines were counted together as “non-pedunculated”
spines. The arrowhead also approximates the minimum distance (30μm) from the cell
soma beyond which dendrites were traced and spine density was sampled. Scale bar,
10μm.
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FIGURE 3 – Representative apical dendrites from Golgi-stained pyramidal cells in
layer II,III neocortex. Shown are proximal dendrites (within 30-150μm of cell soma)
from the apical arbors of Golgi-stained pyramidal cells in rat neocortex layer II,III. Panel
A shows a control dendrite with 8.10 pedunculated spines/10μm (110% of group mean)
and 4.05 non-pedunculated spines/10μm (88% of group mean). Panels B, C, and D
show dendrites in the penumbral region of the focal injury. Panel B shows a dendrite at
1hr post-LFPI, with 7.09 pedunculated spines/10μm (102% of group mean) and 4.46
non-pedunculated spines/10μm (92% of group mean). Panel C shows a dendrite at 24hr
post-LFPI, with 4.89 pedunculated spines/10μm (95% of group mean) and 4.14 nonpedunculated spines/10μm (98% of group mean). Panel D shows a dendrite at 1 week
post-LFPI, with 8.05 pedunculated spines/10μm (119% of group mean) and 4.98 nonpedunculated spines/10μm (117% of group mean). Note that not all spines counted are
in focus in these micrographs. Scale bar, 10μm.
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FIGURE 4 – On apical dendrites in neocortexII,III, lateral fluid percussion injury
caused a transient decrease in spine density. Rat brains were recovered 1hr, 24hr,
or 1wk after moderate lateral fluid percussion injury, and subjected to Golgi-Cox
histochemistry. Golgi-stained pyramidal neurons were selected at random from
neocortex layer II,III (“neocortexII,III”), either adjacent to the site of injury (“ipsilateral”;
black bars) or in an analogous region of the contralateral hemisphere (“contralateral”;
gray bars). The density of pedunculated spines (mushroom spines and thin spines) and
the density of non-pedunculated spines (stubby spines and filopodia-like spines) were
each quantified on traced segments of proximal apical dendrites (nneurons > 13). In
ipsilateral neocortexII,III, apical dendritic spine density decreased significantly by 24hr
post-LFPI, relative to controls (A). Further analysis revealed a phenotype-specific
change in spine density, specifically, a decrease in the density of pedunculated spines
(B) with no appreciable change in the density of non-pedunculated spines (C). Both total
and pedunculated spine densities recovered by 1wk post-LFPI (A,B). Meanwhile, in
contralateral neocortexII,III, the spine density of apical dendrites did not differ significantly
from that of controls, at any time point (B). * vs. control, p < 0.05; ** vs. control, p < 0.01
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FIGURE 5 – On basilar dendrites in neocortexII,III, spine density fluctuated during
recovery from lateral fluid percussion injury. Rat brains were recovered 1hr, 24hr, or
1wk after moderate lateral fluid percussion injury and stained using a Golgi-Cox
procedure. Golgi-stained pyramidal neurons were selected at random from neocortex
layer II,III (“neocortexII,III”) either adjacent to the site of injury (“ipsilateral”; black bars) or
in an analogous region of the contralateral hemisphere (“contralateral”; gray bars).
Pedunculated spine density (mushroom spines and thin spines) and non-pedunculated
spine density (stubby spines and filopodia-like spines) were quantified on traced
segments of proximal basilar dendrites (nneurons > 13). The spine density of these
dendrites did not change relative to controls, but showed significant changes across
time points post-LFPI. For example, the total spine density of these dendrites decreased
from 1hr to 24hr post-LFPI in ipsilateral neocortexII,III, and increased from 24hr to 1wk
post-LFPI in bilateral neocortexII,III (A). Further analysis revealed underlying changes in
pedunculated spine density, which decreased from 1hr to 24hr post-LFPI and increased
from 24hr to 1wk post-LFPI, in both hemispheres of neocortexII,III (B). However, there
were no corresponding changes in non-pedunculated spine density, except an increase
from 1hr to 1wk post-LFPI in the contralateral neocortexII,III (C). # vs. other bracketed
group, p < 0.05; ## vs. other bracketed group, p < 0.01; ### vs. other bracketed group,
p < 0.001
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FIGURE 6 - On apical dendrites in hippocampal CA1, lateral fluid percussion
injury caused a delayed increase in spine density. Rat brains were recovered 1hr,
24hr, or 1wk after moderate lateral fluid percussion injury and subjected to Golgi-Cox
histochemistry. Golgi-stained pyramidal neurons were selected at random from
ipsilateral CA1 (black bars) and from contralateral CA1 (gray bars). Pedunculated spine
density (mushroom spines and thin spines) and non-pedunculated spine density (stubby
spines and filopodia-like spines) were quantified on traced segments of proximal apical
dendrites (nneurons > 13). The total spine density of these dendrites increased
significantly at 1wk post-LFPI relative to controls, in both hemispheres of CA1 (A).
Pedunculated spine density increased significantly at 1wk post-LFPI relative to controls
in ipsilateral CA1, and from 24hr to 1wk post-LFPI in contralateral CA1 (B). In addition,
ipsilateral CA1 showed a corresponding increase in non-pedunculated spine density at
1wk post-LFPI (C). * vs. control, p < 0.05; ** vs. control, p < 0.01; *** vs. control, p <
0.001; ## vs. other bracketed group, p < 0.01
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FIGURE 7 – On basilar dendrites in hippocampal CA1, lateral fluid percussion
injury caused a delayed increase in spine density. Rat brains were recovered 1hr,
24hr, or 1wk after moderate lateral fluid percussion injury and stained using a Golgi-Cox
procedure. Golgi-stained pyramidal neurons were selected at random from ipsilateral
CA1 (black bars) and from contralateral CA1 (gray bars). Pedunculated spine density
(mushroom spines and thin spines) and non-pedunculated spine density (stubby spines
and filopodia-like spines) were quantified on traced segments of proximal basilar
dendrites (nneurons > 12). The total spine density of these dendrites increased
significantly at 1wk post-LFPI relative to controls, in both hemispheres of CA1 (A).
Pedunculated spine density increased significantly from 1hr to 1wk post-LFPI and from
24hr to 1wk post-LFPI in ipsilateral CA1, and relative to controls in contralateral CA1
(B). However, there were no corresponding changes in the non-pedunculated spine
density of these dendrites (C). * vs. control, p < 0.05; ## vs. other bracketed group, p <
0.01; ### vs. other bracketed group, p < 0.001
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FIGURE 8 – On apical dendrites in hippocampal CA3, lateral fluid percussion
injury caused a delayed increase in spine density. Rat brains were recovered 1hr,
24hr, or 1wk after moderate lateral fluid percussion injury and subjected to Golgi-Cox
histochemistry. Golgi-stained pyramidal neurons were selected at random from
ipsilateral CA3 (black bars) and from contralateral CA3 (gray bars). Pedunculated spine
density (mushroom spines and thin spines) and non-pedunculated spine density (stubby
spines and filopodia-like spines) were quantified on traced segments of proximal apical
dendrites (nneurons > 10). In ipsilateral CA3, the total spine density of these dendrites
increased significantly at 1wk post-LFPI (A), driven by a rise in pedunculated spine
density (B), relative to controls. In contrast, contralateral CA3 showed only an increase
in pedunculated spine density from 24hr to 1wk post-LFPI (B). In terms of nonpedunculated spine density, the only significant change was an increase from 1hr to
1wk post-LFPI in ipsilateral CA3 (C). * vs. control, p < 0.05; ** vs. control, p < 0.01; # vs.
other bracketed group, p < 0.05
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FIGURE 9 – On basilar dendrites in hippocampal CA3, lateral fluid percussion
injury caused a delayed increase in spine density. Rat brains were recovered 1hr,
24hr, or 1wk after moderate lateral fluid percussion injury and stained using a Golgi-Cox
procedure. Golgi-stained pyramidal neurons were selected at random from ipsilateral
CA3 (black bars) and from contralateral CA3 (gray bars). Pedunculated spine density
(mushroom spines and thin spines) and non-pedunculated spine density (stubby spines
and filopodia-like spines) were quantified on traced segments of proximal basilar
dendrites (nneurons > 12). The total spine density of these dendrites increased
significantly by 1wk post-LFPI relative to controls, in both hemispheres of CA3 (A).
Further analysis revealed underlying changes in pedunculated spine density, which
increased significantly in both hemispheres of CA3 relative to controls (B). In contrast,
non-pedunculated spine density did not change appreciably in either hemisphere of
CA3 relative to controls, but did increase from 1hr to 1wk post-LFPI and from 1hr to
24hr post-LFPI in the ipsilateral CA3 (C). * vs. control, p < 0.05; ** vs. control, p < 0.01;
# vs. other bracketed group, p < 0.05; ### vs. other bracketed group, p < 0.001
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FIGURE 10 – On dentate granule cell dendrites, lateral fluid percussion injury
caused an acute decrease and a delayed increase in spine density. Rat brains
were recovered 1hr, 24hr, or 1wk after moderate lateral fluid percussion injury and
subjected to Golgi-Cox histochemistry. Golgi-stained granule cells were selected at
random from the dorsal leaf of the dentate gyrus (dDG) in the ipsilateral (black bars)
and the contralateral (gray bars) hemispheres. Pedunculated spine density (mushroom
spines and thin spines) and non-pedunculated spine density (stubby spines and
filopodia-like spines) were quantified on traced segments of proximal dendrites (n neurons
> 12). The total spine density of these dendrites increased by 1wk post-LFPI relative to
controls in ipsilateral dDG, as well as from 1hr to 1wk and from 24hr to 1wk in the
contralateral dDG (A). In terms of pedunculated spine density, ipsilateral dDG showed a
significant decrease at 24hr post-LFPI and a significant increase at 1wk post-LFPI,
whereas contralateral dDG showed an increase from 1hr to 1wk post-LFPI and from
24hr to 1wk post-LFPI (B). The non-pedunculated spine density of these dendrites only
changed appreciably in the ipsilateral dDG, where an increase was observed from 1hr
to 1wk post-LFPI and from 24hr to 1wk post-LFPI (C). * vs. control, p < 0.05; # vs. other
bracketed group, p < 0.05; ### vs. other bracketed group, p < 0.001
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FIGURE 11 – FK506 administration increased dendritic spine density in uninjured
neocortexII,III. Rat brains were recovered 2hr (black bars) or 23hr (gray bars) after
FK506 administration (5mg/kg; i.p.), and subjected to Golgi-Cox histochemistry. Golgistained principal cells were selected at random and bilaterally from the following
forebrain regions: neocortexII,III, hippocampus CA1, hippocampal CA3, and the dorsal
leaf of the dentate gyrus (n values are given in Table 1). Pedunculated spine density
and non-pedunculated spine density were quantified on traced segments of proximal
dendrites. By 2hr post-injection, FK506 administration did not significantly affect the
total spine density of these dendrites (A) but caused a significant increase in the
pedunculated spine density of basilar dendrites in neocortexII,III relative to controls (B).
By 23hr post-injection, both the total spine density (A) and pedunculated spine density
(B) of basilar dendrites in neocortexII,III were increased significantly relative to controls.
** vs. control, p < 0.05; ** vs. control, p < 0.01; *** vs. control, p < 0.001;
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FIGURE 12 – FK506 administration prevented a loss of dendritic spine density
following lateral fluid percussion injury. Rats received a lateral brain injury by fluid
percussion and were administered FK506 (5mg/kg; i.p.) 1hr later. Rat brains were
recovered 24hr after injury and subjected to Golgi-Cox histochemistry. Golgi-stained
principal cells were selected at random from the ipsilateral (black bars) and contralateral
(gray bars) hemispheres of neocortexII,III (“Ctx”), hippocampus CA1, hippocampal CA3,
and the dorsal leaf of the dentate gyrus (“DG”; n values are provided in Table 1).
Pedunculated spine density and non-pedunculated spine density were quantified on
proximal dendrites in these regions. Administering FK506 at 1hr post-injury preserved
pedunculated spine density at 24hr post-LFPI on apical dendrites in ipsilateral
neocortexII,III and on granule cell dendrites in ipsilateral dDG (B), dendrites which
otherwise showed significant spine loss at this time point (see Figures 4b and 10b).
Data given as percent of FK506-treated, uninjured controls.
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SUPPLEMENTARY FIGURE 1 – Basilar dendritic spine density in ipsilateral
neocortex after lateral fluid percussion injury. Shown are proximal dendrites (within
30-150ìm of cell soma) from the basilar arbors of Golgi-stained pyramidal cells in rat
neocortexII,III. Panel A shows a control dendrite with 6.64 pedunculated spines/10ìm
(103% of group mean) and 3.92 non-pedunculate spines/10ìm (92% of group mean).
Panels B, C, and D show dendrites in the penumbral region of the focal injury. Panel B
shows a dendrite at 1hr post-LFPI, with 7.59 pedunculated spines/10ìm (97% of group
mean) and 5.77 non-pedunculated spines/10ìm (116% of group mean). Panel C shows
a dendrite at 24hr post-LFPI, with 4.95 pedunculated spines/10ìm (97% of group mean)
and 4.40 non-pedunculated spines/10ìm (104% of group mean). Panel D shows a
dendrite at 1wk post-LFPI, with 9.69 pedunculated spines/10ìm (129% of group mean)
and 5.09 non-pedunculated spines/10ìm (100% of group mean). Note that not all spines
counted are in focus in the micrographs. Scale bar, 10ìm.
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SUPPLEMENTARY FIGURE 2 – Apical dendritic spine density in ipsilateral CA1
after lateral fluid percussion injury. Shown are proximal dendrites (within 30-150μm
of cell soma) from the apical arbors of Golgi-stained pyramidal cells in rat hippocampal
CA1. Panel A shows a control dendrite with 10.00 pedunculated spines/10μm (109% of
group mean) and 4.59 non-pedunculated spines/10μm (82% of group mean). Panel B
shows a dendrite at 1hr post-LFPI, with 10.18 pedunculated spines/10μm (111% of
group mean) and 5.60 non-pedunculated spines/10μm (100% of group mean). Panel C
shows a dendrite at 24hr post-LFPI, with 7.74 pedunculated spines/10μm (84% of group
mean) and 7.07 non-pedunculated spines/10μm (126% of group mean). Panel D shows
a dendrite at 1wk post-LFPI, with 10.38 pedunculated spines/10μm (113% of group
mean) and 7.55 non-pedunculated spines/10μm (135% of group mean). Note that not
all spines counted are in focus in the micrographs. Scale bar, 10μm.
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SUPPLEMENTARY FIGURE 3 – Basilar dendritic spine density in ipsilateral CA3
after lateral fluid percussion injury. Shown are proximal dendrites (within 30-150μm
of cell soma) from the basilar arbors of Golgi-stained pyramidal cells in rat hippocampal
CA3. Panel A shows a control dendrite with 8.56 pedunculated spines/10μm (118% of
group mean) and 5.45 non-pedunculated spines/10μm (98% of group mean). Panel B
shows a dendrite at 1hr post-LFPI, with 7.16 pedunculated spines/10μm (119% of group
mean) and 3.12 non-pedunculated spines/10μm (75% of group mean). Panel C shows a
dendrite at 24hr post-LFPI, with 8.93 pedunculated spines/10μm (139% of group mean)
and 6.20 non-pedunculated spines/10μm (114% of group mean). Panel D shows a
dendrite at 1wk post-LFPI, with 8.90 pedunculated spines/10μm (87% of group mean)
and 5.93 non-pedunculated spines/10μm (86% of group mean). Note that not all spines
counted are in focus in the micrographs. Scale bar, 10μm.
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SUPPLEMENTARY FIGURE 4 – Dendritic spine density in ipsilateral dentate gyrus
after lateral fluid percussion injury. Shown are proximal dendrites (within 30-150μm
of cell soma) of Golgi-stained granule cells in the dorsal leaf of the rat dentate gyrus.
Panel A shows a control dendrite with 10.32 pedunculated spines/10μm (124% of group
mean) and 5.90 non-pedunculated spines/10μm (99% of group mean). Panel B shows a
dendrite at 1hr post-LFPI, with 7.50 pedunculated spines/10μm (97% of group mean)
and 5.28 non-pedunculated spines/10μm (92% of group mean). Panel C shows a
dendrite at 24hr post-LFPI, with 5.96 pedunculated spines/10μm (89% of group mean)
and 5.57 non-pedunculated spines/10μm (98% of group mean). Panel D shows a
dendrite at 1wk post-LFPI, with 9.51 pedunculated spines/10μm (96% of group mean)
and 6.34 non-pedunculated spines/10μm (92% of group mean); note that spine density
was not quantified in the beaded region of this dendrite. Also, not all spines counted are
in focus in the micrographs. Scale bar, 10μm.
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TABLE 1 – Spine densities and n values.
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CHAPTER II
MECHANISMS OF DENDRITIC SPINE REMODELING IN A RAT MODEL OF
TRAUMATIC BRAIN INJURY

INTRODUCTION
A traumatic brain injury (TBI) occurs every 19 seconds in the United States [219]
and is a leading cause of death and disability. TBI typically involves both an immediate,
mechanical destruction of tissue as well as prolonged reactive processes such as
excitotoxicity which develop over a period of hours to days. This secondary injury can
affect cellular function well beyond the site of impact and so may be responsible for
many of the long-lasting neurological deficits associated with TBI [220,221]. However,
this secondary injury may be treatable or even preventable, given the apparent window
for therapeutic intervention.
Calcium-regulated systems have been implicated in the spread of neuronal
damage following ischemia and TBI [32,35,222]. One such system involves the
calcium-regulated phosphatase, calcineurin (CaN) [223,224,225]. CaN mediates many
cellular responses to brain injury, including the expression of cytokines [226] and
neuronal nitric oxide synthase [227], glial apoptosis [228] and activation [229]. CaN
also regulates synaptic plasticity under normal conditions (e.g., [114,230]) and in
various pathological states, including prolonged seizure [118], amyloid beta exposure
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[231], and TBI [186]. Given its regulation by calcium and role in cellular responses to
injury, CaN and its signaling pathways may contribute to the pathology of TBI. Previous
research by our laboratory found both an increase in CaN activity and its re-distribution
to synapses in the rat forebrain after fluid percussion TBI [224,232]. More recently, we
found that these changes coincide with a CaN-dependent loss of dendritic spines in the
rat neocortex and hippocampus after fluid percussion TBI [233]. However, it is unclear
how CaN is involved in this spine loss. Several signaling pathways which connect CaN
activity to spine loss have been characterized in vitro (for review, see [183]). One such
pathway involves remodeling the spine’s actin-rich cytoskeleton by the actin-binding
protein, cofilin [23,118,211]. Another pathway involves the targeted proteolysis of the
spine-stabilizing protein, SPAR (spine-associated Rap guanosine triphosphatase
activating protein) [12,142]. While these pathways have been demonstrated in other
injury models, it is unclear whether they can explain the spine loss we observed in the
TBI model [233]. Therefore, the present study examined the activity and temporal
profile of these CaN-dependent pathways in the fluid percussion model of TBI. We
report significant changes in CaN activity and in its downstream substrates. Together
with our companion paper [233], these experiments characterize cellular mechanisms
through which TBI can cause dendritic spine loss.

MATERIALS AND METHODS
All animal use procedures were performed in strict accordance with the Guide for
the Care and Use of Laboratory Animals described by the National Institutes of Health
and was approved by the Virginia Commonwealth University Institutional Animal Care
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and Use Committee. Animal subjects received ad libitum access to food and water and
were maintained on 12-hour light/dark cycles throughout the experiment. A total of 105
adult, male Sprague-Dawley rats (90 day old; 350-400g) were used in this study.
These rats were randomly distributed among the following treatment groups: controls
(naïve, age-matched; n=20), FK506-only (n=4), TBI-only (n=76), and TBI+FK506 (n=5).

Fluid percussion injury
The TBI and TBI+FK506 groups were surgically prepared for TBI as follows.
First, rats were anesthetized with sodium pentobarbital l (54 mg/kg intraperitoneally; i.p.)
or isoflurane (3% isoflurane in a carrier gas mixture of 30% N2O and 70% O2) and
placed into a stereotactic frame. The scalp was then incised and a 4.8-mm hole was
made over the left hemisphere using a manual trephine centered 4mm caudal to
bregma and -3mm lateral to the sagittal suture. An anchor screw was inserted into the
skull overlying the opposite hemisphere. A modified female Luer-Loc syringe hub
(2.6mm inside diameter) was placed over the exposed dura, affixed with a
cyanoacrylate adhesive, and then secured with dental acrylic. The hub was filled with
sterile saline and the scalp was sutured closed. On the following day, subjects were
anesthetized with isoflurane (4min in 4% isoflurane in a carrier mixture of 30% N 2O and
70% O2) and subjected to fluid percussion of the intact dura over their left parietal
cortex. The fluid percussion device used in these experiments is identical to that
described by Dixon and colleagues [187]. Immediately after fluid percussion injury, the
Luer-Loc fitting, screw, and dental cement were removed from the skull and the scalp
was sutured closed. Subjects were then placed in a supine position and the time at
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which they righted themselves was recorded. Upon recovery of righting reflexes,
subjects were returned to home cages and monitored daily. At 1hr post-TBI, some rats
(n=5; “TBI+FK506”) received a single injection of FK506 (5mg/kg; i.p.; Astellas Pharma
Inc., Tokyo, Japan). As a drug control group, additional age-matched Sprague-Dawley
rats (“FK506 only”; n=4) were administered FK506 (5mg/kg; i.p.) and then sacrificed
23hr after drug administration.

Isolation and homogenization of brain regions
Rats were briefly anesthetized with isoflurane and quickly decapitated at the
following times after TBI: 1hr (n=7); 6hr (n=4); 12hr (n=5); 18hr (n=13); 24hr (n=18);
24hr+FK506 (n=5); 48hr (n=4); 1wk (n=5); 2wk (n=6); and 4wk (n=5). Age-matched
control rats and FK506-only rats were sacrificed along with TBI rats and in the same
manner. Brains were rapidly dissected on an iced Petri dish to reduce postmortem
enzyme activity. Ipsilateral and contralateral hemispheres of neocortex and
hippocampus were dissected whole and separately homogenized with 10 strokes (up
and down) at 12,000 rpm using a motorized homogenizer (TRI-R Instruments, Inc.,
Rockville Center, NY). Brain regions were homogenized in ice-cold homogenization
buffer containing 7mM EGTA, 5mM EDTA, 1mM dithiothreitol, 0.3 mM
phenylmethylsulfonylfluoride, and 300mM sucrose. Neocortical hemispheres and
hippocampal hemispheres were homogenized in 4mL and 2mL of buffer, respectively.
Homogenates were aliquoted and stored at -80°C until use. Homogenates from the
same animals were used for multiple experiments whenever possible. To control for
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storage artifact in the Western analyses of phosphorylated cofilin, samples from postTBI animals were normalized to equivalently-stored control samples.

pNPP assay of CaN activity
CaN activity was measured using the procedure of Pallen and Wang [234], as
optimized by Kurz et al. [224,235]. Briefly, all reaction tubes were prepared on ice and
contained the following: 25mM MOPS (pH 7.0), 1mM DTT, 2mM p-nitrophenyl
phosphate (pNPP) (Sigma-Aldrich; St Louis, MO, U.S.A.). Tubes used to measure
basal CaN activity also contained 2mM EGTA and 2mM EDTA. Tubes used to measure
maximal CaN activity contained the same reagents as basal reactions, with the addition
of 2mM MnCl2. Manganese activates CaN much more strongly than calcium in the
pNPP assay and is therefore used to reveal changes in maximal CaN activity [224].
Final reaction volumes were 1mL. Prior to use, the protein concentrations of all
homogenate samples were determined using the method of Bradford [236]. Reactions
were initiated by the addition of 50μg/mL brain homogenate. Reactions were incubated
at 37°C for 30min in a shaking water bath. Tubes were then removed from the water
bath and placed in ice to stop the reaction. Absorbance of the reaction mixture was
immediately measured at 405nm in a spectrophotometer (UV-2101, Shimadzu Scientific
Instruments, Inc., Columbia, MD). Absorbance units were converted to nmol of pNP
produced by comparison to a pNP concentration standard absorption curve.

Western analysis
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Brain samples were normalized using the Bradford method, resolved by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Mini-Protean II
system, Bio-Rad, Hercules, CA, U.S.A.), and transferred to nitrocellulose membrane
using the Trans-blot system (Bio-Rad). Transfer quality was confirmed by staining the
blots with a reversible protein stain, Ponceau S (Sigma-Aldrich), according to the
manufacturer’s instructions. After de-staining, blots were twice immersed for 15
minutes in blocking solution containing phosphate buffered saline (PBS, pH 7.4), 0.05%
(v/v) polyoxyethylene sorbitan monolaurate (Tween 20), and 2.5% blotting grade dry
milk (Bio-Rad). Blots were then incubated overnight with the appropriate antibody in
blocking solution at 4°C. Antibodies were used at the following dilutions: rabbit anticofilin, 1:500 (catalog #3842, Chemicon International, Temecula, CA, U.S.A.); rabbit
anti-Ser3 phosphorylated cofilin, 1:500 (catalog #3831, Chemicon International); rabbit
anti-PSD-95, 1:1000 (catalog #51-9600, Invitrogen, San Diego, CA, U.S.A.); goat antiE6TP1 (“SPAR”), 1:1000 (catalog #sc-20846, Santa Cruz Biotechnology). Membranes
were then washed in 0.05% Tween 20-PBS three times for 10 minutes each. Next, the
nitrocellulose was incubated for 45min in the appropriate horseradish peroxidaseconjugated secondary antibody (Thermo Scientific, Waltham, MA, U.S.A.), diluted
1:4000 in blocking solution. The blots were then washed 3 times in PBS for 10min each
wash. Immunoreactive bands were revealed by chemiluminescence (Pierce Femto or
Pico Luminol Substrate, Pierce, Rockford, IL, U.S.A.) and exposed to x-ray films (Kodak
X-OMAT) which were then developed on a Kodak X-OMAT developer. The mean
optical densities of immunoreactive bands were measured by computer-assisted
densitometry (GS-800 Calibrated Densitometer, Bio-Rad) and compared to a linear

80

concentration curve as described previously [237]. In the SPAR and PSD-95
experiments, data were normalized to whole-lane optical densities obtained from the
same Ponceau S stained blots [238].

Statistical analysis
Group means were statistically analyzed with GraphPad Prism 4.0 (Graph-Pad
Software, San Diego, CA, U.S.A.). All comparisons were made by one-way analysis of
variance (ANOVA). Post hoc analyses were conducted with either Tukey’s test (only
data related to Figure 19) or Dunnett’s test (all other data). Groups were considered
significantly different if p < 0.05. All data are presented as group mean ± standard
deviation. Sample sizes (n values) are shown on the figures.

RESULTS
Lateral fluid percussion TBI
Adult male rats received a traumatic brain injury by fluid percussion of the dura
overlying their left parietal cortex. The mean fluid percussion pressure was 2.22 ±
0.11atm and did not differ significantly across groups (F [9,64]=1.111, p=0.3678). A
common correlate of injury severity is the latency between injury and the recovery of the
righting reflex (“righting time”) [191]. In the present study, the mean righting time was
7.00 ± 3.19min. This mean righting time corresponds to an injury of moderate severity
(e.g., [239]). Righting time did not differ significantly across groups (F [9,63]=0.9287,
p=0.5068). Some subjects (n=3) exhibited apnea immediately following injury and were
mechanically ventilated until spontaneous respirations resumed (mean duration, 25 ±
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5sec). The acute mortality rate associated with LFPI in this study was approximately
3% (2 of 76 rats died within 7 days of LFPI and so were excluded from all other data).

Lateral TBI enhanced the enzymatic activity of calcineurin
To determine the effect of lateral TBI on CaN activity, ipsilateral and contralateral
hemispheres of neocortex and hippocampus were dissected, separately homogenized,
and subjected to a well-characterized pNPP assay [118,224,235,240] (see Materials
and Methods). Using this approach, CaN activity was measured either in the absence
of stimulating cations (“basal CaN activity”), or in the presence of stimulating cations
(“maximal CaN activity”).
Lateral TBI had a significant effect on basal CaN activity in the ipsilateral
hippocampus, when compared to analogous tissue from control animals (F
[8,56]=5.617, p<0.0001; Figure 13A). Post hoc analysis indicates that this effect was
delayed, as basal CaN activity at 1hr post-TBI did not differ significantly from controls
(p>0.05). By 6hr post-TBI, however, basal CaN activity in this region had increased
significantly over control levels (p<0.01). The increase was transient, as basal CaN
activity did not differ significantly from controls at 12hr, 18hr, or 24hr post-TBI (p>0.05,
each time point). Basal CaN activity increased again at 1wk post-TBI relative to
controls (p<0.01). This increase also appeared to be transient, as basal CaN activity at
2wk and 4wk post-TBI did not differ significantly from controls (p>0.05, each time point).
The contralateral hippocampus also showed a significant change in basal CaN
activity after lateral TBI, when compared to controls (F [8,56]=5.524, p<0.0001; Figure
13B). Like the ipsilateral hippocampus, basal CaN activity in the contralateral
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hippocampus was unchanged at 1hr post-TBI (p>0.05) but increased significantly by 6hr
post-TBI, relative to controls (p<0.01). Basal CaN activity at 12hr post-TBI was also
significantly elevated over control levels (p<0.01). This increase was transient, as basal
CaN activity returned to control levels by 18hr post-TBI and remained near control
levels at the subsequent time points (p>0.05, each time point). Overall, lateral TBI
caused delayed, transient increases in basal CaN activity in the ipsilateral hippocampus
and in the contralateral hippocampus.
The maximal enzymatic activity of CaN was also altered by lateral TBI. In the
ipsilateral hippocampus, for example, TBI had a significant effect on maximal CaN
activity, relative to controls (F [8,56]=3.283, p=0.0039; Figure 13C). The effect was
delayed though, as maximal CaN activity at 1hr and 6hr post-TBI did not differ
significantly from controls (p>0.05, each time point). By 12hr post-TBI, however,
ipsilateral hippocampus showed a significant increase in maximal CaN activity over
control levels (p<0.05). This increase did not persist, as maximal CaN activity was not
significantly altered at 18hr post-TBI, nor at the later time points, relative to controls
(p>0.05, each time point).
The contralateral hippocampus also showed significant changes in maximal CaN
activity after lateral TBI, compared to controls (F [8,56]=4.791, p=0.0002; Figure 13D).
As with basal CaN activity, maximal CaN activity was unchanged at 1hr post-TBI
(p>0.05) but increased significantly at 6hr and 12hr post-TBI, relative to controls (p<0.01
and p<0.05, respectively). The increase did not persist though, as maximal CaN activity
had returned to control levels by 18hr post-TBI and remained near control levels at the
subsequent time points (p>0.05, each time point). Thus, lateral TBI caused delayed but
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transient increases in maximal CaN activity in the ipsilateral hippocampus and in the
contralateral hippocampus.
Lateral TBI altered CaN phosphatase activity in the neocortex as well. In the
ipsilateral neocortex, for example, lateral TBI had a significant effect on basal CaN
activity and maximal CaN activity relative to controls (basal CaN activity, F [7,43]=5.519,
p=0.0001, Figure 14A; maximal CaN activity, F [7,43]=3.264, p=0.0072, Figure 14C).
The effect was delayed though, as neither basal nor maximal CaN activity differed
significantly from controls at the acute time points, 1hr, 6hr, 12hr, and 24hr post-TBI
(p>0.05, each time point). By 1wk post-TBI, however, ipsilateral neocortex showed
significant increases in both basal CaN activity and maximal CaN activity, compared to
control levels (basal CaN activity, p<0.01, Figure 14A; maximal CaN activity, p<0.05,
Figure 14C). Basal and maximal CaN activity were also increased above control levels
at 2wk post-TBI (basal CaN activity, p<0.05, Figure 14A; maximal CaN activity, p<0.01,
Figure 14C) but returned to control levels by 4wk post-TBI (p>0.05; Figure 14A,C).
The contralateral neocortex also underwent significant changes in basal and
maximal CaN activity after lateral TBI, when compared to control tissue (basal CaN
activity, F [7,43]=3.483, p=0.0048, Figure 14B; maximal CaN activity, F [7,43]=3.088,
p=0.0100, Figure 14D). These too were delayed changes, as neither basal nor maximal
CaN activity differed significantly from controls at 1hr, 6hr, 12hr, 24hr, 1wk, or 2wk postTBI (p>0.05, each time point; Figure 14B,D). By 4wk post-TBI, both basal and maximal
CaN activity had increased significantly above control levels (p<0.01; Figure 14B,D).
The data thus demonstrate delayed but transient increases in CaN activity in the
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ipsilateral neocortex, followed weeks later by an increase in CaN activity in the
contralateral neocortex.

Lateral TBI caused time- and region-dependent changes in pSer3-cofilin
immunoreactivity
To further characterize the TBI-induced changes in CaN activity, we examined
the effect of TBI on cofilin, an endogenous protein which is activated downstream of
CaN [131,241]. Cofilin is an actin-binding and -depolymerizing protein critically involved
in both functional and structural remodeling of excitatory synapses [23,242]. CaN
activation leads to de-phosphorylation of a key serine 3 (Ser3) residue on cofilin,
resulting in an increase in cofilin activity [131,241]. To test whether lateral TBI affects
cofilin Ser3 phosphorylation, ipsilateral and contralateral hemispheres of neocortex and
hippocampus were dissected after lateral fluid percussion injury, separately
homogenized, and subjected to Western analysis with a phospho-specific antibody
recognizing the inactivated, serine 3-phosphorylated cofilin (pSer3-cofilin). This
analysis revealed apparent, time-dependent changes in pSer3-cofilin immunoreactivity
in hippocampal and neocortical structures (Figure 15). In both the ipsilateral and
contralateral hippocampi, for example, pSer3-cofilin immunoreactivity appeared to
decrease acutely, within 1hr of TBI, and remain decreased at 24hr post-TBI (Figure
15A,B). However, in animals allowed to recover for 1wk after injury, pSer3-cofilin
immunoreactivity appeared to return to control levels. A different trend was observed in
the neocortex, where pSer3-cofilin immunoreactivity appeared to increase or remain
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unchanged at 1hr post-TBI, but then decrease at the subsequent time points (Figure
15C,D).
To further investigate the apparent changes in pSer3-cofilin immunoreactivity,
additional Westerns were performed for quantitative analysis (Figure 16). These
experiments confirmed that lateral TBI caused time- and region-dependent changes in
pSer3-cofilin immunoreactivity. For example, lateral TBI significantly altered pSer3cofilin immunoreactivity in the ipsilateral hippocampus, when compared to analogous
tissue from controls (F [6,48]=7.953, p<0.0001; Figure 16A). At 1hr post-TBI in the
ipsilateral hippocampus, pSer3-cofilin immunoreactivity appeared to decrease relative to
control levels, though post hoc analysis indicates that this decrease was not statistically
significant (1hr post-TBI vs. controls, p>0.05). Nor did pSer3-cofilin immunoreactivity at
12hr post-TBI differ significantly from controls (p>0.05). However, a significant
decrease in pSer3-cofilin immunoreactivity was observed at 24hr post-TBI, relative to
controls (p<0.05). This decrease did not persist, as pSer3-cofilin immunoreactivity had
returned to control levels by 1wk post-TBI (p>0.05), and was elevated above control
levels at 2wk post-TBI (p<0.01). Surprisingly, at 4wk post-TBI, pSer3-cofilin
immunoreactivity again fell below control levels (p<0.05).
The contralateral hippocampus also underwent significant changes in pSer3cofilin immunoreactivity after lateral TBI, relative to controls (F [6,48]=13.60, p<0.0001;
Figure 16B). Like the ipsilateral hippocampus, the contralateral hippocampus showed
an acute, TBI-induced decrease in pSer3-cofilin immunoreactivity. Specifically, at 1hr,
12hr, and 24hr post-TBI in the contralateral hippocampus, pSer3-cofilin
immunoreactivity was significantly below control levels (p<0.01, each time point). As
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observed in the ipsilateral hemisphere, pSer3-cofilin immunoreactivity returned to
control levels by 1wk post-TBI and did not change significantly thereafter (1wk, 2wk, or
4wk post-TBI, p>0.05). Overall, the data demonstrate an acute, decrease in apparent
pSer3-cofilin immunoreactivity in both hemispheres of the hippocampus.
Lateral TBI also caused significant changes in pSer3-cofilin immunoreactivity in
the neocortex, though these changes differed from those observed in the hippocampus.
In the ipsilateral neocortex, TBI had a significant effect on pSer3-cofilin
immunoreactivity, when compared to controls (F [6,47]=17.27, p<0.0001; Figure 16C).
However, in contrast to what was observed of the hippocampal fractions, lateral TBI
caused an initial increase in pSer3-cofilin immunoreactivity in the ipsilateral neocortex.
Post hoc analysis shows that, at 1hr post-TBI, pSer3-cofilin immunoreactivity in the
ipsilateral neocortex was significantly increased above control levels (p<0.01). This
initial increase was followed by a decrease, as pSer3-cofilin fell substantially below
control levels by 12hr post-TBI (p<0.01). pSer3-cofilin immunoreactivity was
significantly decreased at all subsequent time points as well, relative to controls (24hr
post-TBI, p<0.01; 1wk post-TBI, p<0.05; 2wk post-TBI, p<0.01; 4wk post-TBI, p<0.01).
The contralateral neocortex also showed changes in pSer3-cofilin
immunoreactivity after lateral TBI (F [6,47]=12.61, p<0.0001; Figure 16D), changes
which were similar to those observed of the ipsilateral neocortex. As in the ipsilateral
neocortex, pSer3-cofilin immunoreactivity in the contralateral neocortex increased over
control levels by 1hr post-TBI (p<0.01). However, pSer3-cofilin immunoreactivity
returned to control levels by 12hr post-TBI (p>0.05). The downward trend continued at
24hr post-TBI, when pSer3-cofilin immunoreactivity decreased substantially below

87

control levels (p<0.01). The pSer3-cofilin immunoreactivity at 1wk and 2wk post-TBI
appeared reduced when compared to controls, but not to a statistically significant extent
(p>0.05, each time point). At 4wk post-TBI though, pSer3-cofilin immunoreactivity was
significantly below control levels (p<0.01), similar to what was observed of the ipsilateral
side. In general, lateral TBI caused acute, but transient increases in pSer3-cofilin
immunoreactivity, followed by delayed but persistent decreases, bilaterally in the
neocortex

Lateral TBI generally caused a transient increase in total cofilin protein
To determine whether TBI-induced changes in pSer3-cofilin immunoreactivity
were due to quantitative changes in cofilin protein, Western analyses were repeated
with an antibody recognizing total cofilin protein, regardless of Ser3 phosphorylation.
This antibody was generated using the same peptide sequence as the pSer3-specific
antibody, but without the phosphate at the Ser3 residue. These analyses revealed
significant changes in total cofilin immunoreactivity, though nearly all of these changes
were increases.
Lateral TBI significantly altered total cofilin immunoreactivity in the ipsilateral
hippocampus relative to analogous tissue from control animals (F [6,48]=40.10,
p<0.0001; Figure 17A). Post hoc analysis indicates that total cofilin immunoreactivity at
1hr and 12hr post-TBI in the ipsilateral hippocampus was significantly above control
levels (p<0.05 and p<0.01, respectively). The increase was transient, as total cofilin
immunoreactivity at 24hr and 1wk post-TBI did not differ significantly from controls
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(p>0.05, each time point). Total cofilin immunoreactivity increased above control levels
again, at 2wk post-TBI (p<0.01), but returned to control levels by 4wk post-TBI (p>0.05).
The contralateral hippocampus also underwent significant changes in total cofilin
immunoreactivity after lateral TBI, relative to controls (F [6,49]=6.342, p<0.0001; Figure
17B). In contrast to the ipsilateral hippocampus, acute changes in total cofilin
immunoreactivity were not observed in the contralateral hippocampus, as total cofilin
immunoreactivity did not differ significantly from controls at 1hr or 12hr post-TBI
(p>0.05, each time point). Nor did total cofilin immunoreactivity change significantly at
24hr or 1wk post-TBI, relative to controls (p>0.05, each time point). As observed of the
ipsilateral hippocampus, however, total cofilin immunoreactivity increased above control
levels at 2wk post-TBI (p<0.01) but then returned to control levels by 4wk post-TBI
(p>0.05). Overall, lateral TBI caused acute and delayed increases in total cofilin
immunoreactivity in each hemisphere of hippocampus, but no significant decrease at
any time point tested.
Lateral TBI altered total cofilin immunoreactivity in the neocortex as well. In the
ipsilateral neocortex, TBI had a significant effect on total cofilin immunoreactivity,
compared to controls (F [6,49]=11.20, p<0.0001; Figure 17C). In contrast to the
hippocampal data, post hoc analysis revealed a decrease in total cofilin
immunoreactivity in the ipsilateral neocortex at 1hr post-TBI (p<0.01). This decrease
was transient, as total cofilin immunoreactivity had returned to control levels by 12hr
post-TBI (p>0.05). Total cofilin immunoreactivity remained near control levels at 24hr
and 1wk post-TBI (p>0.05, each time point) but then increased at 2wk post-TBI, relative
to controls (p<0.01). Similar to what was observed of the hippocampus, the increase at
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2wk post-TBI did not persist, as total cofilin immunoreactivity at 4wk post-TBI in the
ipsilateral neocortex did not differ significantly from controls (p>0.05).
The contralateral neocortex, like the hippocampus, did not show a significant loss
of total cofilin immunoreactivity after lateral TBI, at any time point tested. However, TBI
did have a significant effect on total cofilin immunoreactivity in the contralateral
neocortex relative to controls (F [6,49]=5.228, p=0.0003; Figure 17D). In contrast the
ipsilateral neocortex, total cofilin immunoreactivity at 1hr post-TBI in the contralateral
neocortex did not differ significantly from controls (p>0.05). Nor was there a significant
change in total cofilin immunoreactivity at 12hr post-TBI, relative to controls (p>0.05).
At 24hr post-TBI, however, total cofilin immunoreactivity increased significantly above
control levels (p<0.01). This increase did not last, as total cofilin immunoreactivity had
returned to control levels by 1wk post-TBI (p>0.05) and did not differ significantly from
controls at 2wk or 4wk post-TBI (p>0.05). In general, lateral TBI caused delayed but
transient increases in total cofilin immunoreactivity in each hemisphere of neocortex, but
a decrease only at 1hr post-TBI in the ipsilateral hemisphere.

Lateral TBI resulted in time- and region-specific changes in the percentage of Ser3
phosphorylated cofilin
To correct for TBI-induced changes in cofilin protein expression, pSer3-cofilin
immunoreactivity data were normalized to total cofilin immunoreactivity data for each
tissue sample. This yielded a ratio of pSer3-cofilin to total cofilin (“p/t cofilin”) for each
animal, allowing us to determine whether TBI affected the proportion of Ser3-
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phosphorylated cofilin. Statistical analysis of these data revealed significant changes in
p/t cofilin after lateral TBI, as detailed below.
Lateral TBI significantly altered p/t cofilin in the ipsilateral hippocampus, when
compared to controls (F [6,47]=10.71, p<0.0001; Figure 18A). Post hoc analysis
indicates that p/t cofilin was significantly decreased at 1hr, 12hr, and 24hr post-TBI,
relative to controls (p<0.01, each time point). This decrease did not persist, as p/t cofilin
at 1wk and 2wk post-TBI did not differ significantly from controls (p>0.05, each time
point). At 4wk post-TBI, however, p/t cofilin again decreased below control levels
(p<0.01).
The contralateral hippocampus also underwent significant changes in p/t cofilin
after lateral TBI, relative to controls (F [6,48]=16.76, p<0.0001; Figure 18B). Like the
ipsilateral hippocampus, contralateral hippocampus showed acute and delayed
decreases in p/t cofilin. At 1hr, 12hr, and 24hr post-TBI in the contralateral
hippocampus, for example, p/t cofilin was substantially below control levels (p<0.01,
each time point). The decrease appeared to be transient, as p/t cofilin did not differ
significantly from controls at 1wk post-TBI (p>0.05). However, p/t cofilin decreased
again by 2wk post-TBI (p<0.01), relative to controls, before returning to control levels by
4wk post-TBI (p>0.05). Overall, lateral TBI resulted in significant alterations in p/t cofilin
in both the ipsilateral and the contralateral hippocampus.
Lateral TBI altered p/t cofilin immunoreactivity in the neocortex as well. In the
ipsilateral neocortex, for instance, TBI had a significant effect on p/t cofilin, compared to
controls (F [6,47]=28.98, p<0.0001; Figure 18C). Post hoc analysis shows that p/t
cofilin was increased above control levels at 1hr post-TBI (p<0.01). This increase in p/t
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cofilin was followed by decreases at 12hr and 24hr post-TBI, relative to controls (p<0.05
and p<0.01, respectively). By 1wk post-TBI, p/t cofilin had recovered to control levels
(p>0.05). However, additional decreases in p/t cofilin were observed at 2wk and 4wk
post-TBI, relative to controls (p<0.01, each time point).
The contralateral neocortex also showed significant changes in p/t cofilin after
lateral TBI, relative to controls (F [6,47]=17.37, p<0.0001; Figure 18D). As in the
ipsilateral neocortex, p/t cofilin at 1hr post-TBI in the contralateral neocortex was
significantly above control levels (p<0.01). This increase was transient though, as p/t
cofilin had returned to control levels by 12hr post-TBI (p>0.05). The downward trend
continued at 24hr post-TBI, when p/t cofilin decreased substantially below control levels
(p<0.01). Similar decreases in p/t cofilin were observed at all subsequent time points,
24hr, 1wk, 2wk, and 4wk post-TBI, relative to controls (p<0.01, each time point). In
general, both the ipsilateral and contralateral hemispheres of neocortex showed acute
but transient increases in p/t cofilin, followed by delayed but apparently persistent
decreases in p/t cofilin, after lateral TBI.

Post-TBI treatment with FK506 prevented cofilin de-phosphorylation in neocortex but
not hippocampus
In vitro studies have shown that CaN negatively regulates the phosphorylation of
the cofilin Ser3 residue [241], which could explain how pSer3-cofilin immunoreactivity
decreased after TBI in the absence of any overt loss of cofilin protein (see Figures 3
and 4). To test whether CaN caused the apparent de-phosphorylation of cofilin after
TBI, we administered a selective CaN inhibitor, FK506 (5mg/kg, i.p.) to rats at 1hr post-
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TBI and sacrificed them at 24hr post-TBI (“TBI+FK506”). To control for drug effects, an
age-matched group of uninjured rats (n=5) were also injected with FK506 (5mg/kg, i.p.)
and then sacrificed 23hr post-injection (“FK506-only”). Whole hemispheres of
neocortex and hippocampus were dissected, separately homogenized, and subjected to
Western analysis with a phospho-specific antibody recognizing Ser3-phosphorylated
cofilin. Data were then compared across the following groups, using one-way ANOVA
and Tukey’s post hoc test: controls, FK506-only, TBI-only, and TBI+FK506. These
analyses indicate that FK506 treatment had region-specific effects on pSer3-cofilin
immunoreactivity after lateral TBI.
In the ipsilateral hippocampus, for example, pSer3-cofilin immunoreactivity
differed significantly between the treated groups and controls (F [3,34]=20.97, p<0.001;
Figure 19A). Post hoc comparisons revealed a significant reduction in pSer3-cofilin
immunoreactivity in the TBI+FK506 group relative to either the FK506-only group
(p<0.001) or controls (p<0.001). In addition, pSer3-cofilin immunoreactivity did not differ
significantly between the TBI-only and FK506 groups (p>0.05).
Like the ipsilateral hippocampus, pSer3-cofilin immunoreactivity in the
contralateral hippocampus differed significantly between the treated groups and controls
(F [3,32]=36.24, p<0.0001; Figure 19B). Also like the ipsilateral hippocampus, the
contralateral hippocampus showed a significant loss of pSer3-cofilin immunoreactivity in
the FK506+TBI relative to the FK506-only and control groups (p<0.001, each), but no
significant difference between the FK506+TBI and TBI-only groups (p>0.05). The data
thus suggest that the FK506 treatment failed to prevent the 24hr post-TBI loss of pSer3cofilin immunoreactivity in either hemisphere of hippocampus.
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The ipsilateral neocortex also showed significant differences in pSer3-cofilin
immunoreactivity between the control and treated groups (F [3,33]=10.35, p<0.0001;
Figure 19C). In contrast to the hippocampus, however, pSer3-cofilin immunoreactivity
in the ipsilateral neocortex did not differ significantly between the TBI+FK506 group and
the FK506-only group (p>0.05), nor between the TBI+FK506 group and controls
(p>0.05). In addition, pSer3-cofilin immunoreactivity in the FK506+TBI group was
increased substantially over that of the TBI-only group (p<0.001). This increase in
pSer3-cofilin immunoreactivity was not likely due to an increase in cofilin protein
expression, as one-way ANOVA found no significant difference in total cofilin
immunoreactivity between the control and treated groups (control, n=20, 100 ± 15% of
control; FK506-only, n=4, 97 ± 37% of control; TBI-only, n=10, 113 ± 26% of control;
TBI+FK506, n=5, 92 ± 27% of control; F [3,35]=1.320, p=0.2835).
Like the ipsilateral neocortex, pSer3-cofilin immunoreactivity in the contralateral
neocortex differed significantly between the control and treated groups (F [3,33]=4.109,
p=0.0139; Figure 19D). Also like the ipsilateral side, there was no significant difference
in pSer3-cofilin immunoreactivity between the TBI+FK506 group and the control group
(p>0.05), or between the TBI+FK506 group and the FK506-only groups (p>0.05).
Again, however, there was a significant increase in pSer3-cofilin immunoreactivity in the
TBI+FK506 group relative to the TBI-only group (p<0.05) which did not appear to be
due to an increase in cofilin protein (total cofilin immunoreactivity: control, n=20, 100 ±
14% of control; FK506-only, n=4, 102 ± 32% of control; TBI-only, n=10, 200 ± 108% of
control; TBI+FK506, n=5, 118 ± 42% of control; F [3,35]=6.893, p=0.0009; TBI-only vs.
FK506+TBI, p>0.05). The data thus strongly suggest that the FK506 treatment
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prevented the 24hr post-TBI loss of pSer3-cofilin immunoreactivity in both the ipsilateral
QHRFRUWH[ and contralateral QHRFRUWH[.

Lateral TBI caused a decrease in PSD-95 immunoreactivity
Pathological activation of CaN and cofilin are associated with the degeneration of
excitatory synapses in vitro [12,23,211]. To test whether synapse degeneration
occurred in our TBI model, Western blots were used to measure the immunoreactivity of
a post-synaptic marker protein, PSD-95, in neocortical and hippocampal homogenates
obtained 18hr, 24hr, and 48hr after lateral fluid percussion injury. As described below,
TBI caused a significant loss of PSD-95 immunoreactivity in ipsilateral neocortex and
bilateral hippocampus.
Lateral TBI had a significant effect on PSD-95 immunoreactivity in the ipsilateral
hippocampus, when compared to analogous tissue from control animals (F
[3,13]=13.75, p=0.0003; Figure 20A). Post hoc analysis indicates that PSD-95
immunoreactivity at 18hr, 24hr, and 48hr post-TBI in the ipsilateral hippocampus was
significantly below control levels (p<0.01, p<0.05, and p<0.01, respectively). The
contralateral hippocampus also showed significant changes in PSD-95 immunoreactivity
after lateral TBI, relative to controls (F [3,13]=6.890, p=0.0051; Figure 20B). As in the
ipsilateral hippocampus, PSD-95 immunoreactivity in the contralateral hippocampus
decreased below control levels at 18hr and 24hr post-TBI (p<0.05 and p<0.01,
respectively). Unlike the ipsilateral hippocampus, however, PSD-95 immunoreactivity in
the contralateral hippocampus returned to control levels by 48hr post-TBI (p>0.05).
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Overall, lateral TBI caused an acute loss of PSD-95 immunoreactivity bilaterally in the
hippocampus, though the loss appeared to persist longer in the ipsilateral hemisphere.
Lateral TBI also affected PSD-95 immunoreactivity in the ipsilateral neocortex,
when compared to controls (F [3,14]=8.328, p=0.002; Figure 20C). Post hoc analysis
revealed a significant loss of PSD-95 immunoreactivity in the ipsilateral neocortex at
18hr and 24hr post-TBI, relative to controls (p<0.01 and p<0.05, respectively). This loss
did not persist though, as PSD-95 immunoreactivity at 48hr post-TBI did not differ
significantly from controls (p>0.05). Unlike the ipsilateral neocortex, the contralateral
neocortex showed no significant change in PSD-95 immunoreactivity after TBI, when
compared to controls (F [3,13]=2.921, p=0.0739; Figure 20D). The data thus
demonstrate an acute but transient loss of PSD-95 immunoreactivity in the ipsilateral
neocortex after lateral TBI.

Effect of lateral TBI on SPAR immunoreactivity
Injury to hippocampal neurons in vitro can cause a CaN-dependent induction of
serum-induced kinase (Snk), resulting in increased proteolysis of SPAR, a protein which
is critical to post-synaptic stability [12,145,210]. To determine whether SPAR
proteolysis occurred after lateral TBI, SPAR immunoreactivity was measured using
Western blots of neocortical and hippocampal homogenates obtained 18hr, 24hr, and
48hr after lateral fluid percussion injury. No significant change in SPAR
immunoreactivity was detected in either hemisphere of neocortex or hippocampus, at
any post-TBI time point tested, relative to controls (ipsilateral hippocampus, F
[3,14]=3.134, p=0.0593; contralateral hippocampus, F [3,13]=0.8802, p=0.4767;
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ipsilateral neocortex, F [3,14]=0.3530, p=0.7877; contralateral neocortex, F
[3,13]=2.850, p=0.0784; Figure 21). The data therefore suggest that SPAR proteolysis
is unlikely to be a mechanism behind the dendritic spine loss observed in neocortex and
dentate gyrus at 24hr post-TBI [233].

DISCUSSION
The present study examined the effects of lateral fluid percussion on CaN activity
and CaN-dependent signaling in the rat forebrain. An in vitro assay revealed significant,
time-dependent changes in CaN phosphatase activity in the hippocampus and
neocortex after lateral TBI. Changes in CaN activity were further characterized by
Western analyses. These analyses measured the effect of lateral TBI on two signaling
pathways through which CaN regulates the stability of dendritic spines. The results
implicate cellular pathways through which lateral TBI could alter dendritic spine stability.
Together with its companion study [233], the present study demonstrates a specific
cellular mechanism through which lateral TBI can cause a loss of dendritic spines. This
spine loss may be clinically relevant, if it alters inter-neuronal communication and so
contributes to cognitive impairment.
Analogous to what our group observed in midline TBI model [224,232], lateral
TBI resulted in a delayed, transient change in CaN phosphatase activity in the
hippocampus and neocortex. The increase in CaN activity could be explained by an
acute increase in CaN protein, as has been reported in a different model of lateral TBI
[243]. An alternative hypothesis is that CaN activity is enhanced through some posttranslational modification of the enzyme – e.g., a partial proteolytic cleavage which
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disinhibits its phosphatase activity [244], as has been proposed in models of central
fluid percussion injury [224] and status epilepticus [118,235]. Recently, D’Amelio and
colleagues reported evidence of a caspase-3 cleaved, constitutively active fragment of
CaN in a mouse model of Alzheimer’s disease [245]. Enhancement of CaN activity in
this manner would agree with our findings from the midline TBI model, wherein no
change in CaN holoenzyme expression was observed [224]. However, it is noteworthy
that the changes in CaN activity induced by lateral TBI were not as long-lasting as those
induced by midline TBI. Specifically, the increase in CaN activity lasted for hours after
lateral TBI but for weeks after midline TBI [224].
CaN activity can also influenced by endogenous factors, such as Ca 2+ binding,
that cannot be measured by our in vitro assay. These endogenous changes in CaN
activity can, however, be measured by the downstream effects on CaN substrates. The
present study therefore examined a downstream substrate of CaN, cofilin. CaN activity
leads to de-phosphorylation of a key Ser3 residue on cofilin [131], and the removal of
this Ser3 phosphate enables cofilin to bind and de-polymerize actin [246]. The
breakdown of actin filaments by cofilin is critical to synaptic plasticity and a number of
other cellular processes (reviewed in [247]). Therefore, this choice of substrate allowed
us not only to indirectly measure CaN activity, but to directly assess the cellular
consequences of CaN activity.
The present study found that lateral TBI caused time- and region-dependent
changes in pSer3-cofilin immunoreactivity in both the ipsilateral and contralateral
hemispheres of hippocampus and neocortex. These changes could be due to changes
in cofilin protein expression or Ser3 phosphorylation, or both. While total cofilin
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immunoreactivity did change at some post-TBI time points, relative to controls, only
once did it correspond to a change in pSer3-cofilin immunoreactivity (i.e., at 2wk postTBI in the ipsilateral hippocampus, pSer3-cofilin increased and total cofilin increased).
It is therefore reasonable to conclude that all of the decreases in pSer3-cofilin
immunoreactivity we observed were due to decreased Ser3 phosphorylation and not
due to decreased cofilin protein expression. Likewise, all but one of the increases in
pSer3-cofilin immunoreactivity appeared to be due to increased Ser3 phosphorylation,
not to increased cofilin protein expression. A noteworthy example is the loss of pSer3cofilin which occurred bilaterally in the neocortex at 24hr post-TBI. This loss cannot be
attributed alone to a decrease in cofilin protein, because total cofilin immunoreactivity
was unchanged in the ipsilateral neocortex at 24hr post-TBI, and actually increased in
the contralateral neocortex at this time point, relative to controls. Therefore, the loss of
pSer3-cofilin most likely represents Ser3 de-phosphorylation. Previous studies have
shown that this de-phosphorylation can occur downstream of CaN activity [131].
Though our in vitro assay found no significant change in CaN phosphatase activity at
24hr post-TBI, it is possible that some endogenous (e.g., Ca2+-mediated) increase in
CaN activity led to the cofilin de-phosphorylation we observed. Consistent with this
possibility, the present study found that the CaN inhibitor, FK506, administered 1hr
post-TBI, prevented the loss of pSer3-cofilin immunoreactivity bilaterally in the
neocortex at 24hr post-TBI. The data thus suggest that a TBI-induced increase in CaN
activity leads to cofilin de-phosphorylation in the neocortex at 24hr post-TBI.
The results of the present study strongly suggest that TBI causes cofilin dephosphorylation bilaterally in the rat forebrain. The resulting increase in cofilin activity
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could degrade the actin-rich cytoskeleton of dendritic spines, causing the spines to
shrink or collapse [23,118,211]. Since dendritic spines form most of the excitatory
synapses in the brain, their collapse may physically de-stabilize and disrupt synapses.
Indeed, lateral TBI is associated with synapse degeneration, evident in the loss of
synaptic proteins reported in previous studies [207,248] and the loss of PSD-95
immunoreactivity observed in the present study. Thus, a pathological increase in cofilin
activity may result in not only a loss of dendritic spines, but a loss of spine synapses
[211].
Interestingly, the apparent de-phosphorylation of cofilin observed in the present
study coincides with a loss of dendritic spines reported in our companion study [233].
Specifically, the ipsilateral neocortex at 24hr post-TBI shows both cofilin dephosphorylation (Figure 15) and spine loss [233], and both of which are prevented by a
1hr post-TBI administration of FK506. These studies, along with the evidence from
other models (e.g., [23,118,211]), thus implicate cofilin de-phosphorylation as a
mechanism of dendritic spine loss in the neocortex (Figure 22, “Cofilin Pathway”).
Surprisingly, the same FK506 treatment failed to block cofilin de-phosphorylation
in the hippocampus. We suspect that different timing or mechanisms are involved in
cofilin de-phosphorylation in the hippocampus. For example, CaN may have been
activated in the hippocampus earlier than in the neocortex after lateral TBI. Indeed,
cofilin was significantly de-phosphorylated at 1hr post-TBI in the hippocampus, though it
is unclear from the present study whether this de-phosphorylation is CaN-dependent.
However, if CaN is responsible for this acute de-phosphorylation of cofilin, then FK506
may need to be administered earlier than 1hr post-TBI to fully prevent CaN activation in
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the hippocampus. By 1hr post-TBI, CaN may have already conveyed the signal to dephosphorylate cofilin, or may have been cleaved into a catalytically active fragment
which resists inhibition by FK506 [249].
Though FK506 administration failed to block cofilin de-phosphorylation in the
hippocampus, it fully prevented a concurrent loss of dendritic spines in the dentate
gyrus [233]. One possible explanation is that FK506 inhibits CaN to varying degrees
across the subfields of the hippocampus, perhaps due to differential expression of
FK506’s partner in inhibiting CaN, FKBP12 [250]. A more plausible explanation is that a
different mechanism underlies spine loss in the hippocampus, a mechanism which is
CaN-dependent but cofilin-independent. The present study considered one such
mechanism: the proteolysis of SPAR. SPAR is a post-synaptic protein which stabilizes
dendritic spines in hippocampal neurons [141] (Figure 22, “SPAR Pathway“). In
cultured hippocampal neurons, excitotoxic injury triggers a CaN-dependent increase in
Snk protein, resulting in an increased proteolysis of SPAR and a corresponding loss of
dendritic spines [12]. In contrast to these in vitro findings, however, the present study
detected no significant change in SPAR immunoreactivity at 18hr, 24hr, or 48hr postTBI in the hippocampus, nor in the neocortex. One could conclude then that SPAR
proteolysis did not occur after lateral TBI and so is not a major mechanism of spine loss
in this model. However, our data cannot exclude the possibility that SPAR proteolysis
occurred focally - e.g., within the dentate gyrus, the only hippocampal subfield which
showed spine loss [233]. Such a spatially-limited change in SPAR protein would not
likely be detected in a Western analysis of a whole hippocampal hemisphere. Future
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studies using immunohistochemistry or micro-dissection could detect changes in SPAR
protein with better spatial resolution.
Considering the findings of the present study and its companion [233], we
hypothesize that different, CaN-dependent mechanisms underlie spine loss in the
neocortex and dentate gyrus following lateral TBI. In the neocortex, CaN may cause
spine loss through activation (de-phosphorylation) of cofilin, whereas in the dentate
gyrus, CaN may cause spine loss through a cofilin-independent pathway. These
studies do not, however, exclude the possibility of other CaN-dependent mechanisms of
spine loss in this model. Further investigation is needed to definitively characterize the
mechanisms of spine loss following lateral TBI.
Another interesting parallel between the present study and its companion is
found at the 1wk post-TBI time point. By 1wk post-TBI in the present study, cofilin
phosphorylation had returned to control levels bilaterally in the hippocampus. This
recovery represented a substantial increase in cofilin phosphorylation relative to the
preceding time point. At the same 1wk post-TBI time point, our companion study found
an increase in dendritic spine density bilaterally in the hippocampus [233]. The increase
in cofilin phosphorylation and spine density may be related, as the
phosphorylation/inactivation of cofilin would favor the cytoskeletal expansion necessary
for spine growth. Therefore, the increase in cofilin phosphorylation during recovery from
TBI may play a role in the increase in spine density.
The present study and its companion [233] identify potential mechanisms of
dendritic remodeling in the traumatically-injured forebrain. This remodeling could
disrupt neuronal circuits, or facilitate aberrant re-wiring, and so contribute to cognitive
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impairment and other TBI sequelae. CaN inhibition may help to prevent these sequelae
by preserving synaptic circuits following TBI, and so could be a new option for treating a
widespread medical problem that currently has few treatment options.
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FIGURE 13 - Lateral TBI enhanced calcineurin phosphatase activity in the
hippocampus. Hippocampal tissue was isolated from adult rats at specific times after
lateral fluid percussion injury, homogenized, and subjected to an in vitro assay of CaN
enzymatic activity (see Materials and Methods). CaN activity was measured either in
the absence of stimulating cations (“basal CaN activity”), or in the presence of
stimulating cations (“maximal CaN activity”). In the ipsilateral hippocampus, these
experiments revealed increases in basal CaN activity at 6hr and 1wk post-TBI, relative
to controls (A). Similarly, in the contralateral hippocampus, increases in basal CaN
activity were detected at 6hr and 12hr post-TBI, relative to controls (B). Lateral TBI also
affected the maximal activity of CaN, causing increases at 12hr post-TBI in the
ipsilateral hippocampus (C) and at 6hr and 12hr post-TBI in the contralateral
hippocampus (D), compared to controls. All comparisons were made by one-way
ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01
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FIGURE 14 - Lateral TBI enhanced calcineurin phosphatase activity in the
neocortex. Neocortical tissue was isolated from adult rats at specific times after lateral
fluid percussion injury, homogenized, and subjected to an in vitro assay of CaN
enzymatic activity (see Materials and Methods). CaN activity was measured either in
the absence (“basal CaN activity”) or presence (“maximal CaN activity”) of stimulating
cations. In the ipsilateral neocortex, basal CaN activity increased significantly above
control levels by 1wk and 2wk post-TBI (A). The contralateral neocortex also showed
an increase in basal CaN activity, but weeks later, at 4wk post-TBI, compared to
controls (B). The maximal activity of CaN also changed after lateral TBI, increasing
significantly over control levels at 1wk and 2wk post-TBI in the ipsilateral neocortex (C),
and at 4wk post-TBI in the contralateral neocortex (D). All comparisons were made by
one-way ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01
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FIGURE 15 - Lateral TBI caused apparent changes in pSer3-cofilin
immunoreactivity. Western analysis was performed on crude homogenates of whole
ipsilateral and contralateral hemispheres of hippocampus and neocortex dissected from
adult rats 1hr, 24hr, 1wk, or 2wk after lateral TBI, and from age-matched control rats.
The immunoreactivity of Ser3 phosphorylated cofilin (pSer3-cofilin) was detected with a
phospho-specific antibody. Results suggest that the hippocampus and neocortex
underwent time- and region-dependent changes in pSer3-immunoreactivity after lateral
TBI. In both the ipsilateral and contralateral hippocampi, for example, pSer3-cofilin
immunoreactivity appeared to decrease below control levels by 1hr post-TBI and remain
decreased at 24hr post-TBI (A,B). However, by 1wk post-TBI, pSer3-cofilin
immunoreactivity appeared to have increased to control levels or beyond. A different
trend was observed in the neocortex, where pSer3-cofilin immunoreactivity seemed to
initially increase (C) or remain unchanged (D) at 1hr post-TBI, but then decrease at later
time points (C,D).
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FIGURE 16 - Lateral TBI caused time- and region-dependent changes in pSer3cofilin immunoreactivity. Ipsilateral and contralateral hemispheres of hippocampus
and neocortex were dissected from post-TBI rats and their age-matched controls,
separately homogenized, and subjected to immunoblotting with antibodies recognizing
the serine 3 phosphorylated form of cofilin (pSer3-cofilin). Results indicate significant
changes in pSer3-cofilin immunoreactivity following lateral TBI, relative to controls. In
the ipsilateral hippocampus, for example, pSer3-cofilin decreased significantly at 24hr
post-TBI, increased at 2wk post-TBI, but then decreased again at 4wk post-TBI, relative
to controls (A). The contralateral hippocampus also underwent an acute decrease in
pSer3-cofilin immunoreactivity, at 1hr, 12hr, and 24hr post-TBI, compared to controls
(B). The neocortex showed a different pattern of changes in pSer3-cofilin
immunoreactivity, with an increase at 1hr post-TBI followed by decreases at subsequent
time points, in both the ipsilateral neocortex (C) and contralateral neocortex (D), relative
to controls. Specifically, pSer3-cofilin immunoreactivity decreased below control levels
at 12hr post-TBI and all later time points in the ipsilateral neocortex (C), and at 24hr and
4wk post-TBI in the contralateral neocortex (D). All comparisons were made by oneway ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01

110

111

FIGURE 17 - Lateral TBI generally caused a transient increase in total cofilin
immunoreactivity. Western analyses were repeated using an antibody recognizing
cofilin regardless of Ser3 phosphorylation status (“total cofilin”). Analyses revealed
time- and region-dependent changes in total cofilin immunoreactivity, relative to
controls. In the ipsilateral hippocampus, for example, total cofilin immunoreactivity
increased at 1hr, 12hr, and 2wk post-TBI, relative to controls (A). In the contralateral
hippocampus, total cofilin immunoreactivity also increased above control levels, but only
weeks later, at 2wk post-TBI (B). Unlike all other brain regions tested, the ipsilateral
neocortex decreased in total cofilin immunoreactivity, at 1hr post-TBI, relative to
controls. However, total cofilin immunoreactivity returned to control levels by 12hr postTBI, and then increased above control levels weeks later, at 2wk post-TBI (C). The
contralateral neocortex underwent a delayed increase in total cofilin immunoreactivity,
at 24hr post-TBI, relative to controls (D). All comparisons were made by one-way
ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01
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FIGURE 18 - Lateral TBI caused time- and region-dependent changes in the
proportion of Ser3-phosphorylated cofilin. To determine whether TBI affected the
proportion of Ser3 phosphorylated cofilin, pSer3-cofilin immunoreactivity data were
normalized to total cofilin immunoreactivity data for each sample, yielding a ratio of
pSer3-cofilin to total cofilin (“p/t cofilin”). Analysis of these data identified time- and
region-dependent changes in p/t cofilin. In the ipsilateral hippocampus, for example, p/t
cofilin was significantly below control levels at 1hr, 12hr, and 24hr post-TBI, and again
at 4wk post-TBI (A). In the contralateral hippocampus, a similar reduction in p/t cofilin
was observed at 1hr, 12hr, and 24hr post-TBI, and then at 2wk post-TBI, relative to
controls (B). The ipsilateral neocortex showed an increase in p/t cofilin at 1hr post-TBI,
followed by decreases in p/t cofilin at 12hr, 24hr, 2wk and 4wk post-TBI, relative to
controls (C). A similar pattern was observed in the contralateral neocortex, where p/t
cofilin was significantly above control levels at 1hr post-TBI but then dropped below
control levels at 24hr, 1wk, 2wk, and 4wk post-TBI (D). All comparisons were made by
one-way ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01
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FIGURE 19 – A 1hr post-TBI administration of FK506 prevented the 24hr post-TBI
loss of pSer3-cofilin immunoreactivity in the neocortex. Adult rats received either
lateral fluid percussion TBI alone (“TBI only,”), TBI followed by a 1hr post-TBI injection
of FK506 (5mg/kg; i.p.; “TBI+FK506”), FK506 injection but no TBI (“FK506 only”), or no
treatment (“control”). Treated groups were sacrificed at 24hr post-TBI (or 23hr postinjection), along with equivalently-aged control rats. Ipsilateral and contralateral
hemispheres of hippocampus and neocortex were dissected, separately homogenized,
and subjected to immunoblotting with antibodies recognizing either the serine 3phosphorylated cofilin (pSer3-cofilin). Statistical analysis identified region-specific
effects of FK506 treatment on pSer3-cofilin phosphorylation. For example, FK506
treatment did not prevent the loss of pSer3-cofilin at 24hr post-TBI, in either the
ipsilateral hippocampus (A) or contralateral hippocampus (B). In the neocortex,
however, FK506 treatment completely blocked the loss of pSer3-cofilin at 24hr post-TBI
in both the ipsilateral (C) and contralateral (D) hemispheres. All comparisons were
made by one-way ANOVA with Tukey’s post hoc test. *p<0.05 vs. controls; **p<0.01
vs. controls; ***p<0.001 vs. controls; # p<0.05 vs. other bracketed group; ## p<0.01 vs.
other bracketed group; ### p<0.001 vs. other bracketed group
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FIGURE 20 - Lateral TBI caused a loss of PSD-95 immunoreactivity. Ipsilateral and
contralateral hemispheres of hippocampus and neocortex were dissected from adult
rats at 18hr, 24hr, and 48hr after lateral fluid percussion TBI, separately homogenized,
and subjected to immunoblotting with antibody recognizing the post-synaptic protein,
PSD-95. Lateral TBI caused a significant loss of PSD-95 immunoreactivity at 18hr,
24hr, and 48hr post-TBI in the ipsilateral hippocampus (A) and at 18hr and 24hr postTBI in the contralateral hippocampus (B), relative to controls. In the ipsilateral
neocortex, PSD-95 immunoreactivity also decreased significantly below control levels,
at 18hr and 24hr post-TBI (C). In the contralateral neocortex, however, PSD-95
immunoreactivity did not differ significantly from controls, at any time point tested (D). .
All comparisons were made by one-way ANOVA with Dunnett’s post-hoc test. *p <
0.05; **p < 0.01; n.s., no significant differences
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FIGURE 21 – Effect of lateral TBI on SPAR immunoreactivity. Ipsilateral and
contralateral hemispheres of hippocampus and neocortex were dissected from adult
rats at 18hr, 24hr, and 48hr after lateral fluid percussion TBI, separately homogenized,
and subjected to immunoblotting with an antibody recognizing SPAR. No change in
SPAR immunoreactivity was detected at any time point tested, in the ipsilateral
hippocampus (A), contralateral hippocampus (B), ipsilateral neocortex (C), or
contralateral neocortex (D), relative to controls. All comparisons were made by oneway ANOVA with Dunnett’s post hoc test. n.s., no significant differences
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FIGURE 22 – Calcineurin-dependent mechanisms by which brain injury could
cause dendritic spine collapse. Brain injury can cause an increase in the activity of
the calcium-sensitive phosphatase, calcineurin (CaN). CaN-dependent signaling can
then lead to dendritic spine collapse through regionally-distinct signaling pathways. In
the neocortex, for example, CaN activity may lead to a rapid dephosphorylation/activation of the actin-depolymerizing protein, cofilin. Excessive cofilin
activity could disrupt the spine’s actin-rich cytoskeleton, resulting in spine shrinkage or
de-stabilization [23]. In the hippocampus, however, a different mechanism may be
involved - a mechanism involving CaN but not cofilin. For example, an injury-induced
increase in CaN activity can lead to a transcriptional up-regulation of Snk (seruminducible kinase), ultimately resulting in the targeted proteolysis of a spine-stabilizing
protein, SPAR (spine-associated Rap guanosine triphosphatase activating protein) [12].
SPAR loss is associated with degeneration of post-synaptic function and structure,
including spine loss [12,141,145]. Therefore, cofilin activation and SPAR proteolysis
represent different mechanisms by which CaN may cause spine loss. Evidence from
the present study favors cofilin activation as a regional mechanism of spine loss after
TBI but does not rule out focal involvement of SPAR proteolysis.

122

CHAPTER III
TRAUMATIC BRAIN INJURY CAUSES A TACROLIMUS-SENSITIVE INCREASE IN
NON-CONVULSIVE SEIZURES IN A RAT MODEL OF POST-TRAUMATIC EPILEPSY

INTRODUCTION
Every 16 minutes in the U.S., a traumatic brain injury (TBI) occurs which results
in chronic, recurrent seizures [160,163]. This form of acquired epilepsy, known as posttraumatic epilepsy, is often refractory to medications or surgery [168,169] and so can be
a lifelong disability for the victim and a financial burden which extends to their
community. An ideal therapy would prevent or limit the development of post-traumatic
epilepsy, but no such therapy has yet been found [171]. A better understanding of how
the injured brain becomes epileptic, a process called epileptogenesis, should reveal
novel opportunities for preventing post-traumatic epilepsy.
Epileptogenesis is thought to begin within minutes to hours after brain injury
[176,177], though the underlying mechanisms are still unknown. One hypothesis is that
a pathological increase in intracellular calcium triggers molecular changes which
culminate in neuronal hyperexcitability [33,251]. Calcium-sensitive enzymes which
regulate neuronal excitability may thus play a critical role in epileptogenesis. Indeed,
animal models of acquired epilepsy have implicated a calcium-sensitive phosphatase,
calcineurin [251,252,253,254]. Recent research by our lab suggests that calcineurin
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may also be involved in the epileptogenesis after TBI. In a study of lateral fluid
percussion TBI in rats, a well-characterized model of post-traumatic epilepsy [173,255],
we identified an acute post-injury increase in calcineurin activity [186]. This increase
could facilitate epileptogenesis through the dysregulation of hyperpolarizing cyclic
nucleotide-gated (HCN) channels [254] or voltage-gated potassium channels (KV2.1)
[256]. An increase in calcineurin activity may also alter excitatory synaptic circuits by
destabilizing dendritic spines [11,12,118,204,211,233], potentially creating opportunities
for maladaptive plasticity [78]. The increase in calcineurin activity we observed after
TBI could therefore be an early but critical step in epileptogenesis.
The present study characterized the importance of calcineurin activity in a rat
model of post-traumatic epilepsy. We administered the calcineurin inhibitor, Tacrolimus
(FK506), to adult rats 1 hour after lateral fluid percussion TBI and then monitored
spontaneous seizure activity 5 weeks or 33 weeks later. The results indicate a
significant disease-modifying effect of Tacrolimus in this model of post-traumatic
epilepsy.

MATERIALS AND METHODS
Animal Use and Housing Conditions
All animal care and use complied with the Guide for the Care and Use of
Laboratory Animals described by the National Institutes of Health and was approved in
advance by the Virginia Commonwealth University Institutional Animal Care and Use
Committee. Animals received ad libitum access to food and water and were kept in
temperature- and humidity-controlled housing on 12 hour light/dark cycles throughout

124

the experiment. The present study involved a total of 49 male, Sprague-Dawley rats
acquired as adults (90 day old) and randomly assigned to treatment groups in two
experiments. Experiment 1 assessed spontaneous seizure activity at 33 weeks postTBI and involved the following treatment groups: controls (naïve, age-matched rats;
n=7), sham TBI (n=3), TBI Only (n=10), and TBI+TAC (n=14). Experiment 2 examined
spontaneous seizure activity at 5 weeks post-TBI in different rats assigned to the same
treatment groups: control (naïve, age-matched rats; n=4), TBI Only (n=5), and TBI+TAC
(n=6).

Lateral Fluid Percussion Injury
The procedure for lateral fluid percussion injury has been described previously
[186,233] and was identical for Experiments 1 and 2. All rats except controls were each
anesthetized with 3% isoflurane in a carrier gas mixture of 30% N2O and 70% O2 and
placed into a stereotactic frame. A 5mm circular craniotomy was made over the left
hemisphere using a manual trephine centered between Lambda and Bregma
(approximately -4.4mm Bregma), and midway between the sagittal suture and the
lateral ridge. A modified syringe hub was placed over the craniotomy, affixed to the
skull with a cyanoacrylate adhesive, and then secured with dental acrylic. The hub was
filled with sterile saline and the scalp was sutured closed over the hub. On the following
day, the same rats were anesthetized with isoflurane (4min of 4% isoflurane in a carrier
mixture of 30% N2O and 70% O2) and subjected to fluid percussion of the intact dura
over their left parietal cortex. Sham TBI rats received the same dose of isoflurane but
no fluid percussion. The fluid percussion device used in Experiment 1 is identical to that
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described by Dixon and colleagues (Dixon et al., 1987). A newer model of this device
was used in Experiment 2. Fluid percussion pressure was measured at the time of fluid
impact, by an external pressure transducer adjacent to the hub. The Luer-Loc fitting,
screw, and dental cement were removed from the skull and the scalp was sutured
closed immediately after fluid percussion injury (or, in sham TBI rats, immediately after
discontinuation of isoflurane anesthesia). If apnea occurred immediately following TBI,
rats were mechanically ventilated with room air until spontaneous respiration resumed.
Immediately following injury, rats were placed in a supine position and the time at which
they righted themselves was recorded. Body temperature was maintained for at least 1
hour after injury by placement on a heating pad set to “low.” Rats were then returned to
their home cages and monitored daily. Some rats (TBI+TAC) received a single injection
of Tacrolimus (5mg/kg; intraperitoneal, i.p.; Astellas Pharma Inc., Tokyo, Japan) 1 hour
after TBI.

Video-Electrocorticography
Each rat was anesthetized with 3% isoflurane in a carrier gas mixture of 30%
N2O and 70% O2. The scalp was then incised and reflected, and surgical steel screws
with Teflon-coated leads (1.6mm long shafts, 10mm long leads; Plastics One, Norfolk,
VA, U.S.A.) were implanted over the frontal cortex (3.5mm anterior to Bregma, +/2.5mm lateral to midline), the right parietal cortex (2.0mm posterior to Bregma, +2.5mm
lateral to midline) and the left parietal/occipital cortex (8.0mm posterior to Bregma, 2.5mm lateral to midline). To protect underlying brain tissue, electrode screws were
inserted into the skull to a depth of no more than 0.8mm (i.e., half of the electrode screw
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length). Next, the tips of each electrode lead were inserted into a plastic electrode
platform (Plastics One), the entire headset was then secured in place with dental
acrylic, and the scalp was sutured closed around the base of the headset. Rats were
then allowed to recover for at least 3 days prior to EEG recording, after which they were
lightly sedated with isoflurane (i.e., to the point of slowing reflexes) and connected to a
video-ECoG system (BMSI 5000, Nicolet, Middleton, WI, U.S.A.). A bipolar montage
was used, with individual traces representing the voltage difference between (from top
trace to bottom) the two frontal leads, the two ipsilateral leads, the two contralateral
leads, and the two posterior leads. In Experiment 1, video-ECoG was recorded for at
least 12 hours per rat. In Experiment 2, video-ECoG was recorded daily, or every other
day, until at least 40 hours were recorded in total per rat. To ensure the quality of video
data for behavioral analysis, recordings were scheduled so that at least two-thirds of
video would be recorded during light hours.

Analysis of Spontaneous Seizures (Experiments 1 and 2)
Video-ECoG data in Experiment 1 were analyzed offline by three identicallytrained reviewers, one of whom was blinded to treatment groups. In Experiment 2, all
video-ECoG data were analyzed offline by a single reviewer who was blinded to
treatment groups. All ECoG traces were visually reviewed for electrographic seizures,
defined as paroxysmal, rhythmic trains of spikes, waves, or spike-waves with amplitude
at least double that of baseline (i.e., the 3-second epoch preceding the event) and a
duration of 5 seconds or longer. The duration of ECoG discharge was interpreted as
seizure duration. To characterize ECoG power distribution, spectral analysis with
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Insight II software was performed on a representative sample of seizures (200Hz
sampling of ≥3 second epochs; Persyst Corporation, Prescott, AZ). To estimate the
average frequency of seizures (seizures per hour) for each rat, the number of seizures
observed on video-ECoG was divided by the number of video-ECoG hours reviewed.
Seizure behavior was scored by comparison to a modified Racine scale [257]: sudden
freezing was scored as a “0,” facial twitching as a “1,” head bobbing as a “2,” forelimb
clonus as a “3,” rearing as a “4,” and falling or jumping as a “5.” Seizures with a Racine
score of 0 to 2 were considered “non-convulsive,” whereas those with a Racine score of
3 to 5 were identified as “convulsive.” Seizures were characterized as “non-convulsive”
(Racine stage 0 to 2) or “convulsive” (Racine stage 3 to 5) according to the
corresponding behavior.

Ethosuximide and fos-Phenytoin Challenges (Experiment 1)
A subset of rats in Experiment 1 was used for additional experiments involving
conventional anti-seizure medications. Any epileptic, post-TBI rats with a functioning
ECoG headset were included in these experiments, regardless of treatment group.
These rats were administered a single dose of either ethosuximide (“ETX”; 25mg/kg;
i.p.; Sigma Aldrich, St. Louis, MO, U.S.A.) or fos-phenytoin (“fPHT;” 40mg/kg; i.p. APP
Pharmaceuticals, LLC, Schaumburg, IL, U.S.A.) while being monitored with videoECoG. At least 2 hours of video-ECoG were recorded prior to drug administration, and
at least another 2.5 hours were recorded thereafter. A reviewer blind to the time of drug
administration then visually reviewed ECoG traces for electrographic seizures (see
criteria above). Seizure frequency (seizures/hour) and duration were calculated for the
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2 hour period preceding drug administration and for a 2 hour period beginning 30
minutes after drug administration, to allow time for drug absorption. All pre- and postdrug data were normalized to pre-drug data for each rat. To characterize timedependent changes in seizure frequency, seizure frequency was also calculated for 30
minute segments of each video-ECoG recording. To control for hourly fluctuations in
seizure frequency which were not related to drug administration, analyses were
repeated on previously recorded video-ECoG of the same rats, in which the recording
conditions were the same except that no drugs were administered.

Histology and Analysis of Neocortical Volume (Experiments 1 and 2)
Rats were deeply anesthetized with a euthanasia cocktail (390mg/kg of
pentobarbital, 50mg/kg of phenytoin; i.p.) and then transcardially perfused with roomtemperature 0.9% saline followed by phosphate-buffered 4% paraformaldehyde
(Pease’s fixative). Brains were extracted whole and then immersed in Pease’s fixative
overnight at 4ºC. Brains were examined grossly for evidence of electrode injury,
typically appearing as a small (<1mm) brown lesion on the surface of the neocortex
underlying an electrode. Any rats showing such injury were excluded from all analyses.
Brains were blocked to remove tissue rostral to Bregma and caudal to Lambda. Tissue
blocks were then sectioned in the coronal plane by vibratome (Leica, Wetzler,
Germany). Sections were cut slowly and at a thickness of 75μm to minimize fraying and
folding of peri-lesional tissue. Beginning at the hippocampal commissure (-0.8mm
Bregma), every eighth section was retained until 9 sections were collected per brain (1in-8 series, 600μm intervals; last section at -5.6mm Bregma). This range permitted
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analysis of tissue located 3.6mm rostral and 1.2mm caudal to the site of fluid percussion
impact. Slide-mounted sections were stained with thionine, dehydrated in ethanol,
cleared in xylene, and coverslipped with Permount (Thermo Scientific). Sections were
then imaged through a macro lens (0.5x) on a light microscope (Nikon Eclipse E800M).
Images were opened in ImageJ [258], which was then used to trace the borders of the
ipsilateral and contralateral neocortex and measure the enclosed area. The area of the
ipsilateral neocortex was then divided by that of the contralateral neocortex, yielding a
ratio (“RatioCx”) for each brain section [259]. An analogous procedure was used to
calculate a ratio of the hippocampal hemispheres (RatioHp). Regional boundaries and
distances from Bregma were defined according to a stereotaxic atlas [188].

Statistical Analysis
The normality of data distribution was assessed by Shapiro Wilk test (α=0.05).
Normal data were compared by paired Student’s t test, unpaired Student’s t test, or oneway analysis of variance (ANOVA) with Tukey’s post hoc test (for paired, single, or
multiple comparisons, respectively), including the following: FPI pressure, subject age,
post-TBI time, and pre vs. post-fPHT seizure frequency and duration. Non-normal data
were compared by Wilcoxon matched-pairs signed rank test, Mann Whitney test, or
Kruskall-Wallis test with a post hoc Mann Whitney test (for paired, single, or multiple
comparisons, respectively), including the following: righting reflex latency; seizure
frequency; seizure duration; total seizure time; pre- vs. post-ETX seizure frequency;
RatioCx; RatioHp. Acute mortality rate, prevalence of seizures, and prevalence of
thalamic calcifications were compared across groups using a Chi-square test.
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Spearman’s test was used to assess the correlation between seizure frequency and
each histological measure (RatioCx, RatioHp, and thalamic calcifications). When
testing for a correlation between seizure frequency and thalamic calcifications, each rat
was scored as a “1” or “0” depending on the presence or absence of calcifications,
respectively. All statistical analyses were performed with an alpha level of 0.05, using
GraphPad Prism (version 5.0; GraphPad Software, La Jolla, CA, U.S.A.). Data are
reported as mean ± standard deviation (SD) in the text but are illustrated as mean ±
standard error of the mean (SEM) in the figures. N values represent the number of rats,
unless stated otherwise.

RESULTS
The present study used a total of 49 male, Sprague-Dawley rats acquired as
adults (90 day old) and randomly assigned to treatment groups in two experiments.
Rats were subjected to traumatic brain injury (TBI) by lateral fluid percussion and then
monitored for spontaneous seizure activity at either 33 weeks post-TBI (Experiment 1)
or 5 weeks post-TBI (Experiment 2).

Mortality and Severity of Lateral Fluid Percussion Injury
To ensure that TBI severity was comparable between Experiments 1 and 2, we
examined two correlates of TBI severity, the latency to recovery of righting reflex after
TBI (“righting time”) and the acute mortality rate (i.e., within 7 days of TBI). Overall, the
average righting time was 9.1 ± 3.8 minutes and the average mortality rate was 14%.
Neither righting time nor acute mortality rate differed significantly between experiments
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(righting time, p=0.4599; acute mortality rate, χ2 [5]=3.461, p=0.6293), thus indicating
that TBI severity was equivalent between the two experiments.
EXPERIMENT 1 – Adult, male Sprague-Dawley rats (n=34; 14 ± 1 weeks old)
were administered lateral fluid percussion TBI or a sham injury (n=3), or were kept as
age-matched controls (n=7). At 1 hour post-TBI, rats received either a single dose of
the calcineurin inhibitor, Tacrolimus (5mg/kg; i.p.; “TBI+TAC”; n=14) or no injection (“TBI
Only”; n=10). Age at the time of TBI (or sham) did not differ significantly among
treatment groups (F [2,16]=0.4307, p=0.6574; Table 1). Three rats died within 7 days of
TBI (acute mortality rate, 13%), including one rat humanely sacrificed due to severe
motor impairment. Acute mortality rate varied across treatment groups but not to a
statistically significant extent (mortality rates by treatment: TBI Only, 20%; TBI+TAC,
7%; χ2 [2]=0.8816, p=0.6435). The rats which died acutely after TBI were excluded
from all analyses, as were the additional two rats that died after 7 days post-TBI but
before data collection. Three of the surviving rats (TBI+TAC group) exhibited apnea
immediately following TBI and were mechanically ventilated with room air until
spontaneous respirations resumed (mean duration of ventilation, 1.8 ± 1.1 minutes).
Fluid percussion pressure (surviving rats) and righting time (all rats) were measured as
correlates of injury severity. Among the rats surviving TBI and used for video-ECoG
analysis, fluid percussion pressure averaged 2.7 ± 0.1 atmospheres and righting time
averaged 9.5 ± 4.2 minutes (Table 1). Neither fluid percussion pressure nor righting
time differed significantly between TBI Only and TBI+TAC rats (fluid percussion
pressure, t [15]=1.495, p=0.1558; righting time, p=0.5622), which demonstrates that TBI
severity was equivalent between these groups.
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EXPERIMENT 2 – Adult, male Sprague-Dawley rats (n=15; 14 ± 1 weeks old)
were administered lateral fluid percussion TBI, followed 1 hour later by either
Tacrolimus (n=6; TBI+TAC) or no injection (n=5; TBI Only). Uninjured littermates were
kept as age-matched controls (n=4; Control). Two rats in the TBI+TAC group died
within 7 days of TBI (acute mortality rate, 33%) and so were excluded from analysis. All
other rats survived until completion of the experiment. Overall, the acute mortality rate
associated with TBI in Experiment 2 was 18%. Fluid percussion pressure and acute
mortality were again used to approximate injury severity. The mean fluid percussion
pressure among surviving rats was 2.36 ± 0.04 atmospheres, and the mean righting
time was 8.3 ± 2.8 minutes (Table 1). Neither injury measure differed significantly
between TBI Only and TBI+TAC rats (fluid percussion pressure, t [7]=1.562, p=0.1622;
righting time, p=0.9048), indicating that the severity of TBI was equivalent between
these groups.

Video-Electrocorticography Revealed Two Distinct Types of Late Post-Traumatic
Seizures (Experiment 1)
We used simultaneous video-ECoG to monitor spontaneous seizure activity at 33
± 5 weeks after TBI or sham, or at the equivalent age in control rats (Figure 1A,B). One
rat (sham TBI) was excluded from analysis due to a surgical injury of the neocortex
which occurred during implantation of the ECoG electrodes. Age at time of video-ECoG
did not differ significantly among treatment groups (F [3,22]=2.539; p=0.0827; Table 1).
On average, video-ECoG was recorded over the course of 8 ± 7 days for a total of 51 ±
15 hours per rat (Table 1). In one case the ECoG headset detached from a rat after
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only two days of recording, limiting that rat’s ECoG record to 12.4 hours. We confirmed
electrode depth by examining the neocortex post-mortem. Two rats (TBI Only and
TBI+TAC) were each found to have a small (<1mm) neocortical lesion at an electrode
site and so were excluded from all analyses. The remaining 1,315 hours of ECoG data
were visually reviewed for electrographic seizures, defined as paroxysmal, rhythmic
trains of spikes, waves, or spike-waves, lasting 5 seconds or longer and with an
amplitude at least double that of baseline ECoG activity.
All rats exhibited arrhythmic, low-amplitude ECoG activity during awake behavior
(Figure 1C). In sharp contrast to this baseline activity were observed two distinct types
of electrical seizures. One seizure type appeared on the ECoG as a burst of highvoltage spikes, followed by low-voltage fast activity which evolved into high-voltage
spikes and waves (Figure 1D,E). Spectral analysis of these seizures showed dominant
power in the delta (<4Hz) and theta (4 to 8Hz) ranges (Figure 1E). Analysis of the
corresponding video revealed a tonic contraction followed by forelimb clonus, rearing,
and falling (i.e., progression from Racine stage 3 to 5) – we therefore classified these
events as “convulsive seizures.” Previous studies of lateral fluid percussion TBI have
reported similar seizures [173,259].
The present study identified convulsive seizures in two rats (TBI+TAC) during
video-ECoG recording months after TBI. These seizures occurred at a rate of 0.05 ±
0.04 per hour and lasted an average of 95 ± 14 seconds (n=5 seizures; range 78 – 110
seconds). A third rat (TBI Only) exhibited a convulsive seizure prior to video-ECoG, at
13 weeks post-TBI, but no additional seizures during video-ECoG. Overall, only 5
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convulsive seizures were recorded, rarity which precluded further analysis of these
seizures.
The second type of seizure we observed was distinct in terms of electrographic
appearance, spectral profile, and behavioral correlate. This type of seizure appeared
on the ECoG as a rhythmic train of spike-waves, beginning abruptly or building-up
rapidly across all four ECoG leads, and lasting for tens of seconds (Figure 1F). These
discharges had a spike frequency of 6 to 8Hz, peak spectral power in the theta (4 to
8Hz) and beta (12 to 18Hz) ranges (Figure 1G), and could be interrupted by alerting
stimuli such as sudden changes in lighting or noise (data not shown). The
corresponding video showed subtle but stereotyped changes in behavior, ranging from
behavioral arrest (or immobility) to head bobbing (Racine stage 0 to 2) - we termed
these events “non-convulsive seizures.” Similar seizures have been described in
studies of adult rats following lateral [255] or parasagittal fluid percussion TBI
[172,255,260] or neonatal hypoxic injury [261].
We identified spontaneous, non-convulsive seizures at 33 weeks post-TBI in
94% rats (16 of 17), prevalence similar to that observed months after parasagittal fluid
percussion TBI [172,260]. One rat (TBI Only) did not exhibit any non-convulsive
seizures on video-ECoG, only a single convulsive seizure which occurred prior to videoECoG recording (see above). The two other rats with convulsive seizures also
exhibited non-convulsive seizures, though convulsive and non-convulsive seizures were
never observed on the same day in the same rat. A total of 3,279 non-convulsive
seizures were identified in the video-ECoG record of TBI rats.
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Previous ECoG studies have reported idiopathic seizure activity in uninjured
Sprague-Dawley rats, typically beginning around 7-8 months of age (e.g., [172,260]).
Accordingly, the present study identified non-convulsive seizures in 3 of 7 control rats
and 2 of 2 sham TBI rats (average age, 10 ± 2 months). The seizures in control and
sham TBI rats were similar electrographically, characterized by a generalized onset, a
spike-wave morphology, and peak spectral power in the theta and beta ranges (Figure
2A). The corresponding video showed behavioral freezing (or immobility) lasting at
least as long as the electrographic discharge.

TBI and Age Each Increased the Frequency and Duration of Non-Convulsive Seizures
The non-convulsive seizures of age-matched control and sham TBI rats
resembled those of TBI rats (Figure 2A-C). We therefore compared
treatment groups in terms of seizure prevalence, frequency, or duration. Prevalence
was calculated as the percentage of rats observed to have at least 1 seizure during
video-ECoG monitoring. Non-convulsive seizures appeared to be more prevalent in TBI
Only rats (83%) than in control and sham TBI rats (56%, combined), though the
difference was not statistically significant (χ2 [1]=0.8365, p=0.3604).
We also compared the frequency of non-convulsive seizures across groups
(Figure 2D). Data from control and sham TBI rats were pooled for this analysis, since
these groups did not differ significantly in seizure frequency (control, 2.1 ± 2.5 seizures
per hour; Sham TBI, 0.4 ± 0.1 seizures per hour; t [3]=0.9146, p=0.4279). Controls and
sham TBI rats together exhibited 1.4 ± 1.9 non-convulsive seizures per hour (n=243
seizures). The frequency of non-convulsive seizures was 5-fold higher in TBI Only rats
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than in controls/shams (TBI Only rats, 7.0 ± 3.6 non-convulsive seizures per hour;
n=1,713 seizures; TBI Only vs. controls/shams, t [8]=3.075, p=0.0152).
We then analyzed the duration of non-convulsive seizures (Figure 2E). Data
from control and sham TBI rats were again pooled, since seizure duration did not differ
significantly between these groups (control, 7 ± 1 seconds; sham TBI, 6 ± 0 seconds; t
[3]=1.656, p=0.1963). The mean duration of non-convulsive seizures in controls/shams
was 6.8 ± 1.2 seconds. The durations of non-convulsive seizures in TBI Only rats was
twice as long as in controls/shams (13.6 ± 11.6 seconds; t [8]=2.887, p=0.0203; Figure
2E). In addition, the longest non-convulsive seizure recorded in controls/shams was 15
seconds, but in TBI Only rats was 181 seconds.
An increase in seizure frequency and duration could mean that more time per
hour is spent in a seizure state. To test this possibility, we multiplied the averages of
seizure frequency and seizure duration for each rat. This analysis indicated that TBI
Only rats averaged ten-fold more time per hour in a seizure state than did
controls/shams (p=0.0159; Figure 2F). Thus, non-convulsive seizures in TBI Only rats
were significantly more frequent and longer-lasting than in controls/shams.
Previous ECoG studies have shown that idiopathic seizures become more
frequent with age in Sprague-Dawley rats (e.g., [260]). To confirm this in the present
study, we performed video-ECoG monitoring on uninjured rats that were 5 months older
than the controls/shams (older rats, n=2, 12 video-ECoG hours per rat). The older rats
exhibited spontaneous seizures which were electrographically and behaviorally similar
to those of the age-matched controls/shams (data not shown). However, seizure
frequency differed significantly between the older and younger rats (p=0.0206).
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Specifically, the older rats exhibited 9.7 ± 0.4 seizures per hour (n=232 seizures), a 7fold increase in frequency over that of controls/shams (p<0.05; Dunn’s post hoc test).
Interestingly, seizure frequency in older rats was comparable to that of TBI Only rats
(p>0.05).
Older rats also differed from the younger rats in terms of seizure duration
(p=0.0168). Specifically, the idiopathic seizures of older rats lasted 24.5 ± 4.0 seconds
on average (range, 5 – 129 seconds), significantly longer than those of the younger
controls/shams (p<0.05; Dunn’s). However, seizure duration did not differ significantly
between the older rats and the TBI Only rats (p>0.05; Dunn’s). The preliminary data
thus indicate that idiopathic seizures increase in frequency and duration with age, and
suggest that TBI may accelerate this process.

Tacrolimus Administered at One Hour Post-TBI Reduced the Frequency of NonConvulsive Seizures Months Later
Our lab recently demonstrated that calcineurin activity in the rat cortex increases
within hours of lateral fluid percussion TBI [186], suggesting that calcineurin may be
involved in post-traumatic epileptogenesis. We therefore administered a calcineurin
inhibitor, Tacrolimus (5mg/kg; i.p.; TBI+TAC; n=12) to rats 1 hour after lateral fluid
percussion TBI and then monitored the rats by video-ECoG alongside their untreated
counterparts (TBI Only) at 33 ± 5 weeks post-TBI. As mentioned above, 1 TBI+TAC rat
was excluded from analysis due to a small (<1mm) neocortical lesion at an electrode
site. Data from the remaining TBI+TAC rats (n=11) are summarized below.
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Like the TBI Only rats, TBI+TAC rats exhibited spontaneous non-convulsive seizures
months after lateral TBI (Figure 3A). The prevalence of these seizures did not differ
significantly between TBI+TAC rats and TBI Only rats (100% and 83%, respectively;
χ2[1]=1.948, p=0.1628). We then compared TBI groups in terms of seizure frequency
and duration. This analysis indicated that non-convulsive seizures were significantly
less frequent in the TBI+TAC group than in the TBI Only group (p=0.0414; Figure 3B).
However, seizure duration did not differ significantly between the TBI groups (p=0.2127;
Figure 3C). Multiplying seizure frequency by seizure duration for each rat revealed that
TBI+TAC rats averaged significantly less seizure time per hour than did TBI Only rats
(p=0.0414; Figure 3D). The data overall indicate that administering Tacrolimus at 1
hour post-TBI reduced the frequency of spontaneous non-convulsive seizures months
later.
Differences in seizure frequency between groups could be explained by
differences in the light/dark dependency of seizures. For example, since most videoECoG was recorded during light hours, seizure frequency could be underestimated if
more seizures occurred during the dark hours. Plotting seizure onset times on a Raster
did not suggest any light/dark dependence (Figure 4A), and seizure frequency did not
differ significantly between light hours and dark hours of ECoG recording (for each
treatment group, p>0.05 for light vs. dark seizure frequency; paired Student’s t test;
Figure 4B).
Review of the Uaster plots also revealed a clustering pattern to the nonconvulsive seizures, especially in the brain injured rats (Figure 4A). To confirm the
apparent clustering, we averaged the time between seizures for each rat and then
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compared group means (Figure 4C). A binned analysis indicated that about 50% of
non-convulsive seizures occurred within seconds of one another in the TBI Only and
TBI+TAC rats. In the controls/shams however, only about 25% of non-convulsive
seizures occurred within seconds of one another. The apparent increase in seizure
clustering in TBI rats could be due to an increase in seizure frequency. However,
seizure frequency did not differ significantly between the TBI+TAC and controls/shams
(p>0.05), though seizures tended to cluster more in the TBI+TAC rats (Figure 4C). The
data thus suggest that TBI enhances clustering of non-convulsive seizures, independent
of the change in seizure frequency.
Nearly one-third of the ECoG data in Experiment 1 were reviewed blind to
treatment group (28% overall; by treatment group, 0% control/sham, 34% TBI Only, and
43% TBI+TAC). The remaining data were reviewed without blinding and so may have
been subject to experimenter bias. To control for this potential confound, we tested
whether blinding affected seizure identification in the ECoG reviewers. Three ECoG
recordings (~18 ECoG hours total) were analyzed independently by two reviewers, one
of whom was blinded to treatment group. The blinded reviewer counted 8.0 ± 5.3
seizures per recording, whereas the unblinded reviewer counted 8.3 ± 4.6 seizures per
recording. Paired analysis confirmed that seizure counts did not differ significantly
between the blinded and unblinded reviews (p=0.7728; Wilcoxon). The data suggest
that blinding ECoG reviewers to treatment group in the present study did not confound
seizure identification.
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Ethosuximide and fos-Phenytoin Differentially Affected the Frequency of Spontaneous
Non-Convulsive Seizures
The conventional anti-seizure medication, ethosuximide (ETX), LV
effective against multiple types of spontaneous non-convulsive seizures in rat models.
For example, a single dose of ETX (50mg/kg; i.p.) can reduce both the frequency of
absence seizures in a genetic model [262] and the frequency of partial seizures in an
iron-induced neocortical injury model [263]. To determine whether ETX had a similar
effect on non-convulsive seizures in the present study, we administered ETX (50mg/kg;
i.p.) to a subset of epileptic rats (n=6) during video-ECoG. This testing took place 1
week after the rats were monitored for spontaneous seizure activity. To ensure that a
decrease in seizure frequency could be detected, we only included rats which had
exhibited a high frequency of non-convulsive seizures (≥ 5 seizures/hr; n=6 rats).
We assessed seizure frequency and duration during the 2-hour period
immediately preceding ETX administration (“pre-ETX period”) and for the 2-hour period
beginning 30 minutes after ETX administration (“post-ETX period”). During the pre-ETX
period, rats averaged 7.0 ± 9.3 non-convulsive seizures per hour, lasting 14.3 ± 10.8
seconds. Compared to the pre-ETX period, seizure frequency decreased by 92% in the
post-ETX period (p=0.0313, Wilcoxon; Figure 5A,D). The decrease in seizure
frequency was equivalent between TBI rats and uninjured rats (TBI rats, 96 ± 8%
decrease; older, uninjured rats, 83 ± 24% decrease; t [4]=1.082; p=0.3402). We did not
compare seizure duration between the pre-ETX and post-ETX periods, because only 1
rat exhibited seizures during the post-ETX period (post-ETX seizure duration, 10.1 ± 3.5
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seconds). The data overall suggest that ETX reduces the frequency of spontaneous
non-convulsive seizures.
We then treated a different group of epileptic rats (n=4) with another anti-seizure
medication, fos-phenytoin (fPHT; 40mg phenytoin equivalents/kg; i.p.), the pro-drug
form of phenytoin. In contrast to ETX, phenytoin has shown contrary effects in rat
models of non-convulsive seizures. Phenytoin can aggravate absence seizures in
genetic models [264,265] at doses which inhibit partial seizures during electrical [266] or
chemical kindling [267]. The present study used fPHT instead of phenytoin, because
fPHT is more reliably absorbed when administered intraperitoneally but has shown
similar pharmacokinetics and dose-equivalent efficacy in a rat model of partial seizures
[268]. Rats in the present study were administered fPHT 9 ± 6 weeks after monitoring
for spontaneous seizure activity. To ensure that bi-directional changes in seizure
frequency could be detected, we only included rats which exhibited a moderate
frequency of non-convulsive seizures (≈ 2/hr; n=4 rats) at 33 weeks post-TBI.
We measured seizure frequency and duration in the 2-hour period immediately
preceding fPHT administration (“pre-fPHT period”) and in the 2-hour period beginning
30 minutes after fPHT administration (“post-fPHT period”). One rat exhibited no
seizures during the pre- or post-fPHT periods. All other rats showed non-convulsive
seizures during both periods, averaging 1.6 ± 1.3 seizures per hour in the pre-fPHT
period, and 6.1 ± 3.3 seizures per hour in the post-fPHT period (Figure 5B,D). Despite
the nearly 4-fold increase in seizure frequency, a paired analysis found no significant
difference in seizure frequency between the pre- and post-fPHT periods (t [4]=2.423,
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p=0.0725). Nor did seizure duration change significantly after fPHT treatment (prefPHT, 9.7 ± 6.4 seconds; post-fPHT, 8.9 ± 5.5 seconds; t [4]=0.5512, p=0.6108).
The changes in seizure frequency following ETX and fPHT treatment could
represent either normal fluctuations or drug effects. To FRPSDUHWKHVHSRVVLELOLWLHV, we
reviewed previous ECoG of the rats later used in the ETX and fPHT experiments. The
recording conditions for these ECoG were the same as in the ETX and fPHT
experiments, except that no drug was administered. We assessed non-convulsive
seizure frequency in 2-hour periods which were analogous to the pre- and post-drug
periods in the ETX and fPHT experiments. A paired analysis found no significant
difference in seizure frequency between the first and second 2-hour periods, either
among the rats later treated with ETX or among those later treated with fPHT (p=0.4615
and 0.2785, respectively; Wilcoxon; Figure 5C,D). Therefore, the changes in seizure
frequency following administration of ETX and fPHT most likely represent drug effects.

Tacrolimus Did Not Protect against Cortical Atrophy or Thalamic Calcifications following
TBI (Experiment 1)
Lateral fluid percussion TBI causes progressive degeneration of ipsilateral cortex
over the course of a year [269], and the degeneration of certain cortical regions
correlates with the incidence of late spontaneous seizures [259]. Therefore, to
determine the location and extent of cortical degeneration in the present study, we
sacrificed the rats of Experiment 1 at 43 ± 8 weeks post-TBI (or sham) and processed
them for histology, along with age-matched controls. Groups did not differ significantly
either in age at sacrifice or in time between TBI and sacrifice (age at sacrifice, F
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[2,20]=1.438, p=0.2610; time between TBI and sacrifice, F [2,14]=0.1998, p=0.8212;
Table 1). Gross examination of fixed brains from TBI rats revealed an opaque lesion,
1mm or more in diameter, at or just ventral to the site of fluid percussion impact. We
collected coronal sections at 0.6mm intervals between 0.8mm and 5.6mm caudal to
Bregma, stained the sections with thionine and examined them by light microscopy
(Figure 6A,B). Most TBI brains showed at least 1 opaquely-stained lesion in the
ipsilateral thalamus (Figure 6C and inset in Figure 6B). We interpreted these lesions as
thalamic calcifications, based on similar findings in previous studies of fluid percussion
TBI [172,259]. Thalamic calcifications were identified in nearly all TBI rats but never in
control rats (Figure 6C). However, the prevalence of these calcifications did not differ
significantly between TBI Only and TBI+TAC rats (χ2 [1]=0.7804; p=0.3770; Figure 6C).
Nor did the presence of calcifications correlate with seizure frequency, either within or
across groups (p>0.05). The data therefore suggest that thalamic calcifications were
not related to the frequency of non-convulsive seizures after lateral TBI.
Initial examinations also suggested atrophy of the ipsilateral neocortex in all TBI
rats. To quantify the apparent atrophy, we used ImageJ to trace the ipsilateral and
contralateral neocortex in micrographs and then measure the area enclosed by the
tracing (Figure 6B). The traced area of the ipsilateral (left) neocortex was then divided
by that of the contralateral (right) neocortex in each brain section, yielding a ratio of the
two hemispheres (“RatioCx”) [259]. This analysis revealed significant differences in
RatioCx among the treatment groups, as described below.
NEOCORTEX - The RatioCx in control brains was consistent along the rostrocaudal axis, averaging 0.98 ± 0.01 when measured from -0.8mm through -5.6mm
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Bregma (Figure 6D). Cross-comparison of the mean RatioCx revealed significant
differences among treatment groups (mean RatioCx, p=0.0022; Figure 6D2). Post hoc
analysis indicated, for example, that the RatioCx was significantly decreased in TBI
Only rats relative to controls (p=0.0043). The RatioCx in TBI+TAC rats was also
decreased from control levels (p=0.0002). The decrease in RatioCx in TBI+TAC rats
appeared to be comparable to that of TBI Only rats, as the TBI groups did not differ
significantly from one another (p=0.6787). RatioCx decreased most likely due to
atrophy of the ipsilateral neocortex, since the area of the contralateral neocortex did not
differ significantly across treatment groups (control, 10.6 ± 1.4 arbitrary units, A.U.; TBI
Only, 9.9 ± 0.3 A.U.; TBI+TAC, 10.4 ± 0.9 A.U.; p=0.3228, Kruskal-Wallis) [259]. The
data thus demonstrate substantial atrophy of the ipsilateral neocortex by 43 weeks postTBI, and agree with previous findings that Tacrolimus does not prevent neocortical
atrophy following TBI [270,271].
Previous research has shown that the risk of spontaneous seizures increases
with the severity of neocortical atrophy following lateral fluid percussion TBI [259]. We
therefore used linear correlation to test whether seizure frequency and neocortical
atrophy were related. However, mean RatioCx did not correlate with the frequency of
non-convulsive seizures, either within TBI groups or when all TBI groups were
combined (each, p>0.05). The data thus suggest that neocortical atrophy is not related
to non-convulsive seizure frequency after lateral TBI.
We did not perform correlational analysis on convulsive seizure data due to lack
of data. It is worth noting, however, that the two rats exhibiting convulsive seizures on
video-ECoG also had the most severe neocortical atrophy (i.e., first and second lowest
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mean RatioCx among all rats). Quantitative analysis revealed that the RatioCx was
significantly decreased in these two rats, when compared to the TBI rats in which no
convulsive seizures were observed (t [13]=4.563, p=0.0005). The data therefore
support previous research showing a correlation between neocortical atrophy and
convulsive seizures after lateral TBI [259].
HIPPOCAMPUS – We also assessed atrophy in the hippocampus, since
previous research has linked hippocampal asymmetry related to the incidence of late
non-convulsive seizures after fluid percussion TBI [260]. In the present study, we
estimated hippocampal atrophy by tracing the ipsilateral and contralateral hippocampi,
measuring the enclosed areas (Figure 6B), and then calculating a ratio of ipsilateral to
contralateral area (“RatioHp”). Analysis of RatioHp was limited to Bregma levels 3.2mm through -5.6mm for two reasons. First, hippocampal gray matter was not
present in the sections representing -0.8mm and -1.4mm Bregma. Second, the rostral
end of the hippocampus appeared to have shifted caudally after TBI, confounding the
RatioHp in those sections (Figure 6E).
RatioHp in controls was consistent along the rostro-caudal axis, averaging 1.03 ±
0.03 when measured from Bregma levels -3.2mm to -5.6mm (Figure 6E). As with
RatioCx, RatioHp differed significantly among treatment groups (mean RatioHp,
p=0.0028; Figure 6E2). In particular, RatioHp in TBI Only rats was significantly
decreased relative to controls (p=0.0087). TBI+TAC rats also showed a loss of RatioHp
when compared to controls (p=0.0005), but not when compared to TBI Only rats
(p=0.3710). As with RatioCx, RatioHp most likely decreased due to changes in the
ipsilateral hippocampus, since the area of the contralateral hippocampus did not differ
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significantly across treatment groups (control, 4.6 ± 0.4 arbitrary units, A.U.; TBI Only,
4.2 ± 0.4 A.U.; TBI+TAC, 4.6 ± 0.7 A.U.; p=0.3646, Kruskal-Wallis). Overall, the data
suggest that the ipsilateral hippocampus underwent a significant change in volume
and/or shape by 43 weeks post-TBI. While this change is consistent with previous
reports of hippocampal asymmetry after fluid percussion injury [260], it did not appear to
be related to the expression of non-convulsive seizures, since RatioHp did not correlate
with non-convulsive seizure frequency (within or across the TBI groups, p>0.05).

Seizures Were Not Observed at 5 Weeks Post-TBI (Experiment 2)
Spontaneous non-convulsive seizuresFDQ begin a few weeks after lateral
fluid percussion TBI and increase in both frequency and severity over months [255]. To
characterize the timing of seizure development in the present study, we subjected a
different set of rats to lateral fluid percussion TBI and then monitored spontaneous
seizure activity by video-ECoG 5 weeks later (Experiment 2; Figure 7A). The severity of
TBI in Experiment 2 was equivalent to that in Experiment 1 (see Results above), and
the treatment groups were also the same - rats received either a single dose of
Tacrolimus (5mg/kg; i.p.; “TBI+TAC”; n=4) or no injection (“TBI Only”; n=5) at 1 hour
post-TBI. At 5 weeks post-TBI, injured rats and their uninjured littermates (n=4) were
monitored by simultaneous video-ECoG. Video-ECoG was recorded 12 ± 1 hours per
rat, beginning in the morning and completed the same day. A trained observer who was
blinded to treatment group then visually reviewed video-ECoG data offline for evidence
of seizure activity.
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Low-voltage, arrhythmic electrographic activity was observed during awake
behavior in all rats. In contrast to the baseline ECoG activity were observed paroxysmal
discharges lasting less than 5 seconds. These epileptiform discharges were observed
occasionally (<1/hr) in all TBI rats (Figure 7B) and in one control rat (Figure 7C).
However, epileptiform activity lasting longer than 5 seconds was not observed in any
rat. The data thus confirms previous reports that seizure prevalence and/or frequency
increases over months following fluid percussion TBI [172,255,260].

DISCUSSION
The present study describes several major findings related to the long-term
electrographic and anatomical consequences of lateral TBI. For example, video-ECoG
revealed two distinct types of spontaneous seizures in adult rats months after TBI.
These seizure types included convulsive seizures which were infrequent but lasted for
minutes, and non-convulsive seizures which were frequent but lasted tens of seconds
on average. A subset of age-matched, uninjured rats exhibited idiopathic seizures, and
these idiopathic seizures were electrographically and behaviorally similar to the nonconvulsive seizures seen months after TBI. However, the idiopathic seizures were far
less frequent and shorter lasting than the non-convulsive seizures of TBI rats.
Interestingly, administering a calcineurin inhibitor, Tacrolimus (TBI+TAC) at 1 hour postTBI significantly decreased the frequency of non-convulsive seizures months later but
did not protect against cortical atrophy or thalamic calcifications. A second video-ECoG
experiment performed at 5 weeks post-TBI revealed epileptiform discharges but no
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seizures, suggesting that both the convulsive and non-convulsive seizures have a
delayed onset. The context and implications of the major findings are discussed below.
Studies of post-traumatic epilepsy in human patients and rodent models suggest
that epileptogenesis begins within minutes to hours of TBI [176,177]. Our previous
research identified an increase calcineurin activity in the minutes to hours following
lateral fluid percussion TBI [186]. This increase in calcineurin activity could be an early
but critical event in the development of post-traumatic epilepsy, as has been proposed
in other models of acquired epilepsy (reviewed in [251]). Consistent with this possibility,
the present study demonstrated that administering a calcineurin inhibitor, Tacrolimus, 1
hour after TBI reduced the frequency of spontaneous non-convulsive seizures months
later. This finding may shed light on the timing and mechanisms by which nonconvulsive seizures develop after TBI, as it reveals a Tacrolimus-sensitive mechanism
which is engaged acutely after TBI. Though only a single dose of Tacrolimus was
administered in the present study, previous studies suggest that brain levels can remain
stable for days [272]. It is therefore possible that Tacrolimus inhibited calcineurin
activity for days after TBI, potentially blocking the increase in calcineurin activity our lab
previously identified in this model [186]. Importantly, these findings suggest that
pharmacological intervention at a clinically-relevant time point can alter the course of
epilepsy development after TBI.
Further research is needed to characterize the role of calcineurin in
epileptogenesis. One possibility is that a pathological increase in calcineurin activity
leads to the dysregulation of hyperpolarization-activated cation (HCN) channels [254].
Calcineurin has been shown to downregulate gating of HCN channels, resulting in
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neuronal hyperexcitability [254], and a reduction in HCN channel expression in rat
cortex is associated with epileptogenesis after status epilepticus [273,274]. HCN
channelopathy may also explain the spontaneous non-convulsive seizures observed in
the present study. HCN channels are downregulated in subthalamic nuclei in the
tottering mouse, a genetic model of spontaneous non-convulsive seizures [275]. In
addition, mice lacking a subtype of HCN channels (HCN2) also exhibit spontaneous
non-convulsive seizures [276]. It is therefore possible that TBI induces (or exacerbates)
the development of spontaneous non-convulsive seizures through a calcineurindependent dysregulation of HCN channels, and that this process begins within hours or
days of TBI.
Calcineurin may also mediate epileptogenesis through its effects on the immune
system or in synaptic circuits. For example, calcineurin mediates pro-inflammatory
signaling by interleukin-1β and tumor necrosis factor-α, and these signaling pathways
have been strongly implicated in epileptogenesis [226,277,278,279]. An alternative but
not exclusive possibility is that calcineurin facilitates epileptogenesis by destabilizing
dendritic spines. Various injury models have shown that drugs which inhibit calcineurin
activity also block the loss of dendritic spines after injury, including the spine loss we
observed in the neocortex and dentate gyrus after lateral TBI [11,12,118,233]. Since
dendritic spines bear the majority of excitatory synapses in the adult cortex [5], a
widespread and persistent loss of spines could equate to deafferentation.
Deafferentation can induce epileptiform activity in the neocortex [280,281,282],
potentially through a homeostatic increase in network excitability [283]. In addition,
studies of human epileptic tissue have found that spine loss in the dentate gyrus
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correlates with an abnormal prolonging of excitatory post-synaptic responses [284,285],
which could support seizure activity.
Previous studies of the lateral fluid percussion model have reported either
convulsive seizures or non-convulsive seizures in the months following TBI [173,255].
For example, Kharatishvili and colleagues (2006) described infrequent but long-lasting
convulsive seizures in up to 50% of rats after TBI, but did not note any non-convulsive
seizures [173]. In contrast, a study by Curia et al. (2011) found frequent but shortlasting non-convulsive seizures in nearly all rats after TBI, but did not note any
convulsive seizures [255]. The present study is thus the first (to our knowledge) in
which both types of seizures were identified after TBI, and in the same rats.
Methodological differences could explain the discrepant findings in previous studies.
For example, adolescent rats (1 month old) like those used in the Curia et al. (2011)
study may be less likely to develop convulsive seizures after fluid percussion TBI than
the adult rats used in the present study and in the Kharatishvili et al. (2006). Agedependency is characteristic of other models of acquired epilepsy – for example, rats
younger than 25 days are less likely to develop spontaneous convulsive seizures
following experimental status epilepticus [286,287].
While the post-traumatic seizures observed in the present study resemble those
seen in previous studies, questions remain about the nature of the non-convulsive
seizures. Specifically, it is unclear whether these seizures represent an acquired form
of partial epilepsy [288], or an exacerbated form of idiopathic, absence-like epilepsy
[289,290]. Previous studies have reported that the non-convulsive seizures are focal in
origin [172], involve limbic regions, and can be electrographically differentiated from
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idiopathic seizures on the basis of waveform and localization [260]. Subsequent
research also determined that the non-convulsive seizures were insensitive to the antiseizure drug, carisbamate [291], at dosages above those which suppress absence
seizures in rat models [292] (but see also [293]). Overall, the evidence from previous
studies suggests that the non-convulsive seizures are partial seizures, like those
frequently seen in human post-traumatic epilepsy [166,288]. The non-convulsive
seizures in the present study, however, more closely resembled absence seizures. For
example, the seizures we observed typically had a generalized onset, spike-wave
morphology, and dominant spectral power in the theta and beta ranges. These
electrographic features are typical of absence seizures in rats [294]. Also, the nonconvulsive seizures we observed could be interrupted by sensory stimulation,
suppressed by ETX, and exacerbated by fos-phenytoin - also characteristic of absence
seizures [262,264,265,295] (but see also [263,296,297]). However, further
investigation is needed to confirm that the non-convulsive seizures we observed months
after TBI were absence seizures.
Studies of other rat models suggest that brain injury can cause or exacerbate
absence-like seizures in rats. For example, focal thrombolytic damage to rat neocortex
has been shown to impair the excitability of thalamic reticular neurons [298], cells which
normally inhibit thalamocortical circuits implicated in involved in absence seizures [299].
More diffuse brain injuries may also give rise to absence seizures. For example, rats
develop absence-like seizures weeks to months after pilocarpine-induced status
epilepticus [300,301] . For example, Francois and colleagues (2011) found that
administering adult male Sprague-Dawley rats the anti-seizure drug, carisbamate (90 or
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120mg/kg), after pilocarpine-induced status epilepticus reduced by half the number of
rats developing late convulsive seizures [300]. These rats instead developed frequent,
non-convulsive seizures which were not observed in rats with convulsive seizures, and
which were electrographically, behaviorally, and pharmacologically similar to absence
seizures [300]. Though the authors note that a third of age-matched controls also
showed absence-like seizures, the seizures in post-SE rats were nearly ten-fold more
frequent than in controls [300]. Likewise in the present study, non-convulsive seizures
in brain injured rats study were similar in phenotype to idiopathic seizures, but were
significantly more frequent and longer lasting. Together these studies suggest that
brain injury can increase the frequency of absence-like seizures in adult rats [290].
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TABLE 2 – TBI Severity, Age, and Video-ECoG Duration.

Values represent mean ± standard deviation.
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FIGURE 23 – Video-Electrocorticography Revealed Two Distinct Types of Late
Post-Traumatic Seizures. Adult, male Sprague-Dawley rats were subjected to lateral
fluid percussion TBI or sham TBI and then monitored for spontaneous seizure activity
33 ± 5 weeks later, alongside age-matched uninjured controls. A) Timeline of
Experiment 1. B) Placement of fluid percussion impact (FPI) and epidural electrodes
for electrocorticography (ECoG). C) Arrhythmic, low-voltage ECoG activity typical of
awake behavior in all rats, shown as bipolar montage. D) Representative ECoG of
convulsive (tonic-clonic) seizures observed months after TBI. E) On left, enlarged
ECoG trace showing irregular spike-and-wave waveform of convulsive seizures. On
right, spectral analysis of a 3 second epoch showing typical distribution of power during
a convulsive seizure. F) Representative example of ECoG of non-convulsive seizure.
G) On left, enlarged ECoG trace revealing spike-wave waveform of non-convulsive
seizures. On right, spectral analysis of a 3 second epoch showing typical distribution of
power during a non-convulsive seizure. All scale bars, 0.4mV by 3sec.
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FIGURE 24 – Late Post-Traumatic Seizures Could Be Distinguished from
Idiopathic Seizures by Frequency and Duration. Video-ECoG was performed on
male Sprague-Dawley rats 33 weeks after lateral fluid percussion TBI (“TBI Only”) or
sham (“Sham TBI”), or at the equivalent age in uninjured littermates (“Control”). A – C)
Representative ECoG and spectral profiles of non-convulsive seizures in an uninjured
control rat, a Sham TBI rat, and a TBI Only rat. D, E) Non-convulsive seizures were
significantly more frequent and longer lasting in TBI Only rats than in controls/shams.
F) TBI Only rats spent on average significantly more time in a non-convulsive seizure
than did controls/shams. Circles and bars on graphs denote individual means and
group means, respectively. Means compared by Kruskal-Wallis test with post hoc Mann
Whitney tests. Scale bars, 0.4mV by 2 seconds. *, p<0.05
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FIGURE 25 – Administering Tacrolimus Acutely after TBI Decreased the
Frequency of Late Non-Convulsive Seizures. Rats were administered a calcineurin
inhibitor, Tacrolimus (5mg/kg; i.p.; “TBI+TAC”) or no injection (“TBI Only”) 1 hour after
lateral fluid percussion TBI, and then monitored by video-ECoG approximately 33
weeks later. A) A typical non-convulsive seizure in a TBI+TAC rat and its spectral
profile. B) TBI+TAC rats exhibited significantly fewer non-convulsive seizures per hour
than did TBI Only rats. C) The average duration of non-convulsive seizures did not
differ significantly between TBI+TAC and TBI Only rats. D) TBI+TAC rats averaged
significantly less time per hour in a non-convulsive seizure than did TBI Only rats.
Circles and bars on graphs denote individual means and group means, respectively.
Means compared by Kruskal-Wallis test with post hoc Mann Whitney tests. All scale
bars, 0.4mV by 2 seconds. * p<0.05
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FIGURE 26 – TBI Increased the Clustering of Non-Convulsive Seizures. Adult,
male Sprague-Dawley rats were administered lateral fluid percussion TBI followed by
Tacrolimus (“TBI+TAC”) or no injection (“TBI Only”), and then were monitored for
spontaneous seizure activity months later, along with age-matched uninjured
(“Controls”) and Sham TBI rats. A) Raster plot with hashes (|) marking the onset times
of spontaneous non-convulsive seizures during typical 10 hour video-ECoG recordings
of Sham TBI, TBI Only, and TBI+TAC rats. B) Seizure frequency did not differ
significantly between light and dark phases (paired Student’s t tests). C) Binned
analysis revealed that a majority of non-convulsive seizures occurred within seconds of
one another in TBI Only rats and TBI+TAC rats, but not in controls/shams.
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FIGURE 27 – Ethosuximide and fos-Phenytoin Differentially Affected the
Frequency of Non-Convulsive Seizures. Non-convulsive seizures were
pharmacologically characterized by administering conventional anti-seizure medications
to epileptic rats during video-ECoG recording. Rats exhibiting a high frequency of nonconvulsive seizures (≥5/hr; n=6) were administered a single dose of ethosuximide
(“ETX,” 50mg/kg, i.p), whereas rats exhibiting a moderate seizure frequency (≈2/hr;
n=4) were administered fos-phenytoin (“fPHT,” 40mg phenytoin equivalents/kg, i.p.). A)
ETX treatment was associated with a significant decrease in the frequency of nonconvulsive seizures. B) fPHT treatment appeared to increase the frequency of nonconvulsive seizures, but not to a statistically significant extent. C) Changes in seizure
frequency after ETX or fPHT treatment likely represent drug effects, since seizure
frequency did not fluctuate significantly in previously-recorded, drug-free recordings of
the same rats (rats later administered ETX, orange; rats later administered fPHT, blue).
D) Temporal profile showing changes in seizure frequency which began soon after drug
administration (vertical dotted line) and which were not observed when no drug was
administered. ETX data compared by Wilcoxon matched-pairs signed rank test. fPHT
data compared by paired Student’s t-tests. All data presented as mean ± standard error
of the mean (S.E.M.). * p<0.05
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FIGURE 28 – TBI Caused Thalamic Calcifications and Cortical Atrophy. Rats were
sacrificed and processed for thionine histology after completion of video-ECoG,
approximately 42 ± 9 weeks after lateral fluid percussion TBI, or at an equivalent age in
uninjured controls. A) Illustration indicating where sections were collected relative to
the site of fluid percussion impact (FPI). B) Low-magnification (0.5x) light micrographs
of representative, thionine-stained sections from -3.8mm Bregma, and the
corresponding traces of neocortex and hippocampus which were used for measuring
area (in black). Inset indicates a thalamic calcification; a smaller calcification can also
be seen in the TBI+TAC image. C) Thalamic calcification from (B, inset) shown at 5x
and 10x magnification, and a graph of the percentage of rats having at least 1 thalamic
calcification. D) TBI Only and TBI+TAC rats showed significant but comparable
decreases in RatioCx when assessed at each Bregma level (D1) and when averaged
across Bregma levels (D2). E) TBI Only and TBI+TAC rats showed significant but
comparable decreases in RatioCx when assessed at the rostral Bregma levels (E 1) and
when averaged from Bregma -3.2mm to -5.6mm (E2). The decrease in RatioHp in the
rostral sections (Bregma -2.0mm and -2.6mm) appeared to be due to shrinkage of the
hippocampus along the rostro-caudal axis; the affected sections were therefore
excluded from the mean RatioHp. Means compared by Kruskal-Wallis test with post
hoc Mann Whitney tests. Scale bar, 0.5mm. *p<0.05 vs. control, **p<0.01 vs. control,
***p<0.001 vs. control
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FIGURE 29 – No Seizures Were Observed at 5 Weeks Post-TBI. Adult, male
Sprague-Dawley rats were subjected to lateral fluid percussion TBI, followed 1 hour
later by administration of Tacrolimus (5mg/kg; i.p.; “TBI+TAC”; n=4) or no injection (“TBI
Only”; n=5), and then were video-ECoG monitored at 5 weeks post-TBI along with
uninjured littermates (“Control;” n=4). A) Timeline of Experiment 2. B) Examples of
paroxysmal electrographic discharges lasting <5 seconds from two different TBI Only
rats. Similar phenomena were observed occasionally (<1/hr) in all TBI rats and were
interpreted as epileptiform discharges. C) An example of the epileptiform activity
exhibited by one control rat. All scale bars, 0.4mV by 3 seconds.
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DISCUSSION

The present study characterized the biochemical, histological, and electrographic
consequences of lateral traumatic brain injury (TBI) in a rat model. Chapter I
demonstrated an acute post-TBI loss of dendritic spines from principal cells of the
ipsilateral neocortex and bilateral dentate gyrus. Administering the calcineurin inhibitor,
Tacrolimus (FK506), 1 hour after TBI prevented this spine loss. Chapter II then
characterized the role of calcineurin in TBI-induced spine loss. Western blots revealed
evidence of an acute post-TBI increase in the cortical activity of cofilin, an actindepolymerizing protein which had been previously implicated in dendritic spine loss
[23,211,241]. Administering Tacrolimus 1 hour after TBI prevented the apparent
activation of cofilin in the neocortex. In addition, enzymatic assays showed an acute
post-TBI increase in calcineurin activity in the hippocampus. Chapter III then assessed
the long-term consequences of an acute post-TBI increase in calcineurin activity.
Specifically, rats were administered a calcineurin inhibitor, Tacrolimus (FK506), at 1
hour post-TBI and then monitored for spontaneous seizure activity months later. This
acute treatment with Tacrolimus reduced the frequency of late non-convulsive seizures
months later. The results presented in these chapters together demonstrate that a
calcineurin inhibitor, Tacrolimus, can mitigate two significant consequences of lateral
TBI, an acute loss of dendritic spines and the delayed development of non-convulsive
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seizures. However, It remains unclear whether the spine loss and seizure development
are related phenomena. The spine loss and seizure development may be two
independent outcomes of a Tacrolimus-sensitive event. Alternatively, spine loss may
be an early but critical event in epileptogenesis, as has been hypothesized previously
[78]. The remainder of this discussion considers the evidence for a causal relationship
between spine loss and epileptogenesis.
Could the spine loss observed in Chapter I somehow give rise to the late
spontaneous seizures seen in Chapter III? Evidence for this possibility comes from a
different model of epileptogenesis, the “cortical undercut” model. In one version of this
model, adult rat neocortex is partially but chronically isolated through mechanical
lesions of the cortical white matter [302]. After an electrographically silent period of
days to weeks, the undercut cortex begins to show recurrent epileptiform activity
[280,303]. Studies of this model have identified potential mechanisms of
epileptogenesis. One mechanism may be the formation of new excitatory circuits, as
epileptogenesis coincides with axonal sprouting and an increase in connectivity among
layer V neurons [304,305]. Furthermore, blocking synaptic activity acutely after cortical
undercut can prevent both the axonal sprouting and the development of epileptiform
activity [306,307,308]. These studies collectively suggest that an up-regulation of
excitatory synapses in the undercut neocortex may give rise to epilepsy.
How could the undercut injury lead to an up-regulation of excitatory synapses?
One possibility is that the deafferentation triggers a compensatory increase in the
strength or number of excitatory synapses [283]. For example, de novo intracortical
connections may develop to replace the severed, extracortical ones [305]. However,
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replacing extracortical connections with intracortical ones could dramatically alter
network dynamics, potentially resulting in hyper-excitable or hyper-synchronous circuits
[283]. Deafferentation could also cause hyper-excitability in the absence of
synaptogenesis, by triggering a homeostatic increase in the sensitivity of surviving
connections [309]. Regardless of the underlying mechanism, these studies show that
deafferentation can trigger an up-regulation of excitatory synapses, potentially resulting
in epilepsy.
The changes in spine density we observed after lateral TBI may reflect synaptic
re-wiring like that observed in the cortical undercut model [305]. In the cortical undercut
model, injury causes a deafferentation of neocortical pyramidal cells and a consequent
up-regulation of excitatory synapses. In the lateral TBI model, we observed an acute
loss and subsequent regrowth of dendritic spines, which could equate to deafferentation
and re-afferentation, respectively. Though spine regrowth may signify circuit restoration
rather than alteration, we also observed an abnormal increase in spine density in the
hippocampus 1 week post-TBI, which suggests de novo synaptogenesis. Lateral TBI
and cortical undercut therefore may both induce epilepsy through a common
mechanism: a compensatory but maladaptive elaboration of excitatory synapses. It is
important to note that, in the present study, spine loss and regrowth were observed on
layer II/III pyramidal neurons, whereas the cortical undercut studies focused on layer V
pyramidals [302,304,305]. Still, deafferentation has been shown to cause an increase
in dendritic spine density on layer II/III pyramidals [310], which suggests that
connectivity in layer II/III is also subject to homeostatic regulation. A loss of dendritic
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spines in layer II/III could therefore trigger compensatory changes in neuronal networks,
and so facilitate epileptogenesis in our TBI model.
While our data raise the possibility that spine loss is involved in post-traumatic
epileptogenesis, many related questions remain unanswered. For example, do the
changes in dendritic spine density we observed after TBI truly represent changes in
synaptic circuitry? This question could be answered with combination of anatomical
and physiological techniques. Anatomical techniques, such as array tomography and
electron microscopy, could be used to correlate spine density with synapse density after
TBI. If these methods detect a change in synapse density, the functional consequences
could then be assessed by electrophysiology and/or functional imaging. For example,
synaptic activity could be measured within fluorescently-labeled neurons showing an
increase in spine density. These experiments would reveal whether the spine
overgrowth at 1 week post-TBI represents an excess of excitatory synapses. Also,
paired intracellular recordings or functional imaging could be used to test whether local
connectivity is enhanced after TBI as it is after cortical undercut [305]. An increase in
synaptic activity or local connectivity would confirm that TBI alters synaptic circuits,
consistent with the changes in dendritic spine density described in Chapter I.
Another important question concerns whether synaptic re-wiring is necessary for
post-traumatic epilepsy. Studies of the cortical undercut model suggest that newlyformed excitatory circuits give rise to epileptiform activity [311]. Do similar circuits form
after lateral fluid percussion TBI? If so, are these circuits responsible for the late
spontaneous seizures described in Chapter III? Excitatory synaptogenesis has been
observed after lateral TBI [209], which could explain the regrowth (and overgrowth) of
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dendritic spines shown in Chapter I. However, it is unclear whether this synaptogenesis
is adaptive or maladaptive (i.e., epileptogenic). To test whether synaptogenesis is
epileptogenic, rats could be treated after TBI with an inhibitor of synaptogenesis and
then monitored for spontaneous seizures months later. For example, the anti-epileptic
drug Gabapentin has been shown to inhibit excitatory synaptogenesis during
development [312] and may similarly interfere with reactive synaptogenesis in the adult
brain [311]. Interestingly, epileptogenesis in the cortical undercut model is delayed
when rats are treated with Gabapentin after the undercut [311]. Another drug, the
experimental Rac1 inhibitor NSC23766, may also block excitatory synaptogenesis in the
adult brain, as it has been shown to prevent spine overgrowth a mouse model of spinal
cord injury [313].
In conclusion, the present study reveals a role for the calcium-sensitive
phosphatase, calcineurin, in TBI pathology. Administering a calcineurin inhibitor to rats
at 1 hour post-TBI prevented the subsequent loss of dendritic spines from principal
cortical cells, likely through downstream inhibition of the actin-depolymerizing protein,
cofilin. The same drug treatment also prevented a TBI-induced increase in nonconvulsive seizures. These findings further our understanding of the mechanisms by
which TBI can alter neural circuitry, and emphasize the potential for calcineurin as a
therapeutic target in the treatment of TBI.
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